faculty_name,faculty_email,publication_type,title,journal,year,doi,url,file_created
Mark Crowther,josips1@mcmaster.ca,journal_articles,Assessing the accuracy of ChatGPT responses to guideline-based inquiries: A cross-sectional study,Canadian Journal of General Internal Medicine,2025,10.3138/cjgim.2024.0017,https://experts.mcmaster.ca/display/publication3598207,2025-07-27T15:03:35.870300
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy and safety of direct oral anticoagulants compared with warfarin in antiphospholipid syndrome. Results of a multicenter retrospective cohort study.,Research and Practice in Thrombosis and Haemostasis,2025,10.1016/j.rpth.2025.102856,https://experts.mcmaster.ca/display/publication3581542,2025-07-27T15:03:35.870311
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predictors of Anemia Recovery in Patients with Pre-existing Anemia Undergoing Metabolic Bariatric Surgery: A Retrospective Cohort Study.,Obesity Surgery,2025,10.1007/s11695-025-07826-4,https://experts.mcmaster.ca/display/publication3567028,2025-07-27T15:03:35.870314
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluation of the MRX PT DOAC assay for detection of clinically relevant factor Xa inhibitor drug levels.,Journal of Thrombosis and Haemostasis,2025,10.1016/j.jtha.2024.12.005,https://experts.mcmaster.ca/display/publication3502363,2025-07-27T15:03:35.870316
Mark Crowther,josips1@mcmaster.ca,journal_articles,Multidisciplinary Expert Guidance for the Management of Severe Bleeding on Oral Anticoagulation: An Algorithm for Practicing Clinicians.,Thrombosis and Haemostasis,2024,10.1055/a-2464-2887,https://experts.mcmaster.ca/display/publication3488416,2025-07-27T15:03:35.870317
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Development of the 2023ACR/EULARAntiphospholipid Syndrome Classification Criteria, PhaseIII‐D Report: Multi Criteria Decision Analysis",Arthritis Care and Research,2024,10.1002/acr.25415,https://experts.mcmaster.ca/display/publication3459123,2025-07-27T15:03:35.870319
Mark Crowther,josips1@mcmaster.ca,journal_articles,An Evaluation of Andexanet Alfa v. Standard of Care for Reversal of Doac-Induced Intracranial Hemorrhage-a Systematic Review and Meta-Analysis,Blood,2024,10.1182/blood-2024-202191,https://experts.mcmaster.ca/display/publication3505165,2025-07-27T15:03:35.870320
Mark Crowther,josips1@mcmaster.ca,journal_articles,Changing the Serum Ferritin Lower Limit of Normal to a Clinical Decision Limit: An Acceptability Survey,Blood,2024,10.1182/blood-2024-206197,https://experts.mcmaster.ca/display/publication3505164,2025-07-27T15:03:35.870322
Mark Crowther,josips1@mcmaster.ca,journal_articles,Diagnostic Accuracy of Erythropoietin and Jakpot in Predicting JAK2-Postiive Erythrocytosis: A Retrospective Cohort Study,Blood,2024,10.1182/blood-2024-206260,https://experts.mcmaster.ca/display/publication3505163,2025-07-27T15:03:35.870323
Mark Crowther,josips1@mcmaster.ca,journal_articles,Genetic or Epigenetic CR1 Deficiency Defines Catastrophic Antiphospholipid Syndrome (CAPS) and Response to Complement Inhibition,Blood,2024,10.1182/blood-2024-207793,https://experts.mcmaster.ca/display/publication3505162,2025-07-27T15:03:35.870325
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety and efficacy of direct oral anticoagulants in chronic kidney disease: a meta-analysis.,Research and Practice in Thrombosis and Haemostasis,2024,10.1016/j.rpth.2024.102584,https://experts.mcmaster.ca/display/publication3485987,2025-07-27T15:03:35.870326
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy of Vitamin C with Fe Supplementation in Iron Deficiency Anemia Patients: A Systematic Review and Meta-Analysis,"Blood: Vessels, Thrombosis & Hemostasis",2024,10.1016/j.bvth.2024.100023,https://experts.mcmaster.ca/display/publication3460410,2025-07-27T15:03:35.870328
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fostamatinib for immune thrombocytopenic purpura in adult patients: A systematic review and meta‐analysis,eJHaem,2024,10.1002/jha2.939,https://experts.mcmaster.ca/display/publication3446634,2025-07-27T15:03:35.870329
Mark Crowther,josips1@mcmaster.ca,journal_articles,Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage,New England Journal of Medicine,2024,10.1056/nejmoa2313040,https://experts.mcmaster.ca/display/publication3431412,2025-07-27T15:03:35.870330
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low recurrent thrombosis rates in single positive antiphospholipid syndrome regardless of type of anticoagulation,Thrombosis Research,2024,10.1016/j.thromres.2024.03.013,https://experts.mcmaster.ca/display/publication3410416,2025-07-27T15:03:35.870332
Mark Crowther,josips1@mcmaster.ca,journal_articles,Total intracranial hemorrhage volume measurement summating all compartments best in traumatic and nontraumatic intracranial bleeding,Brain and Behavior,2024,10.1002/brb3.3481,https://experts.mcmaster.ca/display/publication3427102,2025-07-27T15:03:35.870333
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Subanalysis,Circulation,2024,10.1161/circulationaha.123.066933,https://experts.mcmaster.ca/display/publication3416757,2025-07-27T15:03:35.870334
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulation for mechanical aortic valves: An international survey of current practice patterns and perceptions,Thrombosis Update,2024,10.1016/j.tru.2024.100164,https://experts.mcmaster.ca/display/publication3405198,2025-07-27T15:03:35.870336
Mark Crowther,josips1@mcmaster.ca,journal_articles,A303 SAFETY AND EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH LIVER CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS,Journal of the Canadian Association of Gastroenterology,2024,10.1093/jcag/gwad061.303,https://experts.mcmaster.ca/display/publication3447898,2025-07-27T15:03:35.870337
Mark Crowther,josips1@mcmaster.ca,journal_articles,Primary prevention of venous thromboembolism for cancer patients in randomized controlled trials: a bibliographical analysis of funding and trial characteristics,Research and Practice in Thrombosis and Haemostasis,2024,10.1016/j.rpth.2024.102315,https://experts.mcmaster.ca/display/publication3395280,2025-07-27T15:03:35.870338
Mark Crowther,josips1@mcmaster.ca,journal_articles,Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care,Journal of the American Medical Association (JAMA),2023,10.1001/jama.2023.20820,https://experts.mcmaster.ca/display/publication3299220,2025-07-27T15:03:35.870340
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy of Vitamin C with Iron Supplementation in Iron Deficiency Anemia Patients: A Systematic Review and Meta-Analysis,Blood,2023,10.1182/blood-2023-174801,https://experts.mcmaster.ca/display/publication3397468,2025-07-27T15:03:35.870341
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluating Hemoglobin Thresholds on the Basis of Sex: Preliminary Insights from a Systematic Review,Blood,2023,10.1182/blood-2023-190173,https://experts.mcmaster.ca/display/publication3397469,2025-07-27T15:03:35.870342
Mark Crowther,josips1@mcmaster.ca,journal_articles,Leukostasis Twist in Mantle Cell Lymphoma: Systematic Review and Case Report,Blood,2023,10.1182/blood-2023-173527,https://experts.mcmaster.ca/display/publication3397465,2025-07-27T15:03:35.870344
Mark Crowther,josips1@mcmaster.ca,journal_articles,Risk of Anemia and Vitamin B12 Deficiency in Patients with Type 2 Diabetes Mellitus on Metformin Therapy: A Systematic Review and Meta-Analysis,Blood,2023,10.1182/blood-2023-180994,https://experts.mcmaster.ca/display/publication3397466,2025-07-27T15:03:35.870346
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety and Efficacy of Direct Oral Anticoagulants in Patients with Liver Cirrhosis: A Systematic Review and Meta-Analysis,Blood,2023,10.1182/blood-2023-184638,https://experts.mcmaster.ca/display/publication3397467,2025-07-27T15:03:35.870347
Mark Crowther,josips1@mcmaster.ca,journal_articles,RECURRENCE AFTER ANTICOAGULANT CESSATION IN UNPROVOKED VENOUS THROMBOEMBOLISM: IMPACT OF DEATH AS A COMPETING OUTCOME,Canadian Journal of Diabetes,2023,10.1016/j.jcjd.2023.10.392,https://experts.mcmaster.ca/display/publication3307549,2025-07-27T15:03:35.870349
Mark Crowther,josips1@mcmaster.ca,journal_articles,Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study,Thrombosis Research,2023,10.1016/j.thromres.2023.09.012,https://experts.mcmaster.ca/display/publication3299221,2025-07-27T15:03:35.870350
Mark Crowther,josips1@mcmaster.ca,journal_articles,2023 ACR/EULAR antiphospholipid syndrome classification criteria,Annals of the Rheumatic Diseases,2023,10.1136/ard-2023-224609,https://experts.mcmaster.ca/display/publication3285716,2025-07-27T15:03:35.870352
Mark Crowther,josips1@mcmaster.ca,journal_articles,A new approach to antiphospholipid antibody syndrome,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.102226,https://experts.mcmaster.ca/display/publication3320444,2025-07-27T15:03:35.870353
Mark Crowther,josips1@mcmaster.ca,journal_articles,OC 21.2 Safety of DOACs in Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100661,https://experts.mcmaster.ca/display/publication3397472,2025-07-27T15:03:35.870354
Mark Crowther,josips1@mcmaster.ca,journal_articles,OC 54.3 Direct Oral Anticoagulants vs Low Molecular Weight Heparin in the Management of Patients with Primary or Metastatic Brain Tumours: A Systematic Review and Meta-Analysis,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100594,https://experts.mcmaster.ca/display/publication3397473,2025-07-27T15:03:35.870356
Mark Crowther,josips1@mcmaster.ca,journal_articles,PB0485 Use of DOACs in the Management of Upper Extremity Deep Venous Thrombosis: A Systematic Review,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101900,https://experts.mcmaster.ca/display/publication3397470,2025-07-27T15:03:35.870357
Mark Crowther,josips1@mcmaster.ca,journal_articles,PB1478 Attributes of Randomized Controlled Trials and Their Associations with Funding Sources in Venous Thromboembolism Prophylaxis for Patients with Cancer: A Bibliographical Analysis,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.101863,https://experts.mcmaster.ca/display/publication3397471,2025-07-27T15:03:35.870359
Mark Crowther,josips1@mcmaster.ca,journal_articles,RECURRENCE AFTER ANTICOAGULANT CESSATION IN UNPROVOKED VENOUS THROMBOEMBOLISM: IMPACT OF DEATH AS A COMPETING OUTCOME,Canadian Journal of Cardiology,2023,10.1016/j.cjca.2023.06.407,https://experts.mcmaster.ca/display/publication3303311,2025-07-27T15:03:35.870361
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies",Journal of Thrombosis and Haemostasis,2023,10.1016/j.jtha.2023.06.020,https://experts.mcmaster.ca/display/publication3297277,2025-07-27T15:03:35.870362
Mark Crowther,josips1@mcmaster.ca,journal_articles,The 2023ACR/EULARAntiphospholipid Syndrome Classification Criteria,Arthritis & Rheumatology,2023,10.1002/art.42624,https://experts.mcmaster.ca/display/publication3285717,2025-07-27T15:03:35.870363
Mark Crowther,josips1@mcmaster.ca,journal_articles,Direct oral anticoagulants for the treatment of splanchnic vein thrombosis – A systematic review and meta-analysis,Thrombosis Research,2023,10.1016/j.thromres.2023.06.003,https://experts.mcmaster.ca/display/publication3259136,2025-07-27T15:03:35.870365
Mark Crowther,josips1@mcmaster.ca,journal_articles,Sex differences in thromboprophylaxis of the critically ill: a secondary analysis of a randomized trial,Canadian Journal of Anaesthesia,2023,10.1007/s12630-023-02457-8,https://experts.mcmaster.ca/display/publication3251347,2025-07-27T15:03:35.870366
Mark Crowther,josips1@mcmaster.ca,journal_articles,Neutropénie,CANADIAN MEDICAL ASSOCIATION JOURNAL,2023,10.1503/cmaj.220499-f,https://experts.mcmaster.ca/display/publication3127953,2025-07-27T15:03:35.870368
Mark Crowther,josips1@mcmaster.ca,journal_articles,Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors,Circulation,2023,10.1161/circulationaha.121.057844,https://experts.mcmaster.ca/display/publication3009996,2025-07-27T15:03:35.870369
Mark Crowther,josips1@mcmaster.ca,journal_articles,Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery,Journal of Thoracic and Cardiovascular Surgery,2023,10.1016/j.jtcvs.2022.05.041,https://experts.mcmaster.ca/display/publication2806578,2025-07-27T15:03:35.870371
Mark Crowther,josips1@mcmaster.ca,journal_articles,Convalescent plasma therapy for coronavirus disease 2019 in ambulatory versus hospitalized patients: Efficacy and risk of thromboembolism,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100068,https://experts.mcmaster.ca/display/publication3247318,2025-07-27T15:03:35.870372
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effectiveness and safety of direct oral anticoagulants in patients with venous thromboembolism and creatinine clearance < 30 mL/min,Journal of Thrombosis and Thrombolysis,2023,10.1007/s11239-022-02758-7,https://experts.mcmaster.ca/display/publication2717518,2025-07-27T15:03:35.870374
Mark Crowther,josips1@mcmaster.ca,journal_articles,Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing,Research and Practice in Thrombosis and Haemostasis,2023,10.1016/j.rpth.2023.100107,https://experts.mcmaster.ca/display/publication2981097,2025-07-27T15:03:35.870375
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin Is the Preferred Therapy for Patients With Thrombotic APS,Journal of the American College of Cardiology,2023,10.1016/j.jacc.2022.10.015,https://experts.mcmaster.ca/display/publication2499715,2025-07-27T15:03:35.870377
Mark Crowther,josips1@mcmaster.ca,journal_articles,Neutropenia,CANADIAN MEDICAL ASSOCIATION JOURNAL,2022,10.1503/cmaj.220499,https://experts.mcmaster.ca/display/publication2687778,2025-07-27T15:03:35.870378
Mark Crowther,josips1@mcmaster.ca,journal_articles,Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery,European Journal of Cardio-thoracic Surgery,2022,10.1093/ejcts/ezac488,https://experts.mcmaster.ca/display/publication2632348,2025-07-27T15:03:35.870379
Mark Crowther,josips1@mcmaster.ca,journal_articles,Restrictive versus liberal transfusion for anemic patients with acute myocardial infarction: Systematic review and meta-analysis,Health Sciences Review,2022,10.1016/j.hsr.2022.100059,https://experts.mcmaster.ca/display/publication2443403,2025-07-27T15:03:35.870380
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Historical Perspective on the Reversal of Anticoagulants,Seminars in Thrombosis and Hemostasis,2022,10.1055/s-0042-1753485,https://experts.mcmaster.ca/display/publication2429790,2025-07-27T15:03:35.870382
Mark Crowther,josips1@mcmaster.ca,journal_articles,Coagulation Conundrum,Canadian Journal of General Internal Medicine,2022,10.22374/cjgim.v17i4.641,https://experts.mcmaster.ca/display/publication2606236,2025-07-27T15:03:35.870752
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy and safety of pre-operative insertion of inferior vena cava filter in patients undergoing bariatric surgery: a systematic review,Journal of Thrombosis and Thrombolysis,2022,10.1007/s11239-022-02689-3,https://experts.mcmaster.ca/display/publication2424832,2025-07-27T15:03:35.870767
Mark Crowther,josips1@mcmaster.ca,journal_articles,Direct oral anticoagulants after bariatric surgery—What is the evidence?,Journal of Thrombosis and Haemostasis,2022,10.1111/jth.15823,https://experts.mcmaster.ca/display/publication2357280,2025-07-27T15:03:35.870770
Mark Crowther,josips1@mcmaster.ca,journal_articles,Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial,British Journal of Anaesthesia,2022,10.1016/j.bja.2022.05.012,https://experts.mcmaster.ca/display/publication2336293,2025-07-27T15:03:35.870774
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum,Journal of Thrombosis and Thrombolysis,2022,10.1007/s11239-022-02643-3,https://experts.mcmaster.ca/display/publication2232352,2025-07-27T15:03:35.870778
Mark Crowther,josips1@mcmaster.ca,journal_articles,Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review,European Journal of Haematology,2022,10.1111/ejh.13786,https://experts.mcmaster.ca/display/publication2190840,2025-07-27T15:03:35.870781
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low molecular weight heparin anti-Xa assays can identify patients with clinically important apixaban and rivaroxaban drug levels,Thrombosis Research,2022,10.1016/j.thromres.2022.05.005,https://experts.mcmaster.ca/display/publication2190839,2025-07-27T15:03:35.870785
Mark Crowther,josips1@mcmaster.ca,journal_articles,Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban,Thrombosis and Haemostasis,2022,10.1055/s-0041-1740180,https://experts.mcmaster.ca/display/publication2160254,2025-07-27T15:03:35.870788
Mark Crowther,josips1@mcmaster.ca,journal_articles,Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?,Thrombosis and Haemostasis,2022,10.1055/a-1745-2083,https://experts.mcmaster.ca/display/publication2187655,2025-07-27T15:03:35.870792
Mark Crowther,josips1@mcmaster.ca,journal_articles,Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis,New England Journal of Medicine,2022,10.1056/nejmc2202778,https://experts.mcmaster.ca/display/publication2189153,2025-07-27T15:03:35.870795
Mark Crowther,josips1@mcmaster.ca,journal_articles,Canadian Conference on Medical Education 2022 abstracts,Canadian Medical Education Journal,2022,10.36834/cmej.75002,https://experts.mcmaster.ca/display/publication2189236,2025-07-27T15:03:35.870798
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review,Thrombosis Research,2022,10.1016/j.thromres.2022.02.019,https://experts.mcmaster.ca/display/publication2184292,2025-07-27T15:03:35.870801
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prise en charge d’une surdose intentionnelle d’héparine de bas poids moléculaire,CANADIAN MEDICAL ASSOCIATION JOURNAL,2022,10.1503/cmaj.211083-f,https://experts.mcmaster.ca/display/publication2185960,2025-07-27T15:03:35.870804
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy and safety of low intensity vitamin K antagonists in Western and East-Asian patients with left-sided mechanical heart valves,Journal of Thrombosis and Thrombolysis,2022,10.1007/s11239-021-02568-3,https://experts.mcmaster.ca/display/publication2132983,2025-07-27T15:03:35.870807
Mark Crowther,josips1@mcmaster.ca,journal_articles,Iron chelation therapy in patients with low‐ to intermediate‐risk myelodysplastic syndrome: A systematic review and meta‐analysis,British Journal of Haematology,2022,10.1111/bjh.17998,https://experts.mcmaster.ca/display/publication2155765,2025-07-27T15:03:35.870811
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prognostic Factors Associated With Development of Venous Thromboembolism in Critically Ill Patients—A Systematic Review and Meta-Analysis,Critical Care Medicine,2022,10.1097/ccm.0000000000005382,https://experts.mcmaster.ca/display/publication2135187,2025-07-27T15:03:35.870816
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prophylactic fresh frozen plasma versus prothrombin complex concentrate for preprocedural management of the coagulopathy of liver disease: A systematic review,Research and Practice in Thrombosis and Haemostasis,2022,10.1002/rth2.12724,https://experts.mcmaster.ca/display/publication2232383,2025-07-27T15:03:35.870819
Mark Crowther,josips1@mcmaster.ca,journal_articles,Ketamine administration for acute painful sickle cell crisis: A randomized controlled trial,Academic Emergency Medicine,2022,10.1111/acem.14382,https://experts.mcmaster.ca/display/publication2128532,2025-07-27T15:03:35.870822
Mark Crowther,josips1@mcmaster.ca,journal_articles,VTE Prophylaxis in Critically Ill Adults,Chest,2022,10.1016/j.chest.2021.08.050,https://experts.mcmaster.ca/display/publication2135191,2025-07-27T15:03:35.870826
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of intentional overdose of low-molecular-weight heparin,CANADIAN MEDICAL ASSOCIATION JOURNAL,2022,10.1503/cmaj.211083,https://experts.mcmaster.ca/display/publication2166016,2025-07-27T15:03:35.870829
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment Algorithm in Cancer-Associated Thrombosis: Updated Canadian Expert Consensus,Current Oncology,2021,10.3390/curroncol28060453,https://experts.mcmaster.ca/display/publication2157314,2025-07-27T15:03:35.870833
Mark Crowther,josips1@mcmaster.ca,journal_articles,Equity and Game-Theory Strategies to Promote Gender Diversity and Inclusion in an Academic Health Science Centre,CJC OPEN,2021,10.1016/j.cjco.2021.09.008,https://experts.mcmaster.ca/display/publication2135190,2025-07-27T15:03:35.870836
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19",BMJ Evidence-Based Medicine,2021,10.1136/bmjebm-2020-111499,https://experts.mcmaster.ca/display/publication1934376,2025-07-27T15:03:35.870839
Mark Crowther,josips1@mcmaster.ca,journal_articles,Iron Chelation Therapy in Low- to Intermediate- Risk Myelodysplastic Syndrome Patients: A Systematic Review and Meta-Analysis,Blood,2021,10.1182/blood-2021-153674,https://experts.mcmaster.ca/display/publication2154106,2025-07-27T15:03:35.870843
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review,Blood,2021,10.1182/blood-2021-153374,https://experts.mcmaster.ca/display/publication2154107,2025-07-27T15:03:35.870846
Mark Crowther,josips1@mcmaster.ca,journal_articles,Challenging anticoagulation cases: A case of heparin-induced-thrombocytopenia in the first trimester of pregnancy,Thrombosis Research,2021,10.1016/j.thromres.2021.09.001,https://experts.mcmaster.ca/display/publication2131438,2025-07-27T15:03:35.870849
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluation of the sexual health in people living with hemophilia,Haemophilia,2021,10.1111/hae.14410,https://experts.mcmaster.ca/display/publication2129783,2025-07-27T15:03:35.870853
Mark Crowther,josips1@mcmaster.ca,journal_articles,A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations,Blood Advances,2021,10.1182/bloodadvances.2021005205,https://experts.mcmaster.ca/display/publication2135189,2025-07-27T15:03:35.870857
Mark Crowther,josips1@mcmaster.ca,journal_articles,Detection of right ventricular dysfunction in acute pulmonary embolism by computed tomography or echocardiography: A systematic review and meta‐analysis,Journal of Thrombosis and Haemostasis,2021,10.1111/jth.15453,https://experts.mcmaster.ca/display/publication2010272,2025-07-27T15:03:35.870861
Mark Crowther,josips1@mcmaster.ca,journal_articles,Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria,Arthritis Care and Research,2021,10.1002/acr.24520,https://experts.mcmaster.ca/display/publication1940316,2025-07-27T15:03:35.870864
Mark Crowther,josips1@mcmaster.ca,journal_articles,First Case of COVID-19 N501Y Variant of Concern Infection in a Patient with Chronic HIV Infection,Canadian Journal of General Internal Medicine,2021,10.22374/cjgim.v16i3.573,https://experts.mcmaster.ca/display/publication2717555,2025-07-27T15:03:35.870867
Mark Crowther,josips1@mcmaster.ca,journal_articles,Iron supplementation following bariatric surgery: A systematic review of current strategies,Obesity Reviews,2021,10.1111/obr.13268,https://experts.mcmaster.ca/display/publication1970140,2025-07-27T15:03:35.870870
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reduced‐dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta‐analysis—Response to Commentary,Journal of Thrombosis and Haemostasis,2021,10.1111/jth.15427,https://experts.mcmaster.ca/display/publication2125391,2025-07-27T15:03:35.870874
Mark Crowther,josips1@mcmaster.ca,journal_articles,Catastrophic antiphospholipid syndrome refractory to high-dose intravenous immunoglobulin responsive to therapeutic plasma exchange,Platelets,2021,10.1080/09537104.2020.1802414,https://experts.mcmaster.ca/display/publication1922711,2025-07-27T15:03:35.870877
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluating the quality of systematic reviews and meta-analyses published on direct oral anticoagulants in the past 5 years,BMJ Evidence-Based Medicine,2021,10.1136/bmjebm-2019-111326,https://experts.mcmaster.ca/display/publication1914336,2025-07-27T15:03:35.870880
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Restart of Anticoagulant Therapy and Risk of Thrombosis, Rebleeding, and Death after Factor Xa Inhibitor Reversal in Major Bleeding Patients",Thrombosis and Haemostasis,2021,10.1055/a-1400-6159,https://experts.mcmaster.ca/display/publication1960576,2025-07-27T15:03:35.870883
Mark Crowther,josips1@mcmaster.ca,journal_articles,Detection of Direct Oral Anticoagulants in Patient Urine Samples by Prototype and Commercial Test Strips for DOACs – A Systematic Review and Meta-analysis,TH Open,2021,10.1055/s-0041-1732437,https://experts.mcmaster.ca/display/publication2135188,2025-07-27T15:03:35.870887
Mark Crowther,josips1@mcmaster.ca,journal_articles,Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy,Stroke,2021,10.1161/strokeaha.120.030565,https://experts.mcmaster.ca/display/publication1968631,2025-07-27T15:03:35.870890
Mark Crowther,josips1@mcmaster.ca,journal_articles,Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study,Journal of Thrombosis and Haemostasis,2021,10.1111/jth.15303,https://experts.mcmaster.ca/display/publication1963285,2025-07-27T15:03:35.870894
Mark Crowther,josips1@mcmaster.ca,journal_articles,ANDEXANET ALFA FOR ACUTE BLEEDING DURING TREATMENT WITH ENOXAPARIN,Journal of the American College of Cardiology,2021,10.1016/s0735-1097(21)03212-5,https://experts.mcmaster.ca/display/publication2135194,2025-07-27T15:03:35.870897
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Canadian stroke best practice recommendations:Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020",International Journal of Stroke,2021,10.1177/1747493020968424,https://experts.mcmaster.ca/display/publication1937675,2025-07-27T15:03:35.870900
Mark Crowther,josips1@mcmaster.ca,journal_articles,Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update,Critical Care Medicine,2021,10.1097/ccm.0000000000004899,https://experts.mcmaster.ca/display/publication1958812,2025-07-27T15:03:35.870904
Mark Crowther,josips1@mcmaster.ca,journal_articles,Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin,Research and Practice in Thrombosis and Haemostasis,2021,10.1002/rth2.12474,https://experts.mcmaster.ca/display/publication1961367,2025-07-27T15:03:35.870907
Mark Crowther,josips1@mcmaster.ca,journal_articles,Semi-automatic measurement of intracranial hemorrhage growth on non-contrast CT,International Journal of Stroke,2021,10.1177/1747493019895704,https://experts.mcmaster.ca/display/publication1684798,2025-07-27T15:03:35.870912
Mark Crowther,josips1@mcmaster.ca,journal_articles,Weight-adjusted tinzaparin for venous thromboembolism prophylaxis in bariatric surgery patients weighing 160 kg or more,Thrombosis Research,2021,10.1016/j.thromres.2020.11.021,https://experts.mcmaster.ca/display/publication1939304,2025-07-27T15:03:35.870915
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importance,British Journal of Anaesthesia,2021,10.1016/j.bja.2020.06.051,https://experts.mcmaster.ca/display/publication1920303,2025-07-27T15:03:35.870919
Mark Crowther,josips1@mcmaster.ca,journal_articles,Double Blind Pilot Randomized Trial Comparing Extended Anticoagulation to Placebo Following Major Lung Resection for Cancer,Seminars in Thoracic and Cardiovascular Surgery,2021,10.1053/j.semtcvs.2021.02.032,https://experts.mcmaster.ca/display/publication1961727,2025-07-27T15:03:35.870922
Mark Crowther,josips1@mcmaster.ca,journal_articles,Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study,British Journal of Anaesthesia,2021,10.1016/j.bja.2020.02.028,https://experts.mcmaster.ca/display/publication1918999,2025-07-27T15:03:35.870925
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical management,Critical Reviews in Oncology/Hematology,2021,10.1016/j.critrevonc.2020.103125,https://experts.mcmaster.ca/display/publication1940203,2025-07-27T15:03:35.870929
Mark Crowther,josips1@mcmaster.ca,journal_articles,A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome,Pilot and Feasibility Studies,2020,10.1186/s40814-020-00594-1,https://experts.mcmaster.ca/display/publication1813058,2025-07-27T15:03:35.870936
Mark Crowther,josips1@mcmaster.ca,journal_articles,Correction to: A single-arm feasibility cohort study of rivaroxaban in antiphospholipid syndrome,Pilot and Feasibility Studies,2020,10.1186/s40814-020-00614-0,https://experts.mcmaster.ca/display/publication1914092,2025-07-27T15:03:35.870940
Mark Crowther,josips1@mcmaster.ca,journal_articles,Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide,BMC Medical Research Methodology,2020,10.1186/s12874-020-00964-6,https://experts.mcmaster.ca/display/publication1895932,2025-07-27T15:03:35.870943
Mark Crowther,josips1@mcmaster.ca,journal_articles,Frequency of venous thromboembolism in 6513 patients with COVID-19: a retrospective study,Blood Advances,2020,10.1182/bloodadvances.2020003083,https://experts.mcmaster.ca/display/publication1937415,2025-07-27T15:03:35.870946
Mark Crowther,josips1@mcmaster.ca,journal_articles,Detection of Right Ventricular Dysfunction in Acute Pulmonary Embolism By CT Scan: A Systematic Review and Meta-Analysis,Blood,2020,10.1182/blood-2020-138464,https://experts.mcmaster.ca/display/publication2171392,2025-07-27T15:03:35.870949
Mark Crowther,josips1@mcmaster.ca,journal_articles,Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study,Blood,2020,10.1182/blood-2020-141850,https://experts.mcmaster.ca/display/publication2135198,2025-07-27T15:03:35.870952
Mark Crowther,josips1@mcmaster.ca,journal_articles,Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts,Research and Practice in Thrombosis and Haemostasis,2020,10.1002/rth2.12422,https://experts.mcmaster.ca/display/publication1941244,2025-07-27T15:03:35.870955
Mark Crowther,josips1@mcmaster.ca,journal_articles,Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review,Thrombosis Research,2020,10.1016/j.thromres.2020.08.016,https://experts.mcmaster.ca/display/publication1923505,2025-07-27T15:03:35.870958
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis,The Lancet Haematology,2020,10.1016/s2352-3026(20)30293-3,https://experts.mcmaster.ca/display/publication1927366,2025-07-27T15:03:35.870961
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis,Journal of Vascular Surgery,2020,10.1016/j.jvs.2020.08.009,https://experts.mcmaster.ca/display/publication2135199,2025-07-27T15:03:35.870965
Mark Crowther,josips1@mcmaster.ca,journal_articles,Extended DOAC therapy in patients with VTE and potential risk of recurrence: A systematic review and meta‐analysis,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.14949,https://experts.mcmaster.ca/display/publication1914338,2025-07-27T15:03:35.870969
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis,European Journal of Vascular and Endovascular Surgery,2020,10.1016/j.ejvs.2020.05.016,https://experts.mcmaster.ca/display/publication1916894,2025-07-27T15:03:35.870972
Mark Crowther,josips1@mcmaster.ca,journal_articles,Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta‐analysis,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.14936,https://experts.mcmaster.ca/display/publication1914339,2025-07-27T15:03:35.870976
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.14935,https://experts.mcmaster.ca/display/publication1925838,2025-07-27T15:03:35.870979
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluating Trends in COVID-19 Research Activity in Early 2020: The Creation and Utilization of a Novel Open-Access Database,Cureus,2020,10.7759/cureus.9943,https://experts.mcmaster.ca/display/publication1927443,2025-07-27T15:03:35.870983
Mark Crowther,josips1@mcmaster.ca,journal_articles,Iron deficiency following bariatric surgery: a retrospective cohort study,Blood Advances,2020,10.1182/bloodadvances.2020001880,https://experts.mcmaster.ca/display/publication1921138,2025-07-27T15:03:35.870986
Mark Crowther,josips1@mcmaster.ca,journal_articles,Investigation and management of erythrocytosis,CANADIAN MEDICAL ASSOCIATION JOURNAL,2020,10.1503/cmaj.191587,https://experts.mcmaster.ca/display/publication1921057,2025-07-27T15:03:35.870990
Mark Crowther,josips1@mcmaster.ca,journal_articles,First case of osteosarcoma in a dinosaur: a multimodal diagnosis,The Lancet Oncology,2020,10.1016/s1470-2045(20)30171-6,https://experts.mcmaster.ca/display/publication1920565,2025-07-27T15:03:35.870993
Mark Crowther,josips1@mcmaster.ca,journal_articles,First case of osteosarcoma in a dinosaur: a multimodal diagnosis.,The Lancet Oncology,2020,10.1016/S1470-2045(20)30171-6,https://experts.mcmaster.ca/display/publication1922708,2025-07-27T15:03:35.870996
Mark Crowther,josips1@mcmaster.ca,journal_articles,The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive value,European Journal of Internal Medicine,2020,10.1016/j.ejim.2020.05.025,https://experts.mcmaster.ca/display/publication1915777,2025-07-27T15:03:35.870999
Mark Crowther,josips1@mcmaster.ca,journal_articles,A prospective cohort study comparing achieved anti-factor Xa peak levels in pregnant and non-pregnant patients receiving therapeutic-dose low-molecular-weight heparin,International Journal of Hematology,2020,10.1007/s12185-020-02873-2,https://experts.mcmaster.ca/display/publication1703493,2025-07-27T15:03:35.871003
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparing low-molecular-weight heparin dosing for treatment of venous thromboembolism in patients with obesity (RIETE registry),Blood Advances,2020,10.1182/bloodadvances.2019001373,https://experts.mcmaster.ca/display/publication1914337,2025-07-27T15:03:35.871006
Mark Crowther,josips1@mcmaster.ca,journal_articles,"GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy",Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2019.12.020,https://experts.mcmaster.ca/display/publication1692254,2025-07-27T15:03:35.871009
Mark Crowther,josips1@mcmaster.ca,journal_articles,"GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables",Journal of Clinical Epidemiology,2020,10.1016/j.jclinepi.2019.12.021,https://experts.mcmaster.ca/display/publication1692253,2025-07-27T15:03:35.871012
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombotic microangiopathy in the course of catastrophic antiphospholipid syndrome successfully treated with eculizumab: case report and systematic review of the literature,Lupus,2020,10.1177/0961203320917460,https://experts.mcmaster.ca/display/publication1703120,2025-07-27T15:03:35.871015
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10,Journal of Thrombosis and Haemostasis,2020,10.1111/jth.14772,https://experts.mcmaster.ca/display/publication1695146,2025-07-27T15:03:35.871018
Mark Crowther,josips1@mcmaster.ca,journal_articles,Lower versus Standard INR Targets in Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,Thrombosis and Haemostasis,2020,10.1055/s-0039-3401823,https://experts.mcmaster.ca/display/publication1687825,2025-07-27T15:03:35.871022
Mark Crowther,josips1@mcmaster.ca,journal_articles,A phase 2 PK/PD study of andexanet alfa for reversal of rivaroxaban and edoxaban anticoagulation in healthy volunteers,Blood Advances,2020,10.1182/bloodadvances.2019000885,https://experts.mcmaster.ca/display/publication1695147,2025-07-27T15:03:35.871025
Mark Crowther,josips1@mcmaster.ca,journal_articles,A practical approach to evaluating postoperative thrombocytopenia,Blood Advances,2020,10.1182/bloodadvances.2019001414,https://experts.mcmaster.ca/display/publication1695148,2025-07-27T15:03:35.871028
Mark Crowther,josips1@mcmaster.ca,journal_articles,Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS,Blood,2020,10.1182/blood.2019003863,https://experts.mcmaster.ca/display/publication1683227,2025-07-27T15:03:35.871031
Mark Crowther,josips1@mcmaster.ca,journal_articles,Accuracy of a Rapid Diagnostic Test for the Presence of Direct Oral Factor Xa or Thrombin Inhibitors in Urine—A Multicenter Trial,Thrombosis and Haemostasis,2020,10.1055/s-0039-1700545,https://experts.mcmaster.ca/display/publication1676683,2025-07-27T15:03:35.871035
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effects of ibrutinib on in vitro platelet aggregation in blood samples from healthy donors and donors with platelet dysfunction,Hematology,2020,10.1080/16078454.2020.1730080,https://experts.mcmaster.ca/display/publication1701700,2025-07-27T15:03:35.871039
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial",The Lancet Haematology,2020,10.1016/s2352-3026(19)30219-4,https://experts.mcmaster.ca/display/publication1676682,2025-07-27T15:03:35.871045
Mark Crowther,josips1@mcmaster.ca,journal_articles,Extended vs. standard-duration thromboprophylaxis in acutely ill medical patients: A systematic review and meta-analysis,Thrombosis Research,2019,10.1016/j.thromres.2019.10.027,https://experts.mcmaster.ca/display/publication1676680,2025-07-27T15:03:35.871049
Mark Crowther,josips1@mcmaster.ca,journal_articles,Frequency of arterial thromboembolism in populations with malignancies: A systematic review,Thrombosis Research,2019,10.1016/j.thromres.2019.10.004,https://experts.mcmaster.ca/display/publication1676681,2025-07-27T15:03:35.871301
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effect of Fibrinogen Concentrate vs Cryoprecipitate on Blood Component Transfusion After Cardiac Surgery,Journal of the American Medical Association (JAMA),2019,10.1001/jama.2019.17312,https://experts.mcmaster.ca/display/publication1672727,2025-07-27T15:03:35.871305
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rare Germline Mutations in Complement Regulatory Genes Make the Antiphospholipid Syndrome Catastrophic,Blood,2019,10.1182/blood-2019-129115,https://experts.mcmaster.ca/display/publication1679472,2025-07-27T15:03:35.871307
Mark Crowther,josips1@mcmaster.ca,journal_articles,The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia,Journal of Thrombosis and Haemostasis,2019,10.1111/jth.14587,https://experts.mcmaster.ca/display/publication1657905,2025-07-27T15:03:35.871309
Mark Crowther,josips1@mcmaster.ca,journal_articles,Obtaining and managing data sets for individual participant data meta-analysis: scoping review and practical guide,,2019,10.21203/rs.2.16277/v1,https://experts.mcmaster.ca/display/publication2951105,2025-07-27T15:03:35.871310
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid Syndrome During Septic Shock: Hyper- or Hypocoagulability?: A Case Report,A and A Practice,2019,10.1213/xaa.0000000000001061,https://experts.mcmaster.ca/display/publication1653522,2025-07-27T15:03:35.871312
Mark Crowther,josips1@mcmaster.ca,journal_articles,288Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study,European Heart Journal,2019,10.1093/eurheartj/ehz747.0092,https://experts.mcmaster.ca/display/publication2135216,2025-07-27T15:03:35.871314
Mark Crowther,josips1@mcmaster.ca,journal_articles,Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis,Journal of the American Heart Association,2019,10.1161/jaha.119.012877,https://experts.mcmaster.ca/display/publication1669193,2025-07-27T15:03:35.871315
Mark Crowther,josips1@mcmaster.ca,journal_articles,North America anticoagulation forum guidance on reversal of direct oral anticoagulants,European Journal of Internal Medicine,2019,10.1016/j.ejim.2019.07.009,https://experts.mcmaster.ca/display/publication1657904,2025-07-27T15:03:35.871316
Mark Crowther,josips1@mcmaster.ca,journal_articles,The association between platelet dysfunction and adverse outcomes in cardiac surgical patients,Anaesthesia,2019,10.1111/anae.14631,https://experts.mcmaster.ca/display/publication1660053,2025-07-27T15:03:35.871318
Mark Crowther,josips1@mcmaster.ca,journal_articles,Case Report: Two Cases of Strongyloidiasis Presenting with Thrombotic Events,American Journal of Tropical Medicine and Hygiene,2019,10.4269/ajtmh.19-0347,https://experts.mcmaster.ca/display/publication1646686,2025-07-27T15:03:35.871319
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum,American Journal of Hematology,2019,10.1002/ajh.25475,https://experts.mcmaster.ca/display/publication1635767,2025-07-27T15:03:35.871321
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy,Journal of the American Medical Association (JAMA),2019,10.1001/jama.2019.5358,https://experts.mcmaster.ca/display/publication1641950,2025-07-27T15:03:35.871322
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Exploring regional variations in the cross‐cultural, international implementation of the Patient Reported Outcomes Burdens and Experience (PROBE) study",Haemophilia,2019,10.1111/hae.13703,https://experts.mcmaster.ca/display/publication1634148,2025-07-27T15:03:35.871334
Mark Crowther,josips1@mcmaster.ca,journal_articles,Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors,New England Journal of Medicine,2019,10.1056/nejmoa1814051,https://experts.mcmaster.ca/display/publication1627291,2025-07-27T15:03:35.871336
Mark Crowther,josips1@mcmaster.ca,journal_articles,Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: A systematic review and meta-analysis,Thrombosis Research,2019,10.1016/j.thromres.2019.01.020,https://experts.mcmaster.ca/display/publication1628420,2025-07-27T15:03:35.871338
Mark Crowther,josips1@mcmaster.ca,journal_articles,Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies,European Journal of Epidemiology (EJE),2019,10.1007/s10654-018-0415-7,https://experts.mcmaster.ca/display/publication1558219,2025-07-27T15:03:35.871340
Mark Crowther,josips1@mcmaster.ca,journal_articles,Extended Venous Thromboembolism Prophylaxis after Abdominopelvic Cancer Surgery: A Retrospective Review,Current Oncology,2019,10.3747/co.26.4339,https://experts.mcmaster.ca/display/publication1631349,2025-07-27T15:03:35.871342
Mark Crowther,josips1@mcmaster.ca,journal_articles,496: VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING,Critical Care Medicine,2019,10.1097/01.ccm.0000551248.82909.92,https://experts.mcmaster.ca/display/publication2135240,2025-07-27T15:03:35.871344
Mark Crowther,josips1@mcmaster.ca,journal_articles,59: ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY,Critical Care Medicine,2019,10.1097/01.ccm.0000550851.41971.23,https://experts.mcmaster.ca/display/publication2135241,2025-07-27T15:03:35.871367
Mark Crowther,josips1@mcmaster.ca,journal_articles,How can we reverse bleeding in patients on direct oral anticoagulants?,Kardiologia Polska,2019,10.5603/kp.a2018.0197,https://experts.mcmaster.ca/display/publication1624364,2025-07-27T15:03:35.871372
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Test‐retest properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire and its constituent domains",Haemophilia,2019,10.1111/hae.13649,https://experts.mcmaster.ca/display/publication1612046,2025-07-27T15:03:35.871374
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials,Anesthesiology,2018,10.1097/aln.0000000000002179,https://experts.mcmaster.ca/display/publication1513054,2025-07-27T15:03:35.871375
Mark Crowther,josips1@mcmaster.ca,journal_articles,Erratum to: Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study,Thrombosis and Haemostasis,2018,10.1055/s-0038-1675417,https://experts.mcmaster.ca/display/publication1607134,2025-07-27T15:03:35.871377
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study,Thrombosis Journal,2018,10.1186/s12959-018-0188-y,https://experts.mcmaster.ca/display/publication1618839,2025-07-27T15:03:35.871379
Mark Crowther,josips1@mcmaster.ca,journal_articles,American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy,Blood Advances,2018,10.1182/bloodadvances.2018024893,https://experts.mcmaster.ca/display/publication1610397,2025-07-27T15:03:35.871380
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia,Blood Advances,2018,10.1182/bloodadvances.2018023077,https://experts.mcmaster.ca/display/publication1609442,2025-07-27T15:03:35.871382
Mark Crowther,josips1@mcmaster.ca,journal_articles,Andexanet alfa for the treatment of hemorrhage,Expert Review of Hematology,2018,10.1080/17474086.2018.1532287,https://experts.mcmaster.ca/display/publication1599001,2025-07-27T15:03:35.871383
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of argatroban and fondaparinux for the management of patients with isolated heparin-induced thrombocytopenia,Annals of Hematology,2018,10.1007/s00277-018-3422-6,https://experts.mcmaster.ca/display/publication1567056,2025-07-27T15:03:35.871385
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment Algorithm in Cancer-Associated Thrombosis: Canadian Expert Consensus,Current Oncology,2018,10.3747/co.25.4266,https://experts.mcmaster.ca/display/publication1609441,2025-07-27T15:03:35.871386
Mark Crowther,josips1@mcmaster.ca,journal_articles,Weight‐adjusted tinzaparin for the prevention of venous thromboembolism after bariatric surgery,Journal of Thrombosis and Haemostasis,2018,10.1111/jth.14263,https://experts.mcmaster.ca/display/publication1584363,2025-07-27T15:03:35.871387
Mark Crowther,josips1@mcmaster.ca,journal_articles,Higher-risk APS: do we dare to DOAC?,Blood,2018,10.1182/blood-2018-08-867036,https://experts.mcmaster.ca/display/publication1599000,2025-07-27T15:03:35.871389
Mark Crowther,josips1@mcmaster.ca,journal_articles,Quantifying immature platelets as markers of increased platelet production after coronary artery bypass grafting surgery,European Journal of Haematology,2018,10.1111/ejh.13109,https://experts.mcmaster.ca/display/publication1547439,2025-07-27T15:03:35.871390
Mark Crowther,josips1@mcmaster.ca,journal_articles,Soluble CD200 in secretory phase endometriosis endometrial venules may explain endometriosis pathophysiology and provide a novel treatment target,Journal of Reproductive Immunology,2018,10.1016/j.jri.2018.05.006,https://experts.mcmaster.ca/display/publication1558218,2025-07-27T15:03:35.871392
Mark Crowther,josips1@mcmaster.ca,journal_articles,5069Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI),European Heart Journal,2018,10.1093/eurheartj/ehy566.5069,https://experts.mcmaster.ca/display/publication2135242,2025-07-27T15:03:35.871393
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Psychometric properties of the Patient Reported Outcomes, Burdens and Experiences (PROBE) questionnaire",BMJ Open,2018,10.1136/bmjopen-2018-021900,https://experts.mcmaster.ca/display/publication1584362,2025-07-27T15:03:35.871395
Mark Crowther,josips1@mcmaster.ca,journal_articles,Inferior Vena Cava Filter Placement With Catheter-Directed Lysis,JACC: Cardiovascular Interventions,2018,10.1016/j.jcin.2018.06.013,https://experts.mcmaster.ca/display/publication1575618,2025-07-27T15:03:35.871396
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis,Journal of Thrombosis and Haemostasis,2018,10.1111/jth.14156,https://experts.mcmaster.ca/display/publication1534629,2025-07-27T15:03:35.871398
Mark Crowther,josips1@mcmaster.ca,journal_articles,1109 - Resumption of Anticoagulant Therapy after Anticoagulantrelated Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis,Gastroenterology,2018,10.1016/s0016-5085(18)31124-7,https://experts.mcmaster.ca/display/publication2135243,2025-07-27T15:03:35.871400
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Highlights from the Tenth International Symposium of Thrombosis and Anticoagulation (ISTA X), September 22 and 23, 2017, Salvador, Bahia, Brazil",Journal of Thrombosis and Thrombolysis,2018,10.1007/s11239-018-1639-9,https://experts.mcmaster.ca/display/publication1520915,2025-07-27T15:03:35.871401
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prothrombin Complex Concentrate for Major Bleeding on Factor Xa Inhibitors: A Prospective Cohort Study,Thrombosis and Haemostasis,2018,10.1055/s-0038-1636541,https://experts.mcmaster.ca/display/publication1512696,2025-07-27T15:03:35.871403
Mark Crowther,josips1@mcmaster.ca,journal_articles,Sa1774 - Incidence of Venous Thromboembolic Complications in Controlled Trials of Inflammatory Bowel Disease,Gastroenterology,2018,10.1016/s0016-5085(18)31598-1,https://experts.mcmaster.ca/display/publication3546797,2025-07-27T15:03:35.871405
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial",BMJ Open,2018,10.1136/bmjopen-2017-020741,https://experts.mcmaster.ca/display/publication1516465,2025-07-27T15:03:35.871406
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism,American Journal of Medicine,2018,10.1016/j.amjmed.2017.11.042,https://experts.mcmaster.ca/display/publication1486915,2025-07-27T15:03:35.871408
Mark Crowther,josips1@mcmaster.ca,journal_articles,Resolving Concerns With the Newer Oral Anticoagulant Medications,Journal of the American College of Cardiology,2018,10.1016/j.jacc.2018.01.052,https://experts.mcmaster.ca/display/publication1506168,2025-07-27T15:03:35.871409
Mark Crowther,josips1@mcmaster.ca,journal_articles,Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty,New England Journal of Medicine,2018,10.1056/nejmoa1712746,https://experts.mcmaster.ca/display/publication1500352,2025-07-27T15:03:35.871411
Mark Crowther,josips1@mcmaster.ca,journal_articles,Severe coagulopathy after a massasauga rattlesnake bite,CANADIAN MEDICAL ASSOCIATION JOURNAL,2018,10.1503/cmaj.170783,https://experts.mcmaster.ca/display/publication1520914,2025-07-27T15:03:35.871412
Mark Crowther,josips1@mcmaster.ca,journal_articles,Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study,Thrombosis Research,2018,10.1016/j.thromres.2017.11.020,https://experts.mcmaster.ca/display/publication1520917,2025-07-27T15:03:35.871414
Mark Crowther,josips1@mcmaster.ca,journal_articles,The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding,American Journal of Hematology,2018,10.1002/ajh.24967,https://experts.mcmaster.ca/display/publication1474874,2025-07-27T15:03:35.871415
Mark Crowther,josips1@mcmaster.ca,journal_articles,P735 Incidence of venous thromboembolic complications in controlled trials of inflammatory bowel disease,Journal of Crohn's and Colitis,2018,10.1093/ecco-jcc/jjx180.862,https://experts.mcmaster.ca/display/publication3546798,2025-07-27T15:03:35.871417
Mark Crowther,josips1@mcmaster.ca,journal_articles,Assessment of the Measurement Error in Cyclosporine Levels Drawn Between Peripheral and Central Sources,American Journal of Clinical Pathology,2018,10.1093/ajcp/aqx145,https://experts.mcmaster.ca/display/publication1488168,2025-07-27T15:03:35.871418
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dual and triple antithrombotic therapies: current patterns of practice and controversies,Kardiologia Polska,2018,10.5603/kp.a2018.0112,https://experts.mcmaster.ca/display/publication1558220,2025-07-27T15:03:35.871420
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial,PLoS ONE,2018,10.1371/journal.pone.0198285,https://experts.mcmaster.ca/display/publication1543685,2025-07-27T15:03:35.871421
Mark Crowther,josips1@mcmaster.ca,journal_articles,McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome,Journal of Thrombosis and Haemostasis,2018,10.1111/jth.14192,https://experts.mcmaster.ca/display/publication1560548,2025-07-27T15:03:35.871422
Mark Crowther,josips1@mcmaster.ca,journal_articles,Designing a successful capacity-building program in a low-income country: the St. Joseph’s Health System–McMaster–Makerere International Outreach Program Collaboration for Uganda,Blood Advances,2017,10.1182/bloodadvances.2017gs100057,https://experts.mcmaster.ca/display/publication1686828,2025-07-27T15:03:35.871423
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Khorana Score for the Prediction of Venous Thromboembolism in Patients with Solid Cancer: An Individual Patient Data Meta-Analysis,Blood,2017,10.1182/blood.v130.suppl_1.627.627,https://experts.mcmaster.ca/display/publication2135195,2025-07-27T15:03:35.871425
Mark Crowther,josips1@mcmaster.ca,journal_articles,Autoantibodies against the cell surface–associated chaperone GRP78 stimulate tumor growth via tissue factor,Journal of Biological Chemistry,2017,10.1074/jbc.m117.799908,https://experts.mcmaster.ca/display/publication1473285,2025-07-27T15:03:35.871434
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis,Thrombosis Research,2017,10.1016/j.thromres.2017.11.001,https://experts.mcmaster.ca/display/publication1478566,2025-07-27T15:03:35.871436
Mark Crowther,josips1@mcmaster.ca,journal_articles,Extended venous thromboembolism prophylaxis comparing rivaroxaban to aspirin following total hip and knee arthroplasty,Revue de Chirurgie Orthopedique et Traumatologique,2017,10.1016/j.rcot.2017.09.235,https://experts.mcmaster.ca/display/publication2135245,2025-07-27T15:03:35.871437
Mark Crowther,josips1@mcmaster.ca,journal_articles,Red blood cell storage and in-hospital mortality: a secondary analysis of the INFORM randomised controlled trial,The Lancet Haematology,2017,10.1016/s2352-3026(17)30169-2,https://experts.mcmaster.ca/display/publication1468281,2025-07-27T15:03:35.871439
Mark Crowther,josips1@mcmaster.ca,journal_articles,Association between remote major venous thromboembolism risk factors and the risk of recurrence after a first unprovoked episode,Journal of Thrombosis and Haemostasis,2017,10.1111/jth.13796,https://experts.mcmaster.ca/display/publication1432870,2025-07-27T15:03:35.871440
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa",Blood Advances,2017,10.1182/bloodadvances.2017007112,https://experts.mcmaster.ca/display/publication1486962,2025-07-27T15:03:35.871442
Mark Crowther,josips1@mcmaster.ca,journal_articles,314 Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers by Andexanet Alfa,Neurosurgery,2017,10.1093/neuros/nyx417.314,https://experts.mcmaster.ca/display/publication2135244,2025-07-27T15:03:35.871444
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Bleeding impacting mortality after noncardiac surgery: a protocol to establish diagnostic criteria, estimate prognostic importance, and develop and validate a prediction guide in an international prospective cohort study",CMAJ open,2017,10.9778/cmajo.20160106,https://experts.mcmaster.ca/display/publication1458825,2025-07-27T15:03:35.871446
Mark Crowther,josips1@mcmaster.ca,journal_articles,Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis,Blood,2017,10.1111/jth.13701,https://experts.mcmaster.ca/display/publication172704,2025-07-27T15:03:35.871447
Mark Crowther,josips1@mcmaster.ca,journal_articles,The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia,Research and Practice in Thrombosis and Haemostasis,2017,10.1002/rth2.12004,https://experts.mcmaster.ca/display/publication1575619,2025-07-27T15:03:35.871449
Mark Crowther,josips1@mcmaster.ca,journal_articles,The direct oral anticoagulants: can we finally stop using rat poison?,Blood Advances,2017,10.1182/bloodadvances.2017002907,https://experts.mcmaster.ca/display/publication1520916,2025-07-27T15:03:35.871451
Mark Crowther,josips1@mcmaster.ca,journal_articles,Is low serum albumin level a significant predictor for the development of heparin-induced thrombocytopenia-thrombosis?,Annals of Hematology,2017,10.1007/s00277-017-2971-4,https://experts.mcmaster.ca/display/publication440201,2025-07-27T15:03:35.871452
Mark Crowther,josips1@mcmaster.ca,journal_articles,Specific antidotes for bleeding associated with direct oral anticoagulants,The BMJ,2017,10.1136/bmj.j2216,https://experts.mcmaster.ca/display/publication1015301,2025-07-27T15:03:35.871454
Mark Crowther,josips1@mcmaster.ca,journal_articles,Mortality outcomes in patients transfused with fresher versus older red blood cells: a meta‐analysis,Vox Sanguinis,2017,10.1111/vox.12495,https://experts.mcmaster.ca/display/publication440185,2025-07-27T15:03:35.871455
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reduced-Intensity Rivaroxaban for the Prevention of Recurrent Venous Thromboembolism,New England Journal of Medicine,2017,10.1056/nejme1701628,https://experts.mcmaster.ca/display/publication440211,2025-07-27T15:03:35.871456
Mark Crowther,josips1@mcmaster.ca,journal_articles,Clinical evaluation of a hemochromatosis next‐generation sequencing gene panel,European Journal of Haematology,2017,10.1111/ejh.12820,https://experts.mcmaster.ca/display/publication200868,2025-07-27T15:03:35.871458
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis,ClinicoEconomics and Outcomes Research,2017,10.2147/ceor.s126379,https://experts.mcmaster.ca/display/publication1520918,2025-07-27T15:03:35.871460
Mark Crowther,josips1@mcmaster.ca,journal_articles,Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants,Chest,2017,10.1016/j.chest.2016.08.1462,https://experts.mcmaster.ca/display/publication1520920,2025-07-27T15:03:35.871462
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature,Case Reports in Hematology,2017,10.1155/2017/9261351,https://experts.mcmaster.ca/display/publication1033714,2025-07-27T15:03:35.871463
Mark Crowther,josips1@mcmaster.ca,journal_articles,Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours,Thrombosis and Haemostasis,2017,10.1160/th16-09-0680,https://experts.mcmaster.ca/display/publication172722,2025-07-27T15:03:35.871465
Mark Crowther,josips1@mcmaster.ca,journal_articles,Practice patterns in venous thromboembolism (VTE) prophylaxis in thoracic surgery: a comprehensive Canadian Delphi survey,Journal of Thoracic Disease,2017,10.21037/jtd.2017.01.38,https://experts.mcmaster.ca/display/publication177514,2025-07-27T15:03:35.871467
Mark Crowther,josips1@mcmaster.ca,journal_articles,2015 in hematology and thromboembolism. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 1,Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3776,https://experts.mcmaster.ca/display/publication888686,2025-07-27T15:03:35.871468
Mark Crowther,josips1@mcmaster.ca,journal_articles,Andexanet Alfa for Factor Xa Inhibitor Reversal,New England Journal of Medicine,2016,10.1056/nejmc1613270,https://experts.mcmaster.ca/display/publication871188,2025-07-27T15:03:35.871470
Mark Crowther,josips1@mcmaster.ca,journal_articles,Milestones in VTE treatment. Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 2,Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3778,https://experts.mcmaster.ca/display/publication888684,2025-07-27T15:03:35.871472
Mark Crowther,josips1@mcmaster.ca,journal_articles,VTE treatment in 201 6 and future challenges Dr. Mark Crowther in an interview with Dr. Roman Jaeschke: part 3,Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3780,https://experts.mcmaster.ca/display/publication888682,2025-07-27T15:03:35.871473
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversal of direct oral anticoagulants: a practical approach,Hematology. American Society of Hematology. Education Program,2016,10.1182/asheducation-2016.1.612,https://experts.mcmaster.ca/display/publication925681,2025-07-27T15:03:35.871475
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombosis and anticoagulation in the setting of renal or liver disease,Hematology. American Society of Hematology. Education Program,2016,10.1182/asheducation-2016.1.188,https://experts.mcmaster.ca/display/publication1132028,2025-07-27T15:03:35.871476
Mark Crowther,josips1@mcmaster.ca,journal_articles,A systematic review of using and reporting survival analyses in acute lymphoblastic leukemia literature,BMC Blood Disorders,2016,10.1186/s12878-016-0055-7,https://experts.mcmaster.ca/display/publication172781,2025-07-27T15:03:35.871478
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effect of Short-Term vs. Long-Term Blood Storage on Mortality after Transfusion,New England Journal of Medicine,2016,10.1056/nejmoa1609014,https://experts.mcmaster.ca/display/publication179399,2025-07-27T15:03:35.871487
Mark Crowther,josips1@mcmaster.ca,journal_articles,Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH,Journal of Thrombosis and Haemostasis,2016,10.1111/jth.13481,https://experts.mcmaster.ca/display/publication1520919,2025-07-27T15:03:35.871490
Mark Crowther,josips1@mcmaster.ca,journal_articles,Point-of-Care Hemostatic Testing in Cardiac Surgery,Circulation,2016,10.1161/circulationaha.116.023956,https://experts.mcmaster.ca/display/publication1520921,2025-07-27T15:03:35.871492
Mark Crowther,josips1@mcmaster.ca,journal_articles,Measurement of Dabigatran Drug Levels to Manage Patients Taking Interacting Drugs: A Case Report,American Journal of Medicine,2016,10.1016/j.amjmed.2016.06.017,https://experts.mcmaster.ca/display/publication593626,2025-07-27T15:03:35.871494
Mark Crowther,josips1@mcmaster.ca,journal_articles,Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors,New England Journal of Medicine,2016,10.1056/nejmoa1607887,https://experts.mcmaster.ca/display/publication668653,2025-07-27T15:03:35.871495
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature,Seminars in Thrombosis and Hemostasis,2016,10.1055/s-0036-1581105,https://experts.mcmaster.ca/display/publication1520922,2025-07-27T15:03:35.871505
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal A systematic review and meta-analysis,Thrombosis and Haemostasis,2016,10.1160/th16-04-0266,https://experts.mcmaster.ca/display/publication172737,2025-07-27T15:03:35.871507
Mark Crowther,josips1@mcmaster.ca,journal_articles,The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis,Blood Coagulation and Fibrinolysis,2016,10.1097/mbc.0000000000000446,https://experts.mcmaster.ca/display/publication1520924,2025-07-27T15:03:35.871509
Mark Crowther,josips1@mcmaster.ca,journal_articles,176 Andexanet Alfa,Neurosurgery,2016,10.1227/01.neu.0000489745.07835.03,https://experts.mcmaster.ca/display/publication2135262,2025-07-27T15:03:35.871510
Mark Crowther,josips1@mcmaster.ca,journal_articles,Difficulties in establishing the diagnosis of immune thrombocytopenia: An agreement study,American Journal of Hematology,2016,10.1002/ajh.24404,https://experts.mcmaster.ca/display/publication440282,2025-07-27T15:03:35.871512
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials,European Journal of Epidemiology (EJE),2016,10.1007/s10654-016-0178-y,https://experts.mcmaster.ca/display/publication623726,2025-07-27T15:03:35.871513
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rivaroxaban for treatment of suspected or confirmed heparin‐induced thrombocytopenia study,Journal of Thrombosis and Haemostasis,2016,10.1111/jth.13330,https://experts.mcmaster.ca/display/publication440319,2025-07-27T15:03:35.871515
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?,Current Rheumatology Reports,2016,10.1007/s11926-016-0573-0,https://experts.mcmaster.ca/display/publication440284,2025-07-27T15:03:35.871517
Mark Crowther,josips1@mcmaster.ca,journal_articles,Erratum to: Guidance for the treatment of deep vein thrombosis and pulmonary embolism,Journal of Thrombosis and Thrombolysis,2016,10.1007/s11239-016-1345-4,https://experts.mcmaster.ca/display/publication864556,2025-07-27T15:03:35.871519
Mark Crowther,josips1@mcmaster.ca,journal_articles,Postdischarge venous thromboembolic complications following pulmonary oncologic resection: An underdetected problem,Journal of Thoracic and Cardiovascular Surgery,2016,10.1016/j.jtcvs.2015.11.038,https://experts.mcmaster.ca/display/publication177524,2025-07-27T15:03:35.871520
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation,CANADIAN MEDICAL ASSOCIATION JOURNAL,2016,10.1503/cmaj.150867,https://experts.mcmaster.ca/display/publication440305,2025-07-27T15:03:35.871522
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rapid quantitative D‐dimer to exclude pulmonary embolism: a prospective cohort management study,Journal of Thrombosis and Haemostasis,2016,10.1111/jth.13234,https://experts.mcmaster.ca/display/publication190279,2025-07-27T15:03:35.871524
Mark Crowther,josips1@mcmaster.ca,journal_articles,When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH,Journal of Thrombosis and Haemostasis,2016,10.1111/jth.13227,https://experts.mcmaster.ca/display/publication190268,2025-07-27T15:03:35.871525
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-Molecular-Weight Heparin Did Not Differ from Placebo in Preventing Clinically Important Deep Venous Thrombosis After Surgical Repair of Leg Fracture,Journal of Bone and Joint Surgery. American volume,2016,10.2106/jbjs.15.01442,https://experts.mcmaster.ca/display/publication440315,2025-07-27T15:03:35.871527
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Abstract 212: Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers",Stroke,2016,10.1161/str.47.suppl_1.212,https://experts.mcmaster.ca/display/publication2135192,2025-07-27T15:03:35.871528
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of Low Molecular Weight Heparins in Patients with Renal Failure; Time to Re-evaluate Our Preconceptions,Journal of General Internal Medicine,2016,10.1007/s11606-015-3525-x,https://experts.mcmaster.ca/display/publication668872,2025-07-27T15:03:35.871529
Mark Crowther,josips1@mcmaster.ca,journal_articles,Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With RecurrentClostridium difficileInfection,Journal of the American Medical Association (JAMA),2016,10.1001/jama.2015.18098,https://experts.mcmaster.ca/display/publication128052,2025-07-27T15:03:35.871531
Mark Crowther,josips1@mcmaster.ca,journal_articles,2015 in hematology and thromboembolism,Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3776,https://experts.mcmaster.ca/display/publication1376932,2025-07-27T15:03:35.871532
Mark Crowther,josips1@mcmaster.ca,journal_articles,Direct oral anticoagulants (DOACs) and pregnancy: A plea for better information,Thrombosis and Haemostasis,2016,10.1160/th16-08-0602,https://experts.mcmaster.ca/display/publication440293,2025-07-27T15:03:35.871534
Mark Crowther,josips1@mcmaster.ca,journal_articles,Guidance for the treatment of deep vein thrombosis and pulmonary embolism,Journal of Thrombosis and Thrombolysis,2016,10.1007/s11239-015-1317-0,https://experts.mcmaster.ca/display/publication864562,2025-07-27T15:03:35.871535
Mark Crowther,josips1@mcmaster.ca,journal_articles,Milestones in VTE treatment,Polskie Archiwum Medycyny Wewnetrznej,2016,10.20452/pamw.3778,https://experts.mcmaster.ca/display/publication1376936,2025-07-27T15:03:35.871537
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Modified Early Warning Score (MEWS) Identifies Critical Illness among Ward Patients in a Resource Restricted Setting in Kampala, Uganda: A Prospective Observational Study",PLoS ONE,2016,10.1371/journal.pone.0151408,https://experts.mcmaster.ca/display/publication189791,2025-07-27T15:03:35.871538
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rationale and Design of the Informing Fresh versus Old Red Cell Management (INFORM) Trial: An International Pragmatic Randomized Trial,Transfusion Medicine Reviews,2016,10.1016/j.tmrv.2015.11.002,https://experts.mcmaster.ca/display/publication440387,2025-07-27T15:03:35.871539
Mark Crowther,josips1@mcmaster.ca,journal_articles,The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin,Thrombosis and Haemostasis,2016,10.1160/th16-04-0320,https://experts.mcmaster.ca/display/publication440321,2025-07-27T15:03:35.871541
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol,BMJ Open,2016,10.1136/bmjopen-2015-010569,https://experts.mcmaster.ca/display/publication172785,2025-07-27T15:03:35.871542
Mark Crowther,josips1@mcmaster.ca,journal_articles,Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity,New England Journal of Medicine,2015,10.1056/nejmoa1510991,https://experts.mcmaster.ca/display/publication440348,2025-07-27T15:03:35.871544
Mark Crowther,josips1@mcmaster.ca,journal_articles,101,Critical Care Medicine,2015,10.1097/01.ccm.0000473929.68277.7b,https://experts.mcmaster.ca/display/publication2135272,2025-07-27T15:03:35.871545
Mark Crowther,josips1@mcmaster.ca,journal_articles,Challenges in Measuring Benefit of Clinical Research Training Programs—the ASH Clinical Research Training Institute Example,Journal of Cancer Education,2015,10.1007/s13187-014-0754-3,https://experts.mcmaster.ca/display/publication1520927,2025-07-27T15:03:35.871547
Mark Crowther,josips1@mcmaster.ca,journal_articles,Systematic review of anticoagulant treatment of catheter-related thrombosis,Thrombosis Research,2015,10.1016/j.thromres.2015.08.020,https://experts.mcmaster.ca/display/publication668798,2025-07-27T15:03:35.871548
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants",Thrombosis and Haemostasis,2015,10.1160/th14-12-1036,https://experts.mcmaster.ca/display/publication440363,2025-07-27T15:03:35.871549
Mark Crowther,josips1@mcmaster.ca,journal_articles,Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials,Journal of Thrombosis and Haemostasis,2015,10.1111/jth.13139,https://experts.mcmaster.ca/display/publication172803,2025-07-27T15:03:35.871551
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage",Thrombosis Research,2015,10.1016/j.thromres.2015.10.002,https://experts.mcmaster.ca/display/publication440361,2025-07-27T15:03:35.871553
Mark Crowther,josips1@mcmaster.ca,journal_articles,Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review,Journal of Thrombosis and Haemostasis,2015,10.1111/jth.13117,https://experts.mcmaster.ca/display/publication668937,2025-07-27T15:03:35.871554
Mark Crowther,josips1@mcmaster.ca,journal_articles,The impact of deep vein thrombosis in critically ill patients: a meta-analysis of major clinical outcomes.,Blood Transfusion,2015,10.2450/2015.0277-14,https://experts.mcmaster.ca/display/publication1520923,2025-07-27T15:03:35.871555
Mark Crowther,josips1@mcmaster.ca,journal_articles,Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients,Medicine (United States),2015,10.1097/md.0000000000001479,https://experts.mcmaster.ca/display/publication211482,2025-07-27T15:03:35.871557
Mark Crowther,josips1@mcmaster.ca,journal_articles,A 42-year-old man with elevated ferritin,CANADIAN MEDICAL ASSOCIATION JOURNAL,2015,10.1503/cmaj.140259,https://experts.mcmaster.ca/display/publication440375,2025-07-27T15:03:35.871558
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antidotes for Novel Oral Anticoagulants,"Arteriosclerosis, Thrombosis and Vascular Biology",2015,10.1161/atvbaha.114.303402,https://experts.mcmaster.ca/display/publication440350,2025-07-27T15:03:35.871559
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome,Blood,2015,10.1182/blood-2015-01-622787,https://experts.mcmaster.ca/display/publication440385,2025-07-27T15:03:35.871561
Mark Crowther,josips1@mcmaster.ca,journal_articles,"A Double-Blind, Randomized Controlled Trial of the Prevention of Clinically Important Venous Thromboembolism After Isolated Lower Leg Fractures",Journal of Orthopaedic Trauma,2015,10.1097/bot.0000000000000250,https://experts.mcmaster.ca/display/publication440367,2025-07-27T15:03:35.871563
Mark Crowther,josips1@mcmaster.ca,journal_articles,Aspirin in secondary prevention of recurrent venous thromboembolism,Journal of Thrombosis and Thrombolysis,2015,10.1007/s11239-015-1196-4,https://experts.mcmaster.ca/display/publication440379,2025-07-27T15:03:35.871564
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evaluation of the appropriateness of frozen plasma usage after introduction of prothrombin complex concentrates: a retrospective study,Vox Sanguinis,2015,10.1111/vox.12226,https://experts.mcmaster.ca/display/publication440371,2025-07-27T15:03:35.871565
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments,Annals of Hematology,2015,10.1007/s00277-015-2304-4,https://experts.mcmaster.ca/display/publication440352,2025-07-27T15:03:35.871567
Mark Crowther,josips1@mcmaster.ca,journal_articles,"ANNEXATM-R: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, DEMONSTRATING REVERSAL OF RIVAROXABAN-INDUCED ANTICOAGULATION IN OLDER SUBJECTS BY ANDEXANET ALFA (PRT064445), A UNIVERSAL ANTIDOTE FOR FACTOR XA (FXA) INHIBITORS",Journal of the American College of Cardiology,2015,10.1016/s0735-1097(15)60023-7,https://experts.mcmaster.ca/display/publication2135275,2025-07-27T15:03:35.871568
Mark Crowther,josips1@mcmaster.ca,journal_articles,Clinical Challenges in Patients with Cancer-Associated Thrombosis: Canadian Expert Consensus Recommendations,Current Oncology,2015,10.3747/co.22.2392,https://experts.mcmaster.ca/display/publication801722,2025-07-27T15:03:35.871569
Mark Crowther,josips1@mcmaster.ca,journal_articles,Failure of Anticoagulant Thromboprophylaxis,Critical Care Medicine,2015,10.1097/ccm.0000000000000713,https://experts.mcmaster.ca/display/publication211519,2025-07-27T15:03:35.871570
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis,The Lancet Haematology,2015,10.1016/s2352-3026(15)00003-4,https://experts.mcmaster.ca/display/publication440365,2025-07-27T15:03:35.871572
Mark Crowther,josips1@mcmaster.ca,journal_articles,Sub‐segmental pulmonary embolism in three academic teaching hospitals: a review of management and outcomes,Journal of Thrombosis and Haemostasis,2015,10.1111/jth.12803,https://experts.mcmaster.ca/display/publication1396028,2025-07-27T15:03:35.871573
Mark Crowther,josips1@mcmaster.ca,journal_articles,Venous Thromboembolism Prophylaxis in Critically Ill Patients,Seminars in Thrombosis and Hemostasis,2015,10.1055/s-0034-1398386,https://experts.mcmaster.ca/display/publication440369,2025-07-27T15:03:35.871574
Mark Crowther,josips1@mcmaster.ca,journal_articles,d-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulant Therapy,ACP journal club,2015,10.7326/m14-1275,https://experts.mcmaster.ca/display/publication180116,2025-07-27T15:03:35.871576
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Coronary Artery Calcification, Cardiovascular Events, and Death: A Prospective Cohort Study of Incident Patients on Hemodialysis",Canadian Journal of Kidney Health and Disease,2015,10.1186/s40697-015-0065-6,https://experts.mcmaster.ca/display/publication837924,2025-07-27T15:03:35.871577
Mark Crowther,josips1@mcmaster.ca,journal_articles,Examining the Clinical Use of Hemochromatosis Genetic Testing,Canadian Journal of Gastroenterology and Hepatology,2015,10.1155/2015/941406,https://experts.mcmaster.ca/display/publication200924,2025-07-27T15:03:35.871578
Mark Crowther,josips1@mcmaster.ca,journal_articles,Integrating Electronic Health Records in the Delivery of Optimized Anticoagulation Therapy,Annals of Pharmacotherapy,2015,10.1177/1060028014548570,https://experts.mcmaster.ca/display/publication1520928,2025-07-27T15:03:35.871580
Mark Crowther,josips1@mcmaster.ca,journal_articles,Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities,Blood,2015,10.1182/blood-2014-07-590844,https://experts.mcmaster.ca/display/publication440391,2025-07-27T15:03:35.871581
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding",Thrombosis and Haemostasis,2015,10.1160/th15-01-0063,https://experts.mcmaster.ca/display/publication988010,2025-07-27T15:03:35.871582
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Thromboembolic Events, Recurrent Gastrointestinal Bleeding and Mortality after Resuming Anticoagulant Following Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis",Blood,2014,10.1182/blood.v124.21.2799.2799,https://experts.mcmaster.ca/display/publication2135233,2025-07-27T15:03:35.871583
Mark Crowther,josips1@mcmaster.ca,journal_articles,455,Critical Care Medicine,2014,10.1097/01.ccm.0000457952.01186.20,https://experts.mcmaster.ca/display/publication2135274,2025-07-27T15:03:35.871585
Mark Crowther,josips1@mcmaster.ca,journal_articles,The use of body condition and haematology to detect widespread threatening processes in sleepy lizards (Tiliqua rugosa) in two agricultural environments,Royal Society Open Science,2014,10.1098/rsos.140257,https://experts.mcmaster.ca/display/publication1520925,2025-07-27T15:03:35.871586
Mark Crowther,josips1@mcmaster.ca,journal_articles,Design of the rivaroxaban for heparin-induced thrombocytopenia study,Journal of Thrombosis and Thrombolysis,2014,10.1007/s11239-014-1064-7,https://experts.mcmaster.ca/display/publication440467,2025-07-27T15:03:35.871588
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rofecoxib does not appear to increase the risk of venous thromboembolism: A systematic review of the literature,Thrombosis Research,2014,10.1016/j.thromres.2014.08.030,https://experts.mcmaster.ca/display/publication1520929,2025-07-27T15:03:35.871589
Mark Crowther,josips1@mcmaster.ca,journal_articles,The thrombogenicity of C1 esterase inhibitor (human): Review of the evidence,Allergy and Asthma Proceedings,2014,10.2500/aap.2014.35.3799,https://experts.mcmaster.ca/display/publication1520926,2025-07-27T15:03:35.871590
Mark Crowther,josips1@mcmaster.ca,journal_articles,The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis,Blood,2014,10.1182/blood-2014-07-590323,https://experts.mcmaster.ca/display/publication669243,2025-07-27T15:03:35.871601
Mark Crowther,josips1@mcmaster.ca,journal_articles,Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants,Journal of the American College of Cardiology,2014,10.1016/j.jacc.2014.05.065,https://experts.mcmaster.ca/display/publication440439,2025-07-27T15:03:35.871607
Mark Crowther,josips1@mcmaster.ca,journal_articles,Portal Vein Thrombosis,Clinical and Applied Thrombosis/Hemostasis,2014,10.1177/1076029612473515,https://experts.mcmaster.ca/display/publication914160,2025-07-27T15:03:35.871609
Mark Crowther,josips1@mcmaster.ca,journal_articles,γT‐S195A thrombin reduces the anticoagulant effects of dabigatran in vitro and in vivo,Journal of Thrombosis and Haemostasis,2014,10.1111/jth.12601,https://experts.mcmaster.ca/display/publication418478,2025-07-27T15:03:35.871611
Mark Crowther,josips1@mcmaster.ca,journal_articles,Unusual venous thrombosis,CANADIAN MEDICAL ASSOCIATION JOURNAL,2014,10.1503/cmaj.114-0043,https://experts.mcmaster.ca/display/publication440449,2025-07-27T15:03:35.871613
Mark Crowther,josips1@mcmaster.ca,journal_articles,Heparin-induced thrombocytopenia in the critically ill: Interpreting the 4Ts test in a randomized trial,Journal of Critical Care,2014,10.1016/j.jcrc.2014.02.004,https://experts.mcmaster.ca/display/publication189934,2025-07-27T15:03:35.871614
Mark Crowther,josips1@mcmaster.ca,journal_articles,Venous Thromboembolism in Older Adults: A Community-based Study,American Journal of Medicine,2014,10.1016/j.amjmed.2014.02.011,https://experts.mcmaster.ca/display/publication192652,2025-07-27T15:03:35.871616
Mark Crowther,josips1@mcmaster.ca,journal_articles,Symptomatic Venous Thromboembolism Uncommon without Thromboprophylaxis After Isolated Lower-Limb Fracture,Journal of Bone and Joint Surgery. American volume,2014,10.2106/jbjs.m.00236,https://experts.mcmaster.ca/display/publication925698,2025-07-27T15:03:35.871617
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery,Survey of Anesthesiology,2014,10.1097/01.sa.0000443068.02547.26,https://experts.mcmaster.ca/display/publication2135255,2025-07-27T15:03:35.871618
Mark Crowther,josips1@mcmaster.ca,journal_articles,Myocardial Injury after Noncardiac Surgery,Anesthesiology,2014,10.1097/aln.0000000000000113,https://experts.mcmaster.ca/display/publication53045,2025-07-27T15:03:35.871620
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin Interactions With Antibiotics in the Ambulatory Care Setting,JAMA Internal Medicine,2014,10.1001/jamainternmed.2013.13957,https://experts.mcmaster.ca/display/publication440445,2025-07-27T15:03:35.871621
Mark Crowther,josips1@mcmaster.ca,journal_articles,How I treat target-specific oral anticoagulant–associated bleeding,Blood,2014,10.1182/blood-2013-09-529784,https://experts.mcmaster.ca/display/publication440436,2025-07-27T15:03:35.871622
Mark Crowther,josips1@mcmaster.ca,journal_articles,Practical aspects of new oral anticoagulant use in atrial fibrillation,Polskie Archiwum Medycyny Wewnetrznej,2014,10.20452/pamw.2138,https://experts.mcmaster.ca/display/publication1521001,2025-07-27T15:03:35.871624
Mark Crowther,josips1@mcmaster.ca,journal_articles,Accelerated care versus standard care among patients with hip fracture: the HIP ATTACK pilot trial,CANADIAN MEDICAL ASSOCIATION JOURNAL,2014,10.1503/cmaj.130901,https://experts.mcmaster.ca/display/publication57753,2025-07-27T15:03:35.871625
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comment on: Editorial by Husted et al. “Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel”,Thrombosis and Haemostasis,2014,10.1160/th14-04-0325,https://experts.mcmaster.ca/display/publication1520983,2025-07-27T15:03:35.871626
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence and Clinical Judgment: Vena cava filters,Thrombosis and Haemostasis,2014,10.1160/th13-11-0938,https://experts.mcmaster.ca/display/publication1521016,2025-07-27T15:03:35.871628
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prediction Scores Do Not Correlate with Clinically Adjudicated Categories of Pulmonary Embolism in Critically Ill Patients,Canadian Respiratory Journal,2014,10.1155/2014/296161,https://experts.mcmaster.ca/display/publication211419,2025-07-27T15:03:35.871629
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit,Critical Care,2014,10.1186/cc13844,https://experts.mcmaster.ca/display/publication189926,2025-07-27T15:03:35.871630
Mark Crowther,josips1@mcmaster.ca,journal_articles,Phase 4 research: what happens when the rubber meets the road?,Hematology. American Society of Hematology. Education Program,2013,10.1182/asheducation-2013.1.15,https://experts.mcmaster.ca/display/publication1520931,2025-07-27T15:03:35.871632
Mark Crowther,josips1@mcmaster.ca,journal_articles,The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question,Hematology. American Society of Hematology. Education Program,2013,10.1182/asheducation-2013.1.9,https://experts.mcmaster.ca/display/publication440463,2025-07-27T15:03:35.871633
Mark Crowther,josips1@mcmaster.ca,journal_articles,The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question,Blood,2013,10.1182/blood-2013-07-518423,https://experts.mcmaster.ca/display/publication440464,2025-07-27T15:03:35.871635
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes,Thrombosis Research,2013,10.1016/j.thromres.2013.10.024,https://experts.mcmaster.ca/display/publication440443,2025-07-27T15:03:35.871636
Mark Crowther,josips1@mcmaster.ca,journal_articles,Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis,Intensive Care Medicine,2013,10.1007/s00134-013-3044-3,https://experts.mcmaster.ca/display/publication189977,2025-07-27T15:03:35.871637
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis,Chest,2013,10.1378/chest.13-0121,https://experts.mcmaster.ca/display/publication189988,2025-07-27T15:03:35.871638
Mark Crowther,josips1@mcmaster.ca,journal_articles,The effect of rituximab on vaccine responses in patients with immune thrombocytopenia,Blood,2013,10.1182/blood-2013-04-494096,https://experts.mcmaster.ca/display/publication199313,2025-07-27T15:03:35.871640
Mark Crowther,josips1@mcmaster.ca,journal_articles,"A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Soluble Thrombomodulin, ART-123, in Patients With Sepsis and Suspected Disseminated Intravascular Coagulation*",Critical Care Medicine,2013,10.1097/ccm.0b013e31828e9b03,https://experts.mcmaster.ca/display/publication1520997,2025-07-27T15:03:35.871641
Mark Crowther,josips1@mcmaster.ca,journal_articles,Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness,Chest,2013,10.1378/chest.13-0057,https://experts.mcmaster.ca/display/publication211570,2025-07-27T15:03:35.871643
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment with novel oral anticoagulants,Current Opinion in Hematology,2013,10.1097/moh.0b013e328363c170,https://experts.mcmaster.ca/display/publication1520930,2025-07-27T15:03:35.871645
Mark Crowther,josips1@mcmaster.ca,journal_articles,Nonadherence with INR Monitoring and Anticoagulant Complications,Thrombosis Research,2013,10.1016/j.thromres.2013.06.006,https://experts.mcmaster.ca/display/publication440451,2025-07-27T15:03:35.871646
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversal of target-specific oral anticoagulants,Journal of Thrombosis and Thrombolysis,2013,10.1007/s11239-013-0923-y,https://experts.mcmaster.ca/display/publication1520961,2025-07-27T15:03:35.871647
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban",Cleveland Clinic Journal of Medicine,2013,10.3949/ccjm.80a.13025,https://experts.mcmaster.ca/display/publication440447,2025-07-27T15:03:35.871649
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Relationship Between Fibrinogen Levels After Cardiopulmonary Bypass and Large Volume Red Cell Transfusion in Cardiac Surgery,Anesthesia and Analgesia,2013,10.1213/ane.0b013e318292efa4,https://experts.mcmaster.ca/display/publication440526,2025-07-27T15:03:35.871650
Mark Crowther,josips1@mcmaster.ca,journal_articles,Aspirin Versus Low-Molecular-Weight Heparin for Extended Venous Thromboembolism Prophylaxis After Total Hip Arthroplasty,ACP journal club,2013,10.7326/0003-4819-158-11-201306040-00004,https://experts.mcmaster.ca/display/publication467204,2025-07-27T15:03:35.871651
Mark Crowther,josips1@mcmaster.ca,journal_articles,FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12208,https://experts.mcmaster.ca/display/publication440465,2025-07-27T15:03:35.871653
Mark Crowther,josips1@mcmaster.ca,journal_articles,Optimal treatment duration of venous thrombosis,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12234,https://experts.mcmaster.ca/display/publication1567054,2025-07-27T15:03:35.871654
Mark Crowther,josips1@mcmaster.ca,journal_articles,Review: Blood transfusions are associated with higher mortality than no or restricted transfusions in MI,ACP journal club,2013,10.7326/0003-4819-158-10-201305210-02013,https://experts.mcmaster.ca/display/publication1520932,2025-07-27T15:03:35.871656
Mark Crowther,josips1@mcmaster.ca,journal_articles,Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply,JAMA Internal Medicine,2013,10.1001/jamainternmed.2013.14,https://experts.mcmaster.ca/display/publication440524,2025-07-27T15:03:35.871657
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Abstract 10: Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Pharmacokinetic and Pharmacodynamic Study of PRT064445, a Universal Antidote for Factor Xa Inhibitors","Arteriosclerosis, Thrombosis and Vascular Biology",2013,10.1161/atvb.33.suppl_1.a10,https://experts.mcmaster.ca/display/publication2135193,2025-07-27T15:03:35.871658
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Indications, Complications, and Management of Inferior Vena Cava Filters",JAMA Internal Medicine,2013,10.1001/jamainternmed.2013.343,https://experts.mcmaster.ca/display/publication1520962,2025-07-27T15:03:35.871660
Mark Crowther,josips1@mcmaster.ca,journal_articles,American College of Chest Physicians Guidelines for Heparin-Induced Thrombocytopenia: Response,Chest,2013,10.1378/chest.13-0035,https://experts.mcmaster.ca/display/publication711090,2025-07-27T15:03:35.871661
Mark Crowther,josips1@mcmaster.ca,journal_articles,Medical prophylaxis: the value of an “opt in” policy,Journal of Thrombosis and Thrombolysis,2013,10.1007/s11239-013-0881-4,https://experts.mcmaster.ca/display/publication440536,2025-07-27T15:03:35.871663
Mark Crowther,josips1@mcmaster.ca,journal_articles,Proceedings of the 12th national conference on anticoagulant therapy,Journal of Thrombosis and Thrombolysis,2013,10.1007/s11239-013-0894-z,https://experts.mcmaster.ca/display/publication1520996,2025-07-27T15:03:35.871664
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12106,https://experts.mcmaster.ca/display/publication440528,2025-07-27T15:03:35.871666
Mark Crowther,josips1@mcmaster.ca,journal_articles,The accuracy of the International Normalized Ratio and the American College of Chest Physicians recommendations on the use of vitamin K to reverse over-anticoagulation: a rebuttal,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12119,https://experts.mcmaster.ca/display/publication711096,2025-07-27T15:03:35.871676
Mark Crowther,josips1@mcmaster.ca,journal_articles,Acute management of bleeding in patients on novel oral anticoagulants,European Heart Journal,2013,10.1093/eurheartj/ehs408,https://experts.mcmaster.ca/display/publication440550,2025-07-27T15:03:35.871678
Mark Crowther,josips1@mcmaster.ca,journal_articles,Selectived-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis,ACP journal club,2013,10.7326/0003-4819-158-2-201301150-00003,https://experts.mcmaster.ca/display/publication180338,2025-07-27T15:03:35.871679
Mark Crowther,josips1@mcmaster.ca,journal_articles,A guide to GRADE guidelines for the readers of JTH,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12320,https://experts.mcmaster.ca/display/publication593770,2025-07-27T15:03:35.871681
Mark Crowther,josips1@mcmaster.ca,journal_articles,A response to–There’s madness in their methods,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12142,https://experts.mcmaster.ca/display/publication593784,2025-07-27T15:03:35.871682
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticardiolipin Antibody and Anti-beta 2 Glycoprotein I Antibody Assays,"Methods in molecular biology (Clifton, N.J.)",2013,10.1007/978-1-62703-339-8_32,https://experts.mcmaster.ca/display/publication1599887,2025-07-27T15:03:35.871684
Mark Crowther,josips1@mcmaster.ca,journal_articles,Lupus Anticoagulant Testing,"Methods in molecular biology (Clifton, N.J.)",2013,10.1007/978-1-62703-339-8_7,https://experts.mcmaster.ca/display/publication1520933,2025-07-27T15:03:35.871685
Mark Crowther,josips1@mcmaster.ca,journal_articles,Non-OO blood type influences the risk of recurrent venous thromboembolism,Thrombosis and Haemostasis,2013,10.1160/th13-06-0488,https://experts.mcmaster.ca/display/publication984617,2025-07-27T15:03:35.871687
Mark Crowther,josips1@mcmaster.ca,journal_articles,PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN,Journal of Population Therapeutics and Clinical Pharmacology,2013,,https://experts.mcmaster.ca/display/publication1747884,2025-07-27T15:03:35.871689
Mark Crowther,josips1@mcmaster.ca,journal_articles,Selection and assessment of patients treated with the novel oral anticoagulant drugs: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis,Journal of Thrombosis and Haemostasis,2013,10.1111/jth.12038,https://experts.mcmaster.ca/display/publication1521031,2025-07-27T15:03:35.871690
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombopoietin Receptor Agonists in Primary Immune Thrombocytopenia,Seminars in Hematology,2013,10.1053/j.seminhematol.2013.03.005,https://experts.mcmaster.ca/display/publication1138982,2025-07-27T15:03:35.871692
Mark Crowther,josips1@mcmaster.ca,journal_articles,118,Critical Care Medicine,2012,10.1097/01.ccm.0000424338.40507.87,https://experts.mcmaster.ca/display/publication2135250,2025-07-27T15:03:35.871693
Mark Crowther,josips1@mcmaster.ca,journal_articles,337,Critical Care Medicine,2012,10.1097/01.ccm.0000424555.88727.93,https://experts.mcmaster.ca/display/publication2135251,2025-07-27T15:03:35.871694
Mark Crowther,josips1@mcmaster.ca,journal_articles,Blood smear: fulminant pneumococcal bacteremia,Blood,2012,10.1182/blood-2012-07-444406,https://experts.mcmaster.ca/display/publication1599906,2025-07-27T15:03:35.871696
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis,Blood,2012,10.1182/blood-2012-07-443051,https://experts.mcmaster.ca/display/publication440520,2025-07-27T15:03:35.871697
Mark Crowther,josips1@mcmaster.ca,journal_articles,Uncertainties in baseline risk estimates and confidence in treatment effects,The BMJ,2012,10.1136/bmj.e7401,https://experts.mcmaster.ca/display/publication172965,2025-07-27T15:03:35.871698
Mark Crowther,josips1@mcmaster.ca,journal_articles,Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation,Circulation,2012,10.1161/circulationaha.112.115410,https://experts.mcmaster.ca/display/publication840297,2025-07-27T15:03:35.871699
Mark Crowther,josips1@mcmaster.ca,journal_articles,Aspirine versus HBPM en prévention des TVP après PTH : une étude randomisée en double insu (étude Epcat),Revue de Chirurgie Orthopedique et Traumatologique,2012,10.1016/j.rcot.2012.08.204,https://experts.mcmaster.ca/display/publication2135253,2025-07-27T15:03:35.871701
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding",JAMA Internal Medicine,2012,10.1001/archinternmed.2012.4261,https://experts.mcmaster.ca/display/publication440532,2025-07-27T15:03:35.871702
Mark Crowther,josips1@mcmaster.ca,journal_articles,Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection,Survey of Anesthesiology,2012,10.1097/01.sa.0000418864.09286.3a,https://experts.mcmaster.ca/display/publication2135263,2025-07-27T15:03:35.871704
Mark Crowther,josips1@mcmaster.ca,journal_articles,Approaches to Diagnosing and Managing Anticoagulant-Related Bleeding,Seminars in Thrombosis and Hemostasis,2012,10.1055/s-0032-1326788,https://experts.mcmaster.ca/display/publication1520935,2025-07-27T15:03:35.871705
Mark Crowther,josips1@mcmaster.ca,journal_articles,In Reply,Anesthesiology,2012,10.1097/aln.0b013e3182690d90,https://experts.mcmaster.ca/display/publication440556,2025-07-27T15:03:35.871706
Mark Crowther,josips1@mcmaster.ca,journal_articles,Risk of post‐thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study,Journal of Thrombosis and Haemostasis,2012,10.1111/j.1538-7836.2012.04872.x,https://experts.mcmaster.ca/display/publication440514,2025-07-27T15:03:35.871708
Mark Crowther,josips1@mcmaster.ca,journal_articles,Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis,Survey of Anesthesiology,2012,10.1097/01.sa.0000418885.79414.93,https://experts.mcmaster.ca/display/publication2135254,2025-07-27T15:03:35.871709
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Thromboprophylaxis in medical inpatients reduces pulmonary embolism, increases the risk of major haemorrhage and does not reduce total mortality, producing questionable net clinical benefit",BMJ Evidence-Based Medicine,2012,10.1136/ebmed-2012-100509,https://experts.mcmaster.ca/display/publication1520936,2025-07-27T15:03:35.871711
Mark Crowther,josips1@mcmaster.ca,journal_articles,Ustekinumab associated thrombotic thrombocytopenic purpura,Transfusion and Apheresis Science,2012,10.1016/j.transci.2012.06.024,https://experts.mcmaster.ca/display/publication1520934,2025-07-27T15:03:35.871712
Mark Crowther,josips1@mcmaster.ca,journal_articles,Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab’ fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study,Thrombosis Research,2012,10.1016/j.thromres.2012.05.011,https://experts.mcmaster.ca/display/publication440534,2025-07-27T15:03:35.872105
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dabigatran-Induced Acute Hepatitis,Clinical and Applied Thrombosis/Hemostasis,2012,10.1177/1076029611435840,https://experts.mcmaster.ca/display/publication800001,2025-07-27T15:03:35.872108
Mark Crowther,josips1@mcmaster.ca,journal_articles,Hyperlactatemia and concurrent use of antiretroviral therapy among HIV infected patients in Uganda,African Health Sciences,2012,10.4314/ahs.v12i3.4,https://experts.mcmaster.ca/display/publication660035,2025-07-27T15:03:35.872111
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Prothrombin complex concentrates reduce blood loss in murine coagulopathy induced by warfarin, but not in that induced by dabigatran etexilate",Journal of Thrombosis and Haemostasis,2012,10.1111/j.1538-7836.2012.04863.x,https://experts.mcmaster.ca/display/publication418467,2025-07-27T15:03:35.872112
Mark Crowther,josips1@mcmaster.ca,journal_articles,Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement,Thrombosis Research,2012,10.1016/j.thromres.2012.01.013,https://experts.mcmaster.ca/display/publication1521024,2025-07-27T15:03:35.872114
Mark Crowther,josips1@mcmaster.ca,journal_articles,Assessment of von Willebrand disease as a risk factor for primary postpartum haemorrhage,Haemophilia,2012,10.1111/j.1365-2516.2012.02750.x,https://experts.mcmaster.ca/display/publication1599888,2025-07-27T15:03:35.872116
Mark Crowther,josips1@mcmaster.ca,journal_articles,Erratum,American Journal of Hematology,2012,10.1002/ajh.23252,https://experts.mcmaster.ca/display/publication864845,2025-07-27T15:03:35.872117
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20–21, 2011, Salvador, Bahia, Brazil",Journal of Thrombosis and Thrombolysis,2012,10.1007/s11239-012-0700-3,https://experts.mcmaster.ca/display/publication1521030,2025-07-27T15:03:35.872119
Mark Crowther,josips1@mcmaster.ca,journal_articles,MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot–Marie–Tooth disease type 1B,Brain,2012,10.1093/brain/aws140,https://experts.mcmaster.ca/display/publication1599917,2025-07-27T15:03:35.872121
Mark Crowther,josips1@mcmaster.ca,journal_articles,Newer Anticoagulants in Critically Ill Patients,Critical Care Clinics,2012,10.1016/j.ccc.2012.04.005,https://experts.mcmaster.ca/display/publication440522,2025-07-27T15:03:35.872123
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversal of Warfarin,Circulation,2012,10.1161/circulationaha.111.081489,https://experts.mcmaster.ca/display/publication440530,2025-07-27T15:03:35.872124
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bone marrow aspirate collection and preparation – A comparison of three methods,Clinical and Investigative Medicine,2012,10.25011/cim.v35i3.16586,https://experts.mcmaster.ca/display/publication440561,2025-07-27T15:03:35.872126
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of the Villalta post‐thrombotic syndrome score in the ipsilateral vs. contralateral leg after a first unprovoked deep vein thrombosis,Journal of Thrombosis and Haemostasis,2012,10.1111/j.1538-7836.2012.04713.x,https://experts.mcmaster.ca/display/publication440518,2025-07-27T15:03:35.872128
Mark Crowther,josips1@mcmaster.ca,journal_articles,The effect of blood storage duration on in‐hospital mortality: a randomized controlled pilot feasibility trial,Transfusion,2012,10.1111/j.1537-2995.2011.03521.x,https://experts.mcmaster.ca/display/publication440516,2025-07-27T15:03:35.872129
Mark Crowther,josips1@mcmaster.ca,journal_articles,Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors,American Journal of Hematology,2012,10.1002/ajh.23202,https://experts.mcmaster.ca/display/publication412139,2025-07-27T15:03:35.872130
Mark Crowther,josips1@mcmaster.ca,journal_articles,Iron Overload in Human Disease,New England Journal of Medicine,2012,10.1056/nejmc1202105,https://experts.mcmaster.ca/display/publication695653,2025-07-27T15:03:35.872132
Mark Crowther,josips1@mcmaster.ca,journal_articles,Amyloidosis and Giant Cell Arteritis/Polymyalgia Rheumatica,Journal of Rheumatology,2012,10.3899/jrheum.111013,https://experts.mcmaster.ca/display/publication638788,2025-07-27T15:03:35.872133
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta‐analysis,Journal of Thrombosis and Haemostasis,2012,10.1111/j.1538-7836.2012.04635.x,https://experts.mcmaster.ca/display/publication669890,2025-07-27T15:03:35.872135
Mark Crowther,josips1@mcmaster.ca,journal_articles,Failure to correct International Normalized Ratio and mortality among patients with warfarin‐related major bleeding: an analysis of electronic health records,Journal of Thrombosis and Haemostasis,2012,10.1111/j.1538-7836.2012.04636.x,https://experts.mcmaster.ca/display/publication1521020,2025-07-27T15:03:35.872136
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Prothrombin complex concentrate (PCC, Octaplex®) in patients requiring immediate reversal of vitamin K antagonist anticoagulation",Thrombosis Research,2012,10.1016/j.thromres.2011.12.007,https://experts.mcmaster.ca/display/publication440552,2025-07-27T15:03:35.872137
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversing Anticoagulant Therapy,Current Drug Discovery Technologies,2012,10.2174/1570163811209020143,https://experts.mcmaster.ca/display/publication925710,2025-07-27T15:03:35.872139
Mark Crowther,josips1@mcmaster.ca,journal_articles,"How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch",Blood,2012,10.1182/blood-2011-10-378950,https://experts.mcmaster.ca/display/publication440540,2025-07-27T15:03:35.872140
Mark Crowther,josips1@mcmaster.ca,journal_articles,Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection,Anesthesiology,2012,10.1097/aln.0b013e3182475e39,https://experts.mcmaster.ca/display/publication440542,2025-07-27T15:03:35.872141
Mark Crowther,josips1@mcmaster.ca,journal_articles,A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia,Blood,2012,10.1182/blood-2011-08-374777,https://experts.mcmaster.ca/display/publication211606,2025-07-27T15:03:35.872142
Mark Crowther,josips1@mcmaster.ca,journal_articles,Consequences of suspected heparin-induced thrombocytopenia in the ICU,Critical Care,2012,10.1186/cc11030,https://experts.mcmaster.ca/display/publication2135284,2025-07-27T15:03:35.872144
Mark Crowther,josips1@mcmaster.ca,journal_articles,Diagnosis of DVT,Chest,2012,10.1378/chest.11-2299,https://experts.mcmaster.ca/display/publication455529,2025-07-27T15:03:35.872145
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence-Based Management of Anticoagulant Therapy,Chest,2012,10.1378/chest.11-2295,https://experts.mcmaster.ca/display/publication711230,2025-07-27T15:03:35.872147
Mark Crowther,josips1@mcmaster.ca,journal_articles,"In medical-surgical ICU patients, major bleeding is common but independent of heparin prophylaxis",Critical Care,2012,10.1186/cc11042,https://experts.mcmaster.ca/display/publication2135273,2025-07-27T15:03:35.872148
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral Anticoagulant Therapy,Chest,2012,10.1378/chest.11-2292,https://experts.mcmaster.ca/display/publication1520938,2025-07-27T15:03:35.872149
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment and Prevention of Heparin-Induced Thrombocytopenia,Chest,2012,10.1378/chest.11-2303,https://experts.mcmaster.ca/display/publication711210,2025-07-27T15:03:35.872150
Mark Crowther,josips1@mcmaster.ca,journal_articles,Symptomatic In-Hospital Deep Vein Thrombosis and Pulmonary Embolism Following Hip and Knee Arthroplasty Among Patients Receiving Recommended Prophylaxis,Journal of the American Medical Association (JAMA),2012,10.1001/jama.2011.2029,https://experts.mcmaster.ca/display/publication440619,2025-07-27T15:03:35.872152
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines,Chest,2012,10.1378/chest.11-2301,https://experts.mcmaster.ca/display/publication1520937,2025-07-27T15:03:35.872153
Mark Crowther,josips1@mcmaster.ca,journal_articles,Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,Chest,2012,10.1378/chest.11-2289,https://experts.mcmaster.ca/display/publication820378,2025-07-27T15:03:35.872154
Mark Crowther,josips1@mcmaster.ca,journal_articles,Executive summary: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines,Chest,2012,10.1378/chest.1412s3,https://experts.mcmaster.ca/display/publication1520388,2025-07-27T15:03:35.872156
Mark Crowther,josips1@mcmaster.ca,journal_articles,Introduction to the ninth edition: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines,Chest,2012,10.1378/chest.11-2286,https://experts.mcmaster.ca/display/publication1520398,2025-07-27T15:03:35.872157
Mark Crowther,josips1@mcmaster.ca,journal_articles,Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines,Chest,2012,10.1378/chest.11-2288,https://experts.mcmaster.ca/display/publication211604,2025-07-27T15:03:35.872158
Mark Crowther,josips1@mcmaster.ca,journal_articles,Neutralization of Heparin Activity,Handbook of Experimental Pharmacology,2012,10.1007/978-3-642-23056-1_11,https://experts.mcmaster.ca/display/publication925709,2025-07-27T15:03:35.872159
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility,Blood,2011,10.1182/blood-2011-08-335612,https://experts.mcmaster.ca/display/publication440620,2025-07-27T15:03:35.872161
Mark Crowther,josips1@mcmaster.ca,journal_articles,A multifaceted strategy to reduce inappropriate use of frozen plasma transfusions in the intensive care unit,Journal of Critical Care,2011,10.1016/j.jcrc.2011.02.005,https://experts.mcmaster.ca/display/publication211628,2025-07-27T15:03:35.872162
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Rajasekhar A, Crowther MA. ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients? Hematology Am Soc Hematol Educ Program. 2009;2009:302-304.",Hematology. American Society of Hematology. Education Program,2011,10.1182/asheducation-2011.1.561,https://experts.mcmaster.ca/display/publication440459,2025-07-27T15:03:35.872163
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment of warfarin-associated coagulopathy with vitamin K,Expert Review of Hematology,2011,10.1586/ehm.11.59,https://experts.mcmaster.ca/display/publication1520939,2025-07-27T15:03:35.872165
Mark Crowther,josips1@mcmaster.ca,journal_articles,4Ts HIT Scoring in the Medical-Surgical ICU,Blood,2011,10.1182/blood.v118.21.4669.4669,https://experts.mcmaster.ca/display/publication2135230,2025-07-27T15:03:35.872166
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Retrospective Review of the Management of Patients with Porphyria Cutanea Tarda At a Tertiary Care Centre,Blood,2011,10.1182/blood.v118.21.5290.5290,https://experts.mcmaster.ca/display/publication2135218,2025-07-27T15:03:35.872168
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study,Blood,2011,10.1182/blood.v118.21.1236.1236,https://experts.mcmaster.ca/display/publication2135220,2025-07-27T15:03:35.872169
Mark Crowther,josips1@mcmaster.ca,journal_articles,Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study,Blood,2011,10.1182/blood.v118.21.2299.2299,https://experts.mcmaster.ca/display/publication2135225,2025-07-27T15:03:35.872170
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study,",Blood,2011,10.1182/blood.v118.21.3332.3332,https://experts.mcmaster.ca/display/publication2135224,2025-07-27T15:03:35.872171
Mark Crowther,josips1@mcmaster.ca,journal_articles,Laboratory HIT Testing in Critically Ill Patients,Blood,2011,10.1182/blood.v118.21.198.198,https://experts.mcmaster.ca/display/publication2135226,2025-07-27T15:03:35.872173
Mark Crowther,josips1@mcmaster.ca,journal_articles,Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study,Blood,2011,10.1182/blood.v118.21.712.712,https://experts.mcmaster.ca/display/publication2135217,2025-07-27T15:03:35.872174
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Literature,",Blood,2011,10.1182/blood.v118.21.3334.3334,https://experts.mcmaster.ca/display/publication2135223,2025-07-27T15:03:35.872176
Mark Crowther,josips1@mcmaster.ca,journal_articles,"The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism,",Blood,2011,10.1182/blood.v118.21.4207.4207,https://experts.mcmaster.ca/display/publication2135219,2025-07-27T15:03:35.872177
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low prevalence ofJAK2V617F mutation in patients with first unprovoked venous thromboembolism,British Journal of Haematology,2011,10.1111/j.1365-2141.2011.08701.x,https://experts.mcmaster.ca/display/publication1521004,2025-07-27T15:03:35.872179
Mark Crowther,josips1@mcmaster.ca,journal_articles,Statins in the prevention of venous thromboembolism: A meta-analysis of observational studies,Thrombosis Research,2011,10.1016/j.thromres.2011.05.012,https://experts.mcmaster.ca/display/publication190066,2025-07-27T15:03:35.872180
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Effect of Prothrombotic Blood Abnormalities on Risk of Deep Vein Thrombosis in Users of Hormone Replacement Therapy,Clinical and Applied Thrombosis/Hemostasis,2011,10.1177/1076029610387587,https://experts.mcmaster.ca/display/publication440630,2025-07-27T15:03:35.872182
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence-based focused review of the treatment of idiopathic warm immune hemolytic anemia in adults,Blood,2011,10.1182/blood-2011-05-347708,https://experts.mcmaster.ca/display/publication440618,2025-07-27T15:03:35.872184
Mark Crowther,josips1@mcmaster.ca,journal_articles,Introduction: Practical Issues in Hemostasis and Thrombosis,Seminars in Hematology,2011,10.1053/j.seminhematol.2011.09.001,https://experts.mcmaster.ca/display/publication440627,2025-07-27T15:03:35.872185
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of Bleeding Complications in the Anticoagulated Patient,Seminars in Hematology,2011,10.1053/j.seminhematol.2011.08.008,https://experts.mcmaster.ca/display/publication440613,2025-07-27T15:03:35.872187
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombopoietin-Receptor Agonists for Primary Immune Thrombocytopenia,New England Journal of Medicine,2011,10.1056/nejmct1014202,https://experts.mcmaster.ca/display/publication1520999,2025-07-27T15:03:35.872188
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Pilot Study on the Randomization of Inferior Vena Cava Filter Placement for Venous Thromboembolism Prophylaxis in High-Risk Trauma Patients,Journal of Trauma and Acute Care Surgery,2011,10.1097/ta.0b013e318226ece1,https://experts.mcmaster.ca/display/publication1520971,2025-07-27T15:03:35.872190
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14–16, 2010, São Paulo, Brazil",Journal of Thrombosis and Thrombolysis,2011,10.1007/s11239-011-0592-7,https://experts.mcmaster.ca/display/publication1521010,2025-07-27T15:03:35.872191
Mark Crowther,josips1@mcmaster.ca,journal_articles,A further use for the Harvest plot: a novel method for the presentation of data synthesis,Research Synthesis Methods,2011,10.1002/jrsm.37,https://experts.mcmaster.ca/display/publication1599889,2025-07-27T15:03:35.872193
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predictors of 4-Year Retention Among African American and White Community-Dwelling Participants in the UAB Study of Aging,The Gerontologist,2011,10.1093/geront/gnr024,https://experts.mcmaster.ca/display/publication1521032,2025-07-27T15:03:35.872194
Mark Crowther,josips1@mcmaster.ca,journal_articles,Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study,Journal of Thrombosis and Haemostasis,2011,10.1111/j.1538-7836.2011.04240.x,https://experts.mcmaster.ca/display/publication1085770,2025-07-27T15:03:35.872195
Mark Crowther,josips1@mcmaster.ca,journal_articles,Survival of trauma patients after massive red blood cell transfusion using a high or low red blood cell to plasma transfusion ratio*,Critical Care Medicine,2011,10.1097/ccm.0b013e31820eb517,https://experts.mcmaster.ca/display/publication440610,2025-07-27T15:03:35.872197
Mark Crowther,josips1@mcmaster.ca,journal_articles,Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP),Health Technology Assessment,2011,10.3310/hta15suppl1/03,https://experts.mcmaster.ca/display/publication1521033,2025-07-27T15:03:35.872198
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-Intensity Adjusted-Dose Warfarin for the Prevention of Hemodialysis Catheter Failure,American Society of Nephrology. Clinical Journal,2011,10.2215/cjn.07240810,https://experts.mcmaster.ca/display/publication438901,2025-07-27T15:03:35.872200
Mark Crowther,josips1@mcmaster.ca,journal_articles,The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia,Blood,2011,10.1182/blood-2010-08-302984,https://experts.mcmaster.ca/display/publication440614,2025-07-27T15:03:35.872201
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dalteparin versus Unfractionated Heparin in Critically Ill Patients,New England Journal of Medicine,2011,10.1056/nejmoa1014475,https://experts.mcmaster.ca/display/publication190081,2025-07-27T15:03:35.872203
Mark Crowther,josips1@mcmaster.ca,journal_articles,Update in Hematology and Oncology: Evidence Published in 2010,ACP journal club,2011,10.7326/0003-4819-154-7-201104050-00007,https://experts.mcmaster.ca/display/publication1520955,2025-07-27T15:03:35.872205
Mark Crowther,josips1@mcmaster.ca,journal_articles,Brand Name versus Generic Warfarin: A Systematic Review of the Literature,Pharmacotherapy,2011,10.1592/phco.31.4.386,https://experts.mcmaster.ca/display/publication440609,2025-07-27T15:03:35.872206
Mark Crowther,josips1@mcmaster.ca,journal_articles,PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan,Journal of Critical Care,2011,10.1016/j.jcrc.2011.02.010,https://experts.mcmaster.ca/display/publication190076,2025-07-27T15:03:35.872274
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies,Lupus,2011,10.1177/0961203310395803,https://experts.mcmaster.ca/display/publication1521026,2025-07-27T15:03:35.872277
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of deep vein thrombosis diagnosed during active labour,Thrombosis Research,2011,10.1016/j.thromres.2010.08.011,https://experts.mcmaster.ca/display/publication1520957,2025-07-27T15:03:35.872278
Mark Crowther,josips1@mcmaster.ca,journal_articles,Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review,Transfusion Medicine Reviews,2011,10.1016/j.tmrv.2010.08.007,https://experts.mcmaster.ca/display/publication440667,2025-07-27T15:03:35.872280
Mark Crowther,josips1@mcmaster.ca,journal_articles,Red blood cell transfusion and increased length of storage are not associated with deep vein thrombosis in medical and surgical critically ill patients: a prospective observational cohort study,Critical Care,2011,10.1186/cc10526,https://experts.mcmaster.ca/display/publication190061,2025-07-27T15:03:35.872281
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists,Thrombosis and Haemostasis,2011,10.1160/th11-01-0052,https://experts.mcmaster.ca/display/publication1521014,2025-07-27T15:03:35.872282
Mark Crowther,josips1@mcmaster.ca,journal_articles,The “age” of understanding VKA dose,Blood,2010,10.1182/blood-2010-09-307900,https://experts.mcmaster.ca/display/publication440625,2025-07-27T15:03:35.872284
Mark Crowther,josips1@mcmaster.ca,journal_articles,A team-based approach to warfarin management in long term care: A feasibility study of the MEDeINR electronic decision support system,BMC Geriatrics,2010,10.1186/1471-2318-10-38,https://experts.mcmaster.ca/display/publication440683,2025-07-27T15:03:35.872285
Mark Crowther,josips1@mcmaster.ca,journal_articles,Being underweight may reduce your ability to mobilise peripheral blood stem cells,Transfusion and Apheresis Science,2010,10.1016/j.transci.2010.10.010,https://experts.mcmaster.ca/display/publication1599891,2025-07-27T15:03:35.872286
Mark Crowther,josips1@mcmaster.ca,journal_articles,Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia,Transfusion,2010,10.1111/j.1537-2995.2010.02766.x,https://experts.mcmaster.ca/display/publication440681,2025-07-27T15:03:35.872287
Mark Crowther,josips1@mcmaster.ca,journal_articles,Praktische Behandlung der Warfarin-assoziierten Gerinnungsstörung,Praxis,2010,10.1024/1661-8157/a000335,https://experts.mcmaster.ca/display/publication925711,2025-07-27T15:03:35.872289
Mark Crowther,josips1@mcmaster.ca,journal_articles,The HIT Expert Probability (HEP) Score: a novel pre‐test probability model for heparin‐induced thrombocytopenia based on broad expert opinion,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.04059.x,https://experts.mcmaster.ca/display/publication440645,2025-07-27T15:03:35.872290
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of Incidence and Investigation of In-Hospital Pulmonary Embolism In Patients Receiving Dalteparin Prophylaxis Following Elective Knee Replacement at Two Hospitals,Blood,2010,10.1182/blood.v116.21.4388.4388,https://experts.mcmaster.ca/display/publication2135227,2025-07-27T15:03:35.872292
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prothrombin Complex Concentrate (Octaplex®) In Patients Requiring Immediate Reversal of Vitamin K Antagonist Anticoagulation.,Blood,2010,10.1182/blood.v116.21.1115.1115,https://experts.mcmaster.ca/display/publication2135234,2025-07-27T15:03:35.872293
Mark Crowther,josips1@mcmaster.ca,journal_articles,SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature.,Blood,2010,10.1182/blood.v116.21.1113.1113,https://experts.mcmaster.ca/display/publication2135235,2025-07-27T15:03:35.872294
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors",Haematologica,2010,10.3324/haematol.2010.026989,https://experts.mcmaster.ca/display/publication1521027,2025-07-27T15:03:35.872296
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety of thrombolysis in cerebral venous thrombosis A systematic review of the literature,Thrombosis and Haemostasis,2010,10.1160/TH10-05-0311,https://experts.mcmaster.ca/display/publication1521005,2025-07-27T15:03:35.872297
Mark Crowther,josips1@mcmaster.ca,journal_articles,Systematic review and meta-analysis methodology,Blood,2010,10.1182/blood-2010-05-280883,https://experts.mcmaster.ca/display/publication440655,2025-07-27T15:03:35.872298
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid syndrome,The Lancet,2010,10.1016/s0140-6736(10)60709-x,https://experts.mcmaster.ca/display/publication1521022,2025-07-27T15:03:35.872300
Mark Crowther,josips1@mcmaster.ca,journal_articles,Heparin Treatment in Antiphospholipid Syndrome With Recurrent Pregnancy Loss,Obstetrics and Gynecology,2010,10.1097/aog.0b013e3181f4e012,https://experts.mcmaster.ca/display/publication1521019,2025-07-27T15:03:35.872301
Mark Crowther,josips1@mcmaster.ca,journal_articles,New Anticoagulants for the Prevention of Thromboembolism,Current Pharmaceutical Design,2010,10.2174/138161210793563437,https://experts.mcmaster.ca/display/publication1001324,2025-07-27T15:03:35.872302
Mark Crowther,josips1@mcmaster.ca,journal_articles,Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03958.x,https://experts.mcmaster.ca/display/publication1085897,2025-07-27T15:03:35.872303
Mark Crowther,josips1@mcmaster.ca,journal_articles,Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE,Thrombosis Research,2010,10.1016/j.thromres.2010.06.007,https://experts.mcmaster.ca/display/publication1085937,2025-07-27T15:03:35.872305
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations,Hematology/Oncology Clinics of North America,2010,10.1016/j.hoc.2010.05.005,https://experts.mcmaster.ca/display/publication1520941,2025-07-27T15:03:35.872306
Mark Crowther,josips1@mcmaster.ca,journal_articles,Preface,Hematology/Oncology Clinics of North America,2010,10.1016/j.hoc.2010.06.011,https://experts.mcmaster.ca/display/publication1520940,2025-07-27T15:03:35.872307
Mark Crowther,josips1@mcmaster.ca,journal_articles,Surveillance duplex scanning to prevent venous thromboembolism: does it make a difference in rehabilitation unit patients?,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03915.x,https://experts.mcmaster.ca/display/publication440647,2025-07-27T15:03:35.872308
Mark Crowther,josips1@mcmaster.ca,journal_articles,Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices,Transfusion,2010,10.1111/j.1537-2995.2010.02636.x,https://experts.mcmaster.ca/display/publication440687,2025-07-27T15:03:35.872310
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of the Delphi method to establish guidelines for treatment of thrombosis,Thrombosis Research,2010,10.1016/j.thromres.2010.01.015,https://experts.mcmaster.ca/display/publication2135279,2025-07-27T15:03:35.872311
Mark Crowther,josips1@mcmaster.ca,journal_articles,Inferior vena caval filter insertion prior to bariatric surgery: a systematic review of the literature,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03858.x,https://experts.mcmaster.ca/display/publication1520959,2025-07-27T15:03:35.872312
Mark Crowther,josips1@mcmaster.ca,journal_articles,The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients,Journal of Critical Care,2010,10.1016/j.jcrc.2009.12.006,https://experts.mcmaster.ca/display/publication211651,2025-07-27T15:03:35.872313
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Influence of Perioperative Coagulation Status on Postoperative Blood Loss in Complex Cardiac Surgery,Anesthesia and Analgesia,2010,10.1213/ane.0b013e3181db7991,https://experts.mcmaster.ca/display/publication440665,2025-07-27T15:03:35.872369
Mark Crowther,josips1@mcmaster.ca,journal_articles,Triple Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Stents,Circulation,2010,10.1161/circulationaha.109.924944,https://experts.mcmaster.ca/display/publication440734,2025-07-27T15:03:35.872371
Mark Crowther,josips1@mcmaster.ca,journal_articles,D-dimer testing in pregnant patients: towards determining the next ‘level’ in the diagnosis of deep vein thrombosis,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03783.x,https://experts.mcmaster.ca/display/publication752371,2025-07-27T15:03:35.872373
Mark Crowther,josips1@mcmaster.ca,journal_articles,Practical management of coagulopathy associated with warfarin,The BMJ,2010,10.1136/bmj.c1813,https://experts.mcmaster.ca/display/publication440761,2025-07-27T15:03:35.872374
Mark Crowther,josips1@mcmaster.ca,journal_articles,Practical management of coagulopathy associated with warfarin.,The BMJ,2010,10.1136/bmj.c1813,https://experts.mcmaster.ca/display/publication925713,2025-07-27T15:03:35.872376
Mark Crowther,josips1@mcmaster.ca,journal_articles,Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users,Journal of Thrombosis and Haemostasis,2010,10.1111/j.1538-7836.2010.03756.x,https://experts.mcmaster.ca/display/publication440725,2025-07-27T15:03:35.872377
Mark Crowther,josips1@mcmaster.ca,journal_articles,Risk for postoperative venous thromboembolism in women was increased for ≥ 12 weeks and varied by type of surgery,ACP journal club,2010,10.7326/0003-4819-152-6-201003160-02011,https://experts.mcmaster.ca/display/publication1520942,2025-07-27T15:03:35.872379
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid antibodies in critical illness,Critical Care Medicine,2010,10.1097/ccm.0b013e3181c9e363,https://experts.mcmaster.ca/display/publication1520943,2025-07-27T15:03:35.872381
Mark Crowther,josips1@mcmaster.ca,journal_articles,Intensity of Warfarin Coagulation in the Antiphospholipid Syndrome,Current Rheumatology Reports,2010,10.1007/s11926-009-0070-9,https://experts.mcmaster.ca/display/publication925712,2025-07-27T15:03:35.872382
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboprophylaxis in the intensive care unit: Focus on medical–surgical patients,Critical Care Medicine,2010,10.1097/ccm.0b013e3181c9e344,https://experts.mcmaster.ca/display/publication211652,2025-07-27T15:03:35.872384
Mark Crowther,josips1@mcmaster.ca,journal_articles,The new oral anticoagulants,Blood,2010,10.1182/blood-2009-09-241851,https://experts.mcmaster.ca/display/publication440736,2025-07-27T15:03:35.872385
Mark Crowther,josips1@mcmaster.ca,journal_articles,Interlaboratory variation in heparin monitoring: Lessons from the Quality Management Program of Ontario coagulation surveys,Thrombosis and Haemostasis,2010,10.1160/th10-02-0099,https://experts.mcmaster.ca/display/publication375873,2025-07-27T15:03:35.872387
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10,Thrombosis and Haemostasis,2010,10.1160/th09-12-0822,https://experts.mcmaster.ca/display/publication440649,2025-07-27T15:03:35.872388
Mark Crowther,josips1@mcmaster.ca,journal_articles,Risk of recurrent venous thromboembolism after a first oestrogen-associated episode,Thrombosis and Haemostasis,2010,10.1160/th09-10-0685,https://experts.mcmaster.ca/display/publication1520998,2025-07-27T15:03:35.872390
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety of thrombolysis in cerebral venous thrombosis,Thrombosis and Haemostasis,2010,10.1160/th10-05-0311,https://experts.mcmaster.ca/display/publication1599890,2025-07-27T15:03:35.872391
Mark Crowther,josips1@mcmaster.ca,journal_articles,The vexing problem of guidelines and conflict of interest: a potential solution,ACP journal club,2010,10.7326/0003-4819-152-11-201006010-00254,https://experts.mcmaster.ca/display/publication626967,2025-07-27T15:03:35.872392
Mark Crowther,josips1@mcmaster.ca,journal_articles,The “parallel-cohort RCT”: Novel design aspects and application in the Kids-DOTT trial of pediatric venous thromboembolism,Contemporary Clinical Trials,2010,10.1016/j.cct.2009.11.006,https://experts.mcmaster.ca/display/publication1521017,2025-07-27T15:03:35.872394
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Venous thromboembolism, age and hospitalisation: A potentially deadly combination",Thrombosis and Haemostasis,2010,10.1160/th10-08-0527,https://experts.mcmaster.ca/display/publication1520972,2025-07-27T15:03:35.872395
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Prevalence and morphological types of anaemia and hookworm infestation in the medical emergency ward, Mulago Hospital, Uganda.",SAMJ - South African Medical Journal,2009,,https://experts.mcmaster.ca/display/publication440769,2025-07-27T15:03:35.872396
Mark Crowther,josips1@mcmaster.ca,journal_articles,Inaccurate Doses of Rh Immune Globulin After Rh-Incompatible Fetomaternal Hemorrhage—Survey of Laboratory Practice,Archives of Pathology and Laboratory Medicine,2009,10.5858/133.12.1910,https://experts.mcmaster.ca/display/publication1441004,2025-07-27T15:03:35.872398
Mark Crowther,josips1@mcmaster.ca,journal_articles,Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy,Journal of Thrombosis and Haemostasis,2009,10.1111/j.1538-7836.2009.03598.x,https://experts.mcmaster.ca/display/publication440727,2025-07-27T15:03:35.872399
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?,Obstetrical and Gynecological Survey,2009,10.1097/01.ogx.0000363248.09415.51,https://experts.mcmaster.ca/display/publication1439363,2025-07-27T15:03:35.872401
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Cohort Study of Warfarin Administered to Achieve An INR of 2.0 to 3.0 for the Prevention of Recurrent Venous Thrombosis in Patients with An Antiphospholipid Antibody.,Blood,2009,10.1182/blood.v114.22.3123.3123,https://experts.mcmaster.ca/display/publication2135231,2025-07-27T15:03:35.872402
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.,Blood,2009,10.1182/blood.v114.22.1412.1412,https://experts.mcmaster.ca/display/publication2135228,2025-07-27T15:03:35.872404
Mark Crowther,josips1@mcmaster.ca,journal_articles,Cerebral Venous Thrombosis During Pregnancy in the Setting of Type I Antithrombin Deficiency: Case Report and Literature Review.,Blood,2009,10.1182/blood.v114.22.4447.4447,https://experts.mcmaster.ca/display/publication2135237,2025-07-27T15:03:35.872405
Mark Crowther,josips1@mcmaster.ca,journal_articles,Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the “Men Continue and HERDOO2” Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE).,Blood,2009,10.1182/blood.v114.22.451.451,https://experts.mcmaster.ca/display/publication2135236,2025-07-27T15:03:35.872406
Mark Crowther,josips1@mcmaster.ca,journal_articles,Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically Ill Patients.,Blood,2009,10.1182/blood.v114.22.3995.3995,https://experts.mcmaster.ca/display/publication2135222,2025-07-27T15:03:35.872408
Mark Crowther,josips1@mcmaster.ca,journal_articles,Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin in Patients with Immune Thrombocytopenic Purpura.,Blood,2009,10.1182/blood.v114.22.2418.2418,https://experts.mcmaster.ca/display/publication2135238,2025-07-27T15:03:35.872409
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors.",Blood,2009,10.1182/blood.v114.22.2978.2978,https://experts.mcmaster.ca/display/publication2135232,2025-07-27T15:03:35.872410
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Kids-DOTT Trial: Novel Aspects of the ‘Parallel Cohort RCT‘ Design and Its Application to the Investigation of Duration of Anticoagulant Therapy for Pediatric Venous Thromboembolism.,Blood,2009,10.1182/blood.v114.22.4169.4169,https://experts.mcmaster.ca/display/publication2135221,2025-07-27T15:03:35.872412
Mark Crowther,josips1@mcmaster.ca,journal_articles,Correction: Predicting Deep Venous Thrombosis in Pregnancy,ACP journal club,2009,10.7326/0003-4819-151-7-200910060-00019,https://experts.mcmaster.ca/display/publication752391,2025-07-27T15:03:35.872413
Mark Crowther,josips1@mcmaster.ca,journal_articles,Systematic review and meta-analyses of studies of glutamine supplementation in haematopoietic stem cell transplantation,Bone Marrow Transplantation,2009,10.1038/bmt.2009.41,https://experts.mcmaster.ca/display/publication1599893,2025-07-27T15:03:35.872414
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vitamin K to Correct Overanticoagulation,ACP journal club,2009,10.7326/0003-4819-151-6-200909150-00021,https://experts.mcmaster.ca/display/publication440732,2025-07-27T15:03:35.872415
Mark Crowther,josips1@mcmaster.ca,journal_articles,A logical approach to surgical thromboprophylaxis,Current Opinion in Hematology,2009,10.1097/moh.0b013e32832e99c0,https://experts.mcmaster.ca/display/publication440765,2025-07-27T15:03:35.872417
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency,Current Opinion in Pulmonary Medicine,2009,10.1097/mcp.0b013e32832ea4dd,https://experts.mcmaster.ca/display/publication211663,2025-07-27T15:03:35.872418
Mark Crowther,josips1@mcmaster.ca,journal_articles,ERRATA,Transfusion,2009,10.1111/j.1537-2995.2009.02404.x,https://experts.mcmaster.ca/display/publication1748097,2025-07-27T15:03:35.872918
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention",American Journal of Hematology,2009,10.1002/ajh.21470,https://experts.mcmaster.ca/display/publication593913,2025-07-27T15:03:35.872921
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment",American Journal of Hematology,2009,10.1002/ajh.21469,https://experts.mcmaster.ca/display/publication173061,2025-07-27T15:03:35.872922
Mark Crowther,josips1@mcmaster.ca,journal_articles,The diagnosis of myocardial infarction in critically ill patients: An agreement study,Journal of Critical Care,2009,10.1016/j.jcrc.2008.08.012,https://experts.mcmaster.ca/display/publication190159,2025-07-27T15:03:35.872924
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses (vol 46, pg 1286, 2006)",Transfusion,2009,,https://experts.mcmaster.ca/display/publication211543,2025-07-27T15:03:35.872926
Mark Crowther,josips1@mcmaster.ca,journal_articles,2009 evidence-based clinical practice guidelines for diagnosing a first episode of lower extremities deep vein thrombosis in ambulatory outpatients,Polskie Archiwum Medycyny Wewnetrznej,2009,10.20452/pamw.763,https://experts.mcmaster.ca/display/publication455603,2025-07-27T15:03:35.872928
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of bleeding in patients on antithrombotics: maintaining the balance between thrombosis and hemorrhage,Expert Review of Hematology,2009,10.1586/ehm.09.37,https://experts.mcmaster.ca/display/publication1520956,2025-07-27T15:03:35.872929
Mark Crowther,josips1@mcmaster.ca,journal_articles,Symposium 4: Hot topics in parenteral nutrition A review of the use of glutamine supplementation in the nutritional support of patients undergoing bone-marrow transplantation and traditional cancer therapy,Proceedings of the Nutrition Society,2009,10.1017/s0029665109001384,https://experts.mcmaster.ca/display/publication1521034,2025-07-27T15:03:35.872931
Mark Crowther,josips1@mcmaster.ca,journal_articles,Outcomes and predictors of very stable INR control during chronic anticoagulation therapy,Blood,2009,10.1182/blood-2009-02-207928,https://experts.mcmaster.ca/display/publication440831,2025-07-27T15:03:35.872932
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predicting Deep Venous Thrombosis in Pregnancy: Out in “LEFt” Field?,ACP journal club,2009,10.7326/0003-4819-151-2-200907210-00004,https://experts.mcmaster.ca/display/publication1439358,2025-07-27T15:03:35.872933
Mark Crowther,josips1@mcmaster.ca,journal_articles,A case of apples and pears?,Blood,2009,10.1182/blood-2009-03-211169,https://experts.mcmaster.ca/display/publication1599914,2025-07-27T15:03:35.872934
Mark Crowther,josips1@mcmaster.ca,journal_articles,Definition of major bleeding used by US anticoagulation clinics,Thrombosis Research,2009,10.1016/j.thromres.2008.08.009,https://experts.mcmaster.ca/display/publication1521011,2025-07-27T15:03:35.872936
Mark Crowther,josips1@mcmaster.ca,journal_articles,Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis,Journal of Critical Care,2009,10.1016/j.jcrc.2009.01.010,https://experts.mcmaster.ca/display/publication180254,2025-07-27T15:03:35.872937
Mark Crowther,josips1@mcmaster.ca,journal_articles,In Reply to ‘Erythropoietin and Cancer: An Old Risk’,American Journal of Kidney Diseases,2009,10.1053/j.ajkd.2009.03.007,https://experts.mcmaster.ca/display/publication1520974,2025-07-27T15:03:35.872938
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: A systematic review,Journal of Critical Care,2009,10.1016/j.jcrc.2008.11.002,https://experts.mcmaster.ca/display/publication190158,2025-07-27T15:03:35.872939
Mark Crowther,josips1@mcmaster.ca,journal_articles,Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review,Haematologica,2009,10.3324/haematol.2008.005348,https://experts.mcmaster.ca/display/publication440827,2025-07-27T15:03:35.872941
Mark Crowther,josips1@mcmaster.ca,journal_articles,Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose,Transfusion,2009,10.1111/j.1537-2995.2008.02080.x,https://experts.mcmaster.ca/display/publication440789,2025-07-27T15:03:35.872942
Mark Crowther,josips1@mcmaster.ca,journal_articles,JAK2V617F mutation for the early diagnosis of Ph− myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis,Blood,2009,10.1182/blood-2008-12-196014,https://experts.mcmaster.ca/display/publication1520993,2025-07-27T15:03:35.872943
Mark Crowther,josips1@mcmaster.ca,journal_articles,Adverse Prognostic Significance of Thrombocytopenia in Acute Coronary Syndrome,Circulation,2009,10.1161/circulationaha.109.858316,https://experts.mcmaster.ca/display/publication440738,2025-07-27T15:03:35.872945
Mark Crowther,josips1@mcmaster.ca,journal_articles,Validation of a diagnostic approach to exclude recurrent venous thromboembolism,Journal of Thrombosis and Haemostasis,2009,10.1111/j.1538-7836.2009.03324.x,https://experts.mcmaster.ca/display/publication1086070,2025-07-27T15:03:35.872946
Mark Crowther,josips1@mcmaster.ca,journal_articles,Severe Hemolytic Anemia Post–Renal Transplantation Produced by Donor Anti-D Passenger Lymphocytes: Case Report and Literature Review,Transfusion Medicine Reviews,2009,10.1016/j.tmrv.2008.12.005,https://experts.mcmaster.ca/display/publication440835,2025-07-27T15:03:35.872947
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral Vitamin K Versus Placebo to Correct Excessive Anticoagulation in Patients Receiving Warfarin,ACP journal club,2009,10.7326/0003-4819-150-5-200903030-00005,https://experts.mcmaster.ca/display/publication440803,2025-07-27T15:03:35.872948
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: A systematic review of randomized trials,Thrombosis Research,2009,10.1016/j.thromres.2008.09.015,https://experts.mcmaster.ca/display/publication53368,2025-07-27T15:03:35.872950
Mark Crowther,josips1@mcmaster.ca,journal_articles,Acute Kidney Injury After Cardiac Surgery,Circulation,2009,10.1161/circulationaha.108.786913,https://experts.mcmaster.ca/display/publication457535,2025-07-27T15:03:35.872951
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial.",Journal of Rheumatology,2009,10.3899/jrheum.080763),https://experts.mcmaster.ca/display/publication839754,2025-07-27T15:03:35.872952
Mark Crowther,josips1@mcmaster.ca,journal_articles,A systematic review of nutritional support in haematopoietic stem cell transplantation,Proceedings of the Nutrition Society,2009,10.1017/s0029665109001931,https://experts.mcmaster.ca/display/publication2135288,2025-07-27T15:03:35.872953
Mark Crowther,josips1@mcmaster.ca,journal_articles,ASH evidence-based guidelines: what is the role of inferior vena cava filters in the perioperative prevention of venous thromboembolism in bariatric surgery patients?,Hematology. American Society of Hematology. Education Program,2009,10.1182/asheducation-2009.1.302,https://experts.mcmaster.ca/display/publication925715,2025-07-27T15:03:35.872955
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation,Blood Coagulation and Fibrinolysis,2009,10.1097/mbc.0b013e32831be9da,https://experts.mcmaster.ca/display/publication440815,2025-07-27T15:03:35.872956
Mark Crowther,josips1@mcmaster.ca,journal_articles,Introduction to surrogates and evidence-based mini-reviews,Hematology. American Society of Hematology. Education Program,2009,10.1182/asheducation-2009.1.15,https://experts.mcmaster.ca/display/publication925717,2025-07-27T15:03:35.872958
Mark Crowther,josips1@mcmaster.ca,journal_articles,Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists,Thrombosis and Haemostasis,2009,10.1160/th08-12-0842,https://experts.mcmaster.ca/display/publication1521023,2025-07-27T15:03:35.872959
Mark Crowther,josips1@mcmaster.ca,journal_articles,Venous thromboembolism and bleeding in a community setting,Thrombosis and Haemostasis,2009,10.1160/th08-06-0352,https://experts.mcmaster.ca/display/publication440791,2025-07-27T15:03:35.872960
Mark Crowther,josips1@mcmaster.ca,journal_articles,Erythropoietin-Stimulating Agents: Ongoing Concerns With Safety,American Journal of Kidney Diseases,2008,10.1053/j.ajkd.2008.10.006,https://experts.mcmaster.ca/display/publication1520944,2025-07-27T15:03:35.873207
Mark Crowther,josips1@mcmaster.ca,journal_articles,Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial,Blood,2008,10.1182/blood-2008-06-163279,https://experts.mcmaster.ca/display/publication440819,2025-07-27T15:03:35.873209
Mark Crowther,josips1@mcmaster.ca,journal_articles,Preventing and managing bleeding complications in anticoagulated patients: A case based approach,Thrombosis Research,2008,10.1016/j.thromres.2008.08.015,https://experts.mcmaster.ca/display/publication1520945,2025-07-27T15:03:35.873211
Mark Crowther,josips1@mcmaster.ca,journal_articles,Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review,BMC Geriatrics,2008,10.1186/1471-2318-8-13,https://experts.mcmaster.ca/display/publication914419,2025-07-27T15:03:35.873212
Mark Crowther,josips1@mcmaster.ca,journal_articles,Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients,Blood,2008,10.1182/blood.v112.11.170.170,https://experts.mcmaster.ca/display/publication2135212,2025-07-27T15:03:35.873213
Mark Crowther,josips1@mcmaster.ca,journal_articles,Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study,Blood,2008,10.1182/blood.v112.11.3027.3027,https://experts.mcmaster.ca/display/publication2135208,2025-07-27T15:03:35.873215
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review.,Blood,2008,10.1182/blood.v112.11.3413.3413,https://experts.mcmaster.ca/display/publication1977589,2025-07-27T15:03:35.873217
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Impact of Deep Vein Thrombosis on Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis,Blood,2008,10.1182/blood.v112.11.3023.3023,https://experts.mcmaster.ca/display/publication2135211,2025-07-27T15:03:35.873218
Mark Crowther,josips1@mcmaster.ca,journal_articles,Human-Derived D-Dimer for External Quality Assessment,American Journal of Clinical Pathology,2008,10.1309/ajcpubfrq8q6zwty,https://experts.mcmaster.ca/display/publication375613,2025-07-27T15:03:35.873219
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboprophylaxis in medical–surgical critically ill patients,Current Opinion in Critical Care,2008,10.1097/mcc.0b013e32830c484d,https://experts.mcmaster.ca/display/publication211692,2025-07-27T15:03:35.873221
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>,JAMA Internal Medicine,2008,10.1001/archinte.168.16.1805,https://experts.mcmaster.ca/display/publication180349,2025-07-27T15:03:35.873222
Mark Crowther,josips1@mcmaster.ca,journal_articles,Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy,CANADIAN MEDICAL ASSOCIATION JOURNAL,2008,10.1503/cmaj.080493,https://experts.mcmaster.ca/display/publication1520994,2025-07-27T15:03:35.873223
Mark Crowther,josips1@mcmaster.ca,journal_articles,Pharmacokinetics of High‐Dose Abetimus Sodium in Normal Subjects With Specific Assessment of Effect on Coagulation,Journal of Clinical Pharmacology,2008,10.1177/0091270008319465,https://experts.mcmaster.ca/display/publication439969,2025-07-27T15:03:35.873225
Mark Crowther,josips1@mcmaster.ca,journal_articles,Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum,Annals of Pharmacotherapy,2008,10.1345/aph.1l098,https://experts.mcmaster.ca/display/publication864246,2025-07-27T15:03:35.873226
Mark Crowther,josips1@mcmaster.ca,journal_articles,Preventing Venous Thromboembolism in Critically Ill Patients,Seminars in Thrombosis and Hemostasis,2008,10.1055/s-0028-1092877,https://experts.mcmaster.ca/display/publication211688,2025-07-27T15:03:35.873227
Mark Crowther,josips1@mcmaster.ca,journal_articles,Pharmacology and Management of the Vitamin K Antagonists,Chest,2008,10.1378/chest.08-0670,https://experts.mcmaster.ca/display/publication820071,2025-07-27T15:03:35.873229
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents,Blood,2008,10.1182/blood-2007-10-120543,https://experts.mcmaster.ca/display/publication439941,2025-07-27T15:03:35.873230
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombotic thrombocytopenic purpura: 2008 Update,Cleveland Clinic Journal of Medicine,2008,10.3949/ccjm.75.5.369,https://experts.mcmaster.ca/display/publication439925,2025-07-27T15:03:35.873231
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Reply,American Journal of Medicine,2008,10.1016/j.amjmed.2007.11.011,https://experts.mcmaster.ca/display/publication1520980,2025-07-27T15:03:35.873233
Mark Crowther,josips1@mcmaster.ca,journal_articles,"The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies",European Heart Journal,2008,10.1093/eurheartj/ehn104,https://experts.mcmaster.ca/display/publication439945,2025-07-27T15:03:35.873234
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis,Journal of Thrombosis and Haemostasis,2008,10.1111/j.1538-7836.2007.02847.x,https://experts.mcmaster.ca/display/publication439953,2025-07-27T15:03:35.873235
Mark Crowther,josips1@mcmaster.ca,journal_articles,Incidence of venous thromboembolism in patients undergoing thoracotomy for lung cancer,Journal of Thoracic and Cardiovascular Surgery,2008,10.1016/j.jtcvs.2007.10.036,https://experts.mcmaster.ca/display/publication1521018,2025-07-27T15:03:35.873237
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Multicenter Trial of the Effectiveness of ζ-Globin Enzyme-Linked Immunosorbent Assay and Hemoglobin H Inclusion Body Screening for the Detection of α0-Thalassemia Trait,American Journal of Clinical Pathology,2008,10.1309/mnpf3xxxvax5nm9h,https://experts.mcmaster.ca/display/publication439937,2025-07-27T15:03:35.873238
Mark Crowther,josips1@mcmaster.ca,journal_articles,Re-examining aggressive anticoagulant therapy: the case of acute coronary syndromes,Nature Reviews Cardiology,2008,10.1038/ncpcardio1059,https://experts.mcmaster.ca/display/publication668142,2025-07-27T15:03:35.873239
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Red Blood Cell Agglutination d-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy,Obstetrical and Gynecological Survey,2008,10.1097/ogx.0b013e31815eb460,https://experts.mcmaster.ca/display/publication2135282,2025-07-27T15:03:35.873241
Mark Crowther,josips1@mcmaster.ca,journal_articles,Addition of graduated compression stockings to fondaparinux did not reduce risk for venous thromboembolism after hip surgery,ACP journal club,2008,10.7326/acpjc-2008-148-1-021,https://experts.mcmaster.ca/display/publication1079822,2025-07-27T15:03:35.873242
Mark Crowther,josips1@mcmaster.ca,journal_articles,Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings,Critical Care,2008,10.1186/cc6815,https://experts.mcmaster.ca/display/publication190193,2025-07-27T15:03:35.873244
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence-Based Guidelines—An Introduction,Hematology. American Society of Hematology. Education Program,2008,10.1182/asheducation-2008.1.26,https://experts.mcmaster.ca/display/publication925734,2025-07-27T15:03:35.873245
Mark Crowther,josips1@mcmaster.ca,journal_articles,Geographic variation in the reversal of vitamin K antagonist-associated coagulopathy,Critical Care,2008,10.1186/cc6441,https://experts.mcmaster.ca/display/publication2135269,2025-07-27T15:03:35.873247
Mark Crowther,josips1@mcmaster.ca,journal_articles,Has the incidence of deep vein thrombosis in patients undergoing total hip/knee arthroplasty changed over time? A systematic review of randomized controlled trials,Thrombosis Research,2008,10.1016/j.thromres.2008.05.005,https://experts.mcmaster.ca/display/publication670709,2025-07-27T15:03:35.873248
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of Excessive Anticoagulant Effect Due to Vitamin K Antagonists,Hematology. American Society of Hematology. Education Program,2008,10.1182/asheducation-2008.1.266,https://experts.mcmaster.ca/display/publication925730,2025-07-27T15:03:35.873249
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reply,Annals of Thoracic Surgery,2008,10.1016/j.athoracsur.2007.07.072,https://experts.mcmaster.ca/display/publication439961,2025-07-27T15:03:35.873250
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversal of vitamin K antagonist-associated coagulopathy: A survey of current practice,Thrombosis Research,2008,10.1016/j.thromres.2008.06.003,https://experts.mcmaster.ca/display/publication928355,2025-07-27T15:03:35.873252
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin prophylaxis: prevalence, incidence and risk factors",Critical Care,2008,10.1186/cc6810,https://experts.mcmaster.ca/display/publication180350,2025-07-27T15:03:35.873253
Mark Crowther,josips1@mcmaster.ca,journal_articles,What Is the Evidence for the Off-label Use of Recombinant Factor VIIa (rFVIIa) in the Acute Reversal of Warfarin?,Hematology. American Society of Hematology. Education Program,2008,10.1182/asheducation-2008.1.36,https://experts.mcmaster.ca/display/publication925732,2025-07-27T15:03:35.873254
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Negative D-dimer Excludes Recurrent Deep Vein Thrombosis: Results of a Multicentre Management Study.,Blood,2007,10.1182/blood.v110.11.698.698,https://experts.mcmaster.ca/display/publication2135215,2025-07-27T15:03:35.873256
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulation for the prevention of central venous catheter associated-thrombosis: an evidence based commentary,Polskie Archiwum Medycyny Wewnetrznej,2007,10.20452/pamw.238,https://experts.mcmaster.ca/display/publication925739,2025-07-27T15:03:35.873257
Mark Crowther,josips1@mcmaster.ca,journal_articles,How we diagnose and treat thrombotic manifestations of the antiphospholipid syndrome: a case-based review,Blood,2007,10.1182/blood-2006-10-041814,https://experts.mcmaster.ca/display/publication439951,2025-07-27T15:03:35.873259
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulant Prophylaxis for Hospitalized Medical Patients,ACP journal club,2007,10.7326/0003-4819-147-7-200710020-00023,https://experts.mcmaster.ca/display/publication439933,2025-07-27T15:03:35.873260
Mark Crowther,josips1@mcmaster.ca,journal_articles,In response,Annals of Internal Medicine,2007,10.7326/0003-4819-147-7-200710020-00023,https://experts.mcmaster.ca/display/publication1748463,2025-07-27T15:03:35.873262
Mark Crowther,josips1@mcmaster.ca,journal_articles,Inferior Vena Cava Filters in the Management of Venous Thromboembolism,American Journal of Medicine,2007,10.1016/j.amjmed.2007.07.015,https://experts.mcmaster.ca/display/publication439971,2025-07-27T15:03:35.873263
Mark Crowther,josips1@mcmaster.ca,journal_articles,The management of anticoagulated patients requiring dental extraction: a cross‐sectional survey of oral and maxillofacial surgeons and hematologists,Journal of Thrombosis and Haemostasis,2007,10.1111/j.1538-7836.2007.02700.x,https://experts.mcmaster.ca/display/publication668191,2025-07-27T15:03:35.873264
Mark Crowther,josips1@mcmaster.ca,journal_articles,Targeting Anemia with Erythropoietin during Critical Illness,New England Journal of Medicine,2007,10.1056/nejme078150,https://experts.mcmaster.ca/display/publication190207,2025-07-27T15:03:35.873266
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid antibiodies: a critical review of the literature,Current Opinion in Hematology,2007,10.1097/moh.0b013e3282a4a65f,https://experts.mcmaster.ca/display/publication439965,2025-07-27T15:03:35.873267
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low molecular weight heparin and bleeding in patients with chronic renal failure,Current Opinion in Pulmonary Medicine,2007,10.1097/mcp.0b013e328216430d,https://experts.mcmaster.ca/display/publication668118,2025-07-27T15:03:35.873268
Mark Crowther,josips1@mcmaster.ca,journal_articles,In response,Annals of Internal Medicine,2007,10.7326/0003-4819-147-4-200708210-00019,https://experts.mcmaster.ca/display/publication1749731,2025-07-27T15:03:35.873269
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rituximab for Patients with Idiopathic Thrombocytopenic Purpura,ACP journal club,2007,10.7326/0003-4819-147-4-200708210-00019,https://experts.mcmaster.ca/display/publication439947,2025-07-27T15:03:35.873271
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Red Blood Cell Agglutinationd-Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy,ACP journal club,2007,10.7326/0003-4819-147-3-200708070-00005,https://experts.mcmaster.ca/display/publication1439364,2025-07-27T15:03:35.873272
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin,Journal of Thrombosis and Thrombolysis,2007,10.1007/s11239-007-0022-z,https://experts.mcmaster.ca/display/publication439959,2025-07-27T15:03:35.873274
Mark Crowther,josips1@mcmaster.ca,journal_articles,CLINICALLY - IMPORTANT VENOUS THROMBOEMBOLISM (CIVTE) FOLLOWING ISOLATED LEG FRACTURES DISTAL TO THE KNEE: EPIDEMIOLOGY AND PREVENTION: THE D-KAF (DALTEPARIN IN KNEE TO ANKLE FRACTURE) TRIAL,Journal of Thrombosis and Haemostasis,2007,10.1111/j.1538-7836.2007.tb01708.x,https://experts.mcmaster.ca/display/publication2135248,2025-07-27T15:03:35.873275
Mark Crowther,josips1@mcmaster.ca,journal_articles,DALTEPARIN THROMBOPROPHYLAXIS IN CRITICALLY ILL PATIENTS WITH SEVERE RENAL INSUFFICIENCY: THE DIRECT STUDY,Journal of Thrombosis and Haemostasis,2007,10.1111/j.1538-7836.2007.tb00774.x,https://experts.mcmaster.ca/display/publication2135249,2025-07-27T15:03:35.873276
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fresh frozen plasma transfusion in critically ill patients*,Critical Care Medicine,2007,10.1097/01.ccm.0000269370.59214.97,https://experts.mcmaster.ca/display/publication190212,2025-07-27T15:03:35.873278
Mark Crowther,josips1@mcmaster.ca,journal_articles,The role of recombinant factor VIIa in on-pump cardiac surgery: Proceedings of the Canadian Consensus Conference,Canadian Journal of Anaesthesia,2007,10.1007/bf03022322,https://experts.mcmaster.ca/display/publication440109,2025-07-27T15:03:35.873279
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin Cessation Before Cardiopulmonary Bypass: Lessons Learned from a Randomized Controlled Trial of Oral Vitamin K,Annals of Thoracic Surgery,2007,10.1016/j.athoracsur.2007.03.014,https://experts.mcmaster.ca/display/publication440149,2025-07-27T15:03:35.873280
Mark Crowther,josips1@mcmaster.ca,journal_articles,Should you add aspirin to your heart patient's warfarin regimen?,Journal of Family Practice,2007,,https://experts.mcmaster.ca/display/publication668215,2025-07-27T15:03:35.873282
Mark Crowther,josips1@mcmaster.ca,journal_articles,Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss.,Journal of Rheumatology,2007,,https://experts.mcmaster.ca/display/publication440123,2025-07-27T15:03:35.873283
Mark Crowther,josips1@mcmaster.ca,journal_articles,Paper-based dosing algorithms for maintenance of warfarin anticoagulation,Journal of Thrombosis and Thrombolysis,2007,10.1007/s11239-006-9025-4,https://experts.mcmaster.ca/display/publication440143,2025-07-27T15:03:35.873284
Mark Crowther,josips1@mcmaster.ca,journal_articles,An abnormal D-dimer test result indicated that anticoagulant therapy should be continued,BMJ Evidence-Based Medicine,2007,10.1136/ebm.12.2.45,https://experts.mcmaster.ca/display/publication1520946,2025-07-27T15:03:35.873286
Mark Crowther,josips1@mcmaster.ca,journal_articles,An abnormalD-dimer test result indicated that anticoagulation should be continued,ACP journal club,2007,10.7326/acpjc-2007-146-2-029,https://experts.mcmaster.ca/display/publication1520947,2025-07-27T15:03:35.873287
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fondaparinux – evolution or revolution in anticoagulant care?,Polskie Archiwum Medycyny Wewnetrznej,2007,10.20452/pamw.81,https://experts.mcmaster.ca/display/publication1033832,2025-07-27T15:03:35.873289
Mark Crowther,josips1@mcmaster.ca,journal_articles,Meta-analysis: Anticoagulant Prophylaxis to Prevent Symptomatic Venous Thromboembolism in Hospitalized Medical Patients,ACP journal club,2007,10.7326/0003-4819-146-4-200702200-00007,https://experts.mcmaster.ca/display/publication440131,2025-07-27T15:03:35.873290
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario,American Journal of Clinical Pathology,2007,10.1309/p6hm33f4d05t30ym,https://experts.mcmaster.ca/display/publication440111,2025-07-27T15:03:35.873291
Mark Crowther,josips1@mcmaster.ca,journal_articles,Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease,JAMA Internal Medicine,2007,10.1001/archinte.167.2.117,https://experts.mcmaster.ca/display/publication668230,2025-07-27T15:03:35.873293
Mark Crowther,josips1@mcmaster.ca,journal_articles,Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura,ACP journal club,2007,10.7326/0003-4819-146-1-200701020-00006,https://experts.mcmaster.ca/display/publication440133,2025-07-27T15:03:35.873294
Mark Crowther,josips1@mcmaster.ca,journal_articles,A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.,Journal of Population Therapeutics and Clinical Pharmacology,2007,,https://experts.mcmaster.ca/display/publication882480,2025-07-27T15:03:35.873296
Mark Crowther,josips1@mcmaster.ca,journal_articles,A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.,Journal of Population Therapeutics and Clinical Pharmacology,2007,,https://experts.mcmaster.ca/display/publication882485,2025-07-27T15:03:35.873297
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prevention and treatment of venous thromboembolism in the elderly patient.,Clinical interventions in aging,2007,10.2147/ciia.s12159904,https://experts.mcmaster.ca/display/publication440740,2025-07-27T15:03:35.873298
Mark Crowther,josips1@mcmaster.ca,journal_articles,Trials and Tribulations of Systematic Reviews and Meta-Analyses,Hematology. American Society of Hematology. Education Program,2007,10.1182/asheducation-2007.1.493,https://experts.mcmaster.ca/display/publication211707,2025-07-27T15:03:35.873300
Mark Crowther,josips1@mcmaster.ca,journal_articles,When is HIT Really HIT?,Annals of Thoracic Surgery,2007,10.1016/j.athoracsur.2006.07.006,https://experts.mcmaster.ca/display/publication439957,2025-07-27T15:03:35.873301
Mark Crowther,josips1@mcmaster.ca,journal_articles,Elevated Cardiac Troponin Measurements in Critically Ill Patients,JAMA Internal Medicine,2006,10.1001/archinte.166.22.2446,https://experts.mcmaster.ca/display/publication211734,2025-07-27T15:03:35.873302
Mark Crowther,josips1@mcmaster.ca,journal_articles,ELEVATED TROPONIN MEASUREMENTS IN THE CRITICALLY ILL.,Critical Care Medicine,2006,10.1097/00003246-200612002-00203,https://experts.mcmaster.ca/display/publication2135252,2025-07-27T15:03:35.873304
Mark Crowther,josips1@mcmaster.ca,journal_articles,New anticoagulants and the management of their bleeding complications,Transfusion Alternatives in Transfusion Medicine,2006,10.1111/j.1778-428x.2006.00026.x,https://experts.mcmaster.ca/display/publication2135278,2025-07-27T15:03:35.873305
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety and Efficacy of Anti-Fibrinolytics in Orthopedic Surgery: A Meta-Analysis of Randomized Trials.,Blood,2006,10.1182/blood.v108.11.628.628,https://experts.mcmaster.ca/display/publication2135202,2025-07-27T15:03:35.873307
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Management of Anticoagulated Patients Requiring Dental Extraction: A Cross-Sectional Survey of Oral Surgeons and Hematologists.,Blood,2006,10.1182/blood.v108.11.629.629,https://experts.mcmaster.ca/display/publication2135201,2025-07-27T15:03:35.873308
Mark Crowther,josips1@mcmaster.ca,journal_articles,Unexpected Harmful Side Effects Triggered by Immune Modulation.,Blood,2006,10.1182/blood.v108.11.4008.4008,https://experts.mcmaster.ca/display/publication2171393,2025-07-27T15:03:35.873309
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of Therapeutic Dose Low Molecular Weight Heparin in Patients with Renal Insufficiency: Analysis of Anti-Xa Levels and Creatinine Clearance.,Blood,2006,10.1182/blood.v108.11.884.884,https://experts.mcmaster.ca/display/publication2135200,2025-07-27T15:03:35.873310
Mark Crowther,josips1@mcmaster.ca,journal_articles,Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.,Journal of Rheumatology,2006,,https://experts.mcmaster.ca/display/publication1520948,2025-07-27T15:03:35.873312
Mark Crowther,josips1@mcmaster.ca,journal_articles,Acquired Thrombophilia during Pregnancy,Obstetrics and Gynecology Clinics of North America,2006,10.1016/j.ogc.2006.05.006,https://experts.mcmaster.ca/display/publication1520967,2025-07-27T15:03:35.873314
Mark Crowther,josips1@mcmaster.ca,journal_articles,The metabolic syndrome and the risk of venous thrombosis: a case–control study,Journal of Thrombosis and Haemostasis,2006,10.1111/j.1538-7836.2006.02132.x,https://experts.mcmaster.ca/display/publication1521025,2025-07-27T15:03:35.873316
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms,Journal of Thrombosis and Haemostasis,2006,10.1111/j.1538-7836.2006.01986.x,https://experts.mcmaster.ca/display/publication1521012,2025-07-27T15:03:35.873317
Mark Crowther,josips1@mcmaster.ca,journal_articles,Natural history of cerebral vein thrombosis: a systematic review,Blood,2006,10.1182/blood-2005-12-4795,https://experts.mcmaster.ca/display/publication440101,2025-07-27T15:03:35.873318
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses",Transfusion,2006,10.1111/j.1537-2995.2006.00892.x,https://experts.mcmaster.ca/display/publication211736,2025-07-27T15:03:35.873320
Mark Crowther,josips1@mcmaster.ca,journal_articles,What makes a good ICU?,Australian Critical Care,2006,10.1016/s1036-7314(06)80002-0,https://experts.mcmaster.ca/display/publication2135271,2025-07-27T15:03:35.873321
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment of Antiphospholipid Antibody Syndrome—Reply,Journal of the American Medical Association (JAMA),2006,10.1001/jama.296.1.43-a,https://experts.mcmaster.ca/display/publication593557,2025-07-27T15:03:35.873322
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Does Celecoxib Potentiate the Anticoagulant Effect of Warfarin? A Randomized, Double-Blind, Controlled Trial",Annals of Pharmacotherapy,2006,10.1345/aph.1g733,https://experts.mcmaster.ca/display/publication441424,2025-07-27T15:03:35.873323
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study,Haematologica,2006,,https://experts.mcmaster.ca/display/publication1689010,2025-07-27T15:03:35.873325
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety of dalteparin for the prophylaxis of venous thromboembolism in elderly medical patients with renal insufficiency: a pilot study.,Haematologica,2006,,https://experts.mcmaster.ca/display/publication440125,2025-07-27T15:03:35.873326
Mark Crowther,josips1@mcmaster.ca,journal_articles,An Evaluation ofd-Dimer in the Diagnosis of Pulmonary Embolism,ACP journal club,2006,10.7326/0003-4819-144-11-200606060-00007,https://experts.mcmaster.ca/display/publication440139,2025-07-27T15:03:35.873327
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of antiphospholipid antibody syndrome.,Journal of Family Practice,2006,,https://experts.mcmaster.ca/display/publication440103,2025-07-27T15:03:35.873329
Mark Crowther,josips1@mcmaster.ca,journal_articles,Practice patterns for deep vein thrombosis prophylaxis in minimal-access surgery.,Canadian Journal of Surgery,2006,,https://experts.mcmaster.ca/display/publication502639,2025-07-27T15:03:35.873330
Mark Crowther,josips1@mcmaster.ca,journal_articles,Meta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency,ACP journal club,2006,10.7326/0003-4819-144-9-200605020-00011,https://experts.mcmaster.ca/display/publication440121,2025-07-27T15:03:35.873331
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Elevated Cardiac Troponin Levels in Critically Ill Patients: Prevalence, Incidence, and Outcomes",American Journal of Critical Care,2006,10.4037/ajcc2006.15.3.280,https://experts.mcmaster.ca/display/publication211743,2025-07-27T15:03:35.873332
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reliability of electrocardiogram interpretation in critically ill patients,Critical Care Medicine,2006,10.1097/01.CCM.0000214679.23957.90,https://experts.mcmaster.ca/display/publication218356,2025-07-27T15:03:35.873334
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reliability of electrocardiogram interpretation in critically ill patients*,Critical Care Medicine,2006,10.1097/01.ccm.0000214679.23957.90,https://experts.mcmaster.ca/display/publication211744,2025-07-27T15:03:35.873335
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis",Blood,2006,10.1182/blood-2005-09-3578,https://experts.mcmaster.ca/display/publication1520949,2025-07-27T15:03:35.873336
Mark Crowther,josips1@mcmaster.ca,journal_articles,Azathioprine and inhibition of the anticoagulant effect of warfarin: Evidence from a case report and a literature review,American Journal of Geriatric Pharmacotherapy,2006,10.1016/j.amjopharm.2006.03.001,https://experts.mcmaster.ca/display/publication925753,2025-07-27T15:03:35.873338
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of Antiphospholipid Antibody Syndrome,Journal of the American Medical Association (JAMA),2006,10.1001/jama.295.9.1050,https://experts.mcmaster.ca/display/publication440193,2025-07-27T15:03:35.873339
Mark Crowther,josips1@mcmaster.ca,journal_articles,Minimizing errors of omission: Behavioural rEenforcement of Heparin to Avert Venous Emboli: The BEHAVE Study*,Critical Care Medicine,2006,10.1097/01.ccm.0000201886.84135.cb,https://experts.mcmaster.ca/display/publication190244,2025-07-27T15:03:35.873340
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Risk of Hemorrhage Among Patients With Warfarin-Associated Coagulopathy,Journal of the American College of Cardiology,2006,10.1016/j.jacc.2005.09.058,https://experts.mcmaster.ca/display/publication1521013,2025-07-27T15:03:35.873342
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding in patients with renal insufficiency: A practical guide to clinical management,Thrombosis Research,2006,10.1016/j.thromres.2005.03.029,https://experts.mcmaster.ca/display/publication440137,2025-07-27T15:03:35.873343
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dalteparin versus Warfarin for the Prevention of Recurrent Venous Thromboembolic Events in Cancer Patients,PharmacoEconomics (Auckland),2006,10.2165/00019053-200624060-00006,https://experts.mcmaster.ca/display/publication1520970,2025-07-27T15:03:35.873345
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effect of chronic kidney disease on red blood cell rheology.,Clinical Hemorheology and Microcirculation,2006,10.3233/chm-2006-862,https://experts.mcmaster.ca/display/publication871512,2025-07-27T15:03:35.873346
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy",Thrombosis and Haemostasis,2006,10.1160/th06-03-0129,https://experts.mcmaster.ca/display/publication440113,2025-07-27T15:03:35.873348
Mark Crowther,josips1@mcmaster.ca,journal_articles,Measuring the anticoagulant effect of low molecular weight heparins in the critically ill.,Critical Care,2006,10.1186/cc4978,https://experts.mcmaster.ca/display/publication670477,2025-07-27T15:03:35.873349
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: The Heart Outcomes Prevention Evaluation (HOPE)-2 trial",Canadian Journal of Cardiology,2006,10.1016/s0828-282x(06)70238-0,https://experts.mcmaster.ca/display/publication457188,2025-07-27T15:03:35.873351
Mark Crowther,josips1@mcmaster.ca,journal_articles,The safety of co-administered continuous epidural analgesia and low-molecular-weight heparin after major orthopedic surgery: Assessment of a standardized patient management protocol,Thrombosis and Haemostasis,2006,10.1160/th06-06-0303,https://experts.mcmaster.ca/display/publication1520958,2025-07-27T15:03:35.873352
Mark Crowther,josips1@mcmaster.ca,journal_articles,Uremic bleeding: Pathophysiology and clinical risk factors,Thrombosis Research,2006,10.1016/j.thromres.2005.03.032,https://experts.mcmaster.ca/display/publication440119,2025-07-27T15:03:35.873353
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboembolic complications of malignancy: Part 1: Risk. Commentary,Oncology,2005,,https://experts.mcmaster.ca/display/publication1751902,2025-07-27T15:03:35.873354
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulant prophylaxis in special populations with an indwelling epidural catheter or renal insufficiency,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.001,https://experts.mcmaster.ca/display/publication440105,2025-07-27T15:03:35.873356
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.009,https://experts.mcmaster.ca/display/publication211756,2025-07-27T15:03:35.873357
Mark Crowther,josips1@mcmaster.ca,journal_articles,Deep venous thrombosis: clinically silent in the intensive care unit,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.011,https://experts.mcmaster.ca/display/publication211759,2025-07-27T15:03:35.873358
Mark Crowther,josips1@mcmaster.ca,journal_articles,On the need for a workshop on venous thromboembolism in critical care,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.004,https://experts.mcmaster.ca/display/publication211761,2025-07-27T15:03:35.873360
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical intensive care unit patients",Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.005,https://experts.mcmaster.ca/display/publication211760,2025-07-27T15:03:35.873361
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.010,https://experts.mcmaster.ca/display/publication211755,2025-07-27T15:03:35.873362
Mark Crowther,josips1@mcmaster.ca,journal_articles,Research agenda: venous thromboembolism in medical-surgical critically ill patients,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.006,https://experts.mcmaster.ca/display/publication211752,2025-07-27T15:03:35.873364
Mark Crowther,josips1@mcmaster.ca,journal_articles,The diagnosis of deep venous thrombosis and pulmonary embolism in medical-surgical intensive care unit patients,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.003,https://experts.mcmaster.ca/display/publication190249,2025-07-27T15:03:35.873366
Mark Crowther,josips1@mcmaster.ca,journal_articles,The incidence and impact of lupus anticoagulants among patients in the intensive care unit.,Saudi Medical Journal,2005,,https://experts.mcmaster.ca/display/publication888806,2025-07-27T15:03:35.873367
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factors",Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.008,https://experts.mcmaster.ca/display/publication211757,2025-07-27T15:03:35.873368
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboprophylaxis in medical-surgical intensive care unit patients,Journal of Critical Care,2005,10.1016/j.jcrc.2005.09.007,https://experts.mcmaster.ca/display/publication190248,2025-07-27T15:03:35.873370
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.,Blood,2005,10.1182/blood.v106.11.583.583,https://experts.mcmaster.ca/display/publication2135205,2025-07-27T15:03:35.873371
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anti-Xa Levels and Renal Function: Analysis of the First 32 Patients in the Tinzaparin in Renal Insufficiency for Venous Thromboembolism Study.,Blood,2005,10.1182/blood.v106.11.906.906,https://experts.mcmaster.ca/display/publication2135204,2025-07-27T15:03:35.873373
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low Molecular Weight Heparin and Bleeding in Patients with Severe Renal Failure: A Meta-Analysis.,Blood,2005,10.1182/blood.v106.11.907.907,https://experts.mcmaster.ca/display/publication2135203,2025-07-27T15:03:35.873374
Mark Crowther,josips1@mcmaster.ca,journal_articles,Rituximab for the Treatment of Adults with ITP: A Systematic Review.,Blood,2005,10.1182/blood.v106.11.1241.1241,https://experts.mcmaster.ca/display/publication2135207,2025-07-27T15:03:35.873375
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of Low Dose Oral Vitamin K in the Treatment of Patients with INR Values of More Than 10.0.,Blood,2005,10.1182/blood.v106.11.547.547,https://experts.mcmaster.ca/display/publication2135206,2025-07-27T15:03:35.873376
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulation therapy in the antiphospholipid syndrome: recent advances,Current Opinion in Pulmonary Medicine,2005,10.1097/01.mcp.0000174229.24854.2e,https://experts.mcmaster.ca/display/publication440215,2025-07-27T15:03:35.873378
Mark Crowther,josips1@mcmaster.ca,journal_articles,Long‐duration therapy with low molecular weight heparin in patients with antiphospholipid antibody syndrome resistant to warfarin therapy,Journal of Thrombosis and Haemostasis,2005,10.1111/j.1538-7836.2005.01516.x,https://experts.mcmaster.ca/display/publication1521000,2025-07-27T15:03:35.873379
Mark Crowther,josips1@mcmaster.ca,journal_articles,Proficiency Testing of Reticulocyte Counting in Ontario,Laboratory Hematology,2005,10.1532/lh96.05013,https://experts.mcmaster.ca/display/publication1520950,2025-07-27T15:03:35.873380
Mark Crowther,josips1@mcmaster.ca,journal_articles,Should Aspirin Be Discontinued Before Coronary Artery Bypass Surgery?,Circulation,2005,10.1161/circulationaha.105.546697,https://experts.mcmaster.ca/display/publication440203,2025-07-27T15:03:35.873381
Mark Crowther,josips1@mcmaster.ca,journal_articles,Perioperative Anticoagulation for Patients With Mechanical Heart Valves: A Survey of Current Practice,ACC Cardiosource Review Journal,2005,10.1016/j.accreview.2005.08.011,https://experts.mcmaster.ca/display/publication2135280,2025-07-27T15:03:35.873383
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Are Brand-Name and Generic Warfarin Interchangeable? Multiple N-of-1 Randomized, Crossover Trials",Annals of Pharmacotherapy,2005,10.1345/aph.1g003,https://experts.mcmaster.ca/display/publication440187,2025-07-27T15:03:35.873384
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bleeding in Cardiac Surgery: Its Prevention and Treatment—an Evidence-Based Review,Critical Care Clinics,2005,10.1016/j.ccc.2005.04.003,https://experts.mcmaster.ca/display/publication440219,2025-07-27T15:03:35.873385
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors",Critical Care Medicine,2005,10.1097/01.ccm.0000171207.95319.b2,https://experts.mcmaster.ca/display/publication190259,2025-07-27T15:03:35.873386
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombo-embolic complications of malignancy - Part 2: Management - The Linenberger/Wittkowsky article reviewed,Oncology,2005,,https://experts.mcmaster.ca/display/publication1520989,2025-07-27T15:03:35.873630
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana‐Farber Cancer Institute protocols: effect of age and risk stratification of disease,British Journal of Haematology,2005,10.1111/j.1365-2141.2005.05528.x,https://experts.mcmaster.ca/display/publication412726,2025-07-27T15:03:35.873647
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin Maintenance Dosing Patterns in Clinical Practice,Chest,2005,10.1378/chest.127.6.2049,https://experts.mcmaster.ca/display/publication1521008,2025-07-27T15:03:35.873652
Mark Crowther,josips1@mcmaster.ca,journal_articles,Systematic Overview of Warfarin and Its Drug and Food Interactions,JAMA Internal Medicine,2005,10.1001/archinte.165.10.1095,https://experts.mcmaster.ca/display/publication885852,2025-07-27T15:03:35.873655
Mark Crowther,josips1@mcmaster.ca,journal_articles,Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case–control study,Journal of Thrombosis and Haemostasis,2005,10.1111/j.1538-7836.2005.01268.x,https://experts.mcmaster.ca/display/publication440179,2025-07-27T15:03:35.873659
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Randomized Trial of Diagnostic Strategies after Normal Proximal Vein Ultrasonography for Suspected Deep Venous Thrombosis:d-Dimer Testing Compared with Repeated Ultrasonography,ACP journal club,2005,10.7326/0003-4819-142-7-200504050-00007,https://experts.mcmaster.ca/display/publication440207,2025-07-27T15:03:35.873662
Mark Crowther,josips1@mcmaster.ca,journal_articles,Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis,Journal of Thrombosis and Haemostasis,2005,10.1111/j.1538-7836.2005.01216.x,https://experts.mcmaster.ca/display/publication467260,2025-07-27T15:03:35.873665
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid antibody syndrome: recent findings on managing this challenging condition.,Cleveland Clinic Journal of Medicine,2005,10.3949/ccjm.72.3.245,https://experts.mcmaster.ca/display/publication440195,2025-07-27T15:03:35.873669
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Video laparoscopic surgery: is out-of-hospital thromboprophylaxis necessary? (vol 3, pg 216, 2004)",Journal of Thrombosis and Haemostasis,2005,,https://experts.mcmaster.ca/display/publication440217,2025-07-27T15:03:35.873672
Mark Crowther,josips1@mcmaster.ca,journal_articles,Tailoring warfarin induction doses to reflect individual and disease-specific factors,American Journal of Medicine,2005,10.1016/j.amjmed.2004.11.015,https://experts.mcmaster.ca/display/publication1521006,2025-07-27T15:03:35.873675
Mark Crowther,josips1@mcmaster.ca,journal_articles,Video laparoscopic surgery: is out‐of‐hospital thromboprophylaxis necessary?,Journal of Thrombosis and Haemostasis,2005,10.1111/j.1538-7836.2005.01111.x,https://experts.mcmaster.ca/display/publication440181,2025-07-27T15:03:35.873678
Mark Crowther,josips1@mcmaster.ca,journal_articles,Acute myocardial infarction: incidence and outcomes in an intensive care unit,Critical Care,2005,10.1186/cc3378,https://experts.mcmaster.ca/display/publication2135257,2025-07-27T15:03:35.873681
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulants and Gastrointestinal Bleeding,Canadian Journal of Gastroenterology and Hepatology,2005,10.1155/2005/709102,https://experts.mcmaster.ca/display/publication1520954,2025-07-27T15:03:35.873684
Mark Crowther,josips1@mcmaster.ca,journal_articles,Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians.,Journal of Population Therapeutics and Clinical Pharmacology,2005,,https://experts.mcmaster.ca/display/publication885851,2025-07-27T15:03:35.873687
Mark Crowther,josips1@mcmaster.ca,journal_articles,Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery,Thrombosis and Haemostasis,2005,10.1160/th05-01-0064,https://experts.mcmaster.ca/display/publication914214,2025-07-27T15:03:35.873690
Mark Crowther,josips1@mcmaster.ca,journal_articles,Elevated troponin and myocardial infarction in the intensive care unit: a prospective study.,Critical Care,2005,10.1186/cc3816,https://experts.mcmaster.ca/display/publication211764,2025-07-27T15:03:35.873693
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence based treatment of the antiphospholipid syndromeII. Optimal anticoagulant therapy for thrombosis,Thrombosis Research,2005,10.1016/s0049-3848(04)00350-0,https://experts.mcmaster.ca/display/publication440189,2025-07-27T15:03:35.873696
Mark Crowther,josips1@mcmaster.ca,journal_articles,Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients,Intensive Care Medicine,2005,10.1007/s00134-004-2467-2,https://experts.mcmaster.ca/display/publication211795,2025-07-27T15:03:35.873700
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.,Haematologica,2005,,https://experts.mcmaster.ca/display/publication440209,2025-07-27T15:03:35.873702
Mark Crowther,josips1@mcmaster.ca,journal_articles,Pathogenesis of Atherosclerosis,Hematology. American Society of Hematology. Education Program,2005,10.1182/asheducation-2005.1.436,https://experts.mcmaster.ca/display/publication925759,2025-07-27T15:03:35.873705
Mark Crowther,josips1@mcmaster.ca,journal_articles,Perioperative Anticoagulation in Patients with Mechanical Heart Valves Undergoing Elective Surgery: Results of a Survey Conducted among Korean Physicians,Yonsei Medical Journal,2005,10.3349/ymj.2005.46.1.66,https://experts.mcmaster.ca/display/publication440197,2025-07-27T15:03:35.873708
Mark Crowther,josips1@mcmaster.ca,journal_articles,The reliability of electrocardiogram interpretation in critically ill patients,Critical Care,2005,10.1186/cc3383,https://experts.mcmaster.ca/display/publication2135268,2025-07-27T15:03:35.873711
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Troponin incidence, prevalence and prognosis among critically ill patients",Critical Care,2005,10.1186/cc3374,https://experts.mcmaster.ca/display/publication2135267,2025-07-27T15:03:35.873714
Mark Crowther,josips1@mcmaster.ca,journal_articles,Patients with severe sepsis vary markedly in their ability to generate activated protein C,Blood,2004,10.1182/blood-2004-03-1203,https://experts.mcmaster.ca/display/publication190288,2025-07-27T15:03:35.873717
Mark Crowther,josips1@mcmaster.ca,journal_articles,Managing oral anticoagulant therapy in patients with mechanical heart valves undergoing elective surgery,Blood Coagulation and Fibrinolysis,2004,10.1097/00001721-200412000-00001,https://experts.mcmaster.ca/display/publication440225,2025-07-27T15:03:35.873720
Mark Crowther,josips1@mcmaster.ca,journal_articles,Perioperative Anticoagulation for Patients with Mechanical Heart Valves: A Survey of Current Practice,Journal of Thrombosis and Thrombolysis,2004,10.1007/s11239-005-0346-5,https://experts.mcmaster.ca/display/publication440183,2025-07-27T15:03:35.873726
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Failure,Journal of the American Society of Nephrology,2004,10.1097/01.asn.0000145014.80714.35,https://experts.mcmaster.ca/display/publication211797,2025-07-27T15:03:35.873729
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety and efficacy of low molecular weight heparins for hem dialysis in patients with end-stage renal failure: A meta-analysis of randomized trials,Journal of the American Society of Nephrology,2004,10.1097/01.ASN.0000145014.80714.35,https://experts.mcmaster.ca/display/publication218328,2025-07-27T15:03:35.873732
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Prospective Cohort Study of the Epidemiology of Symptomatic Venous Thromboembolism (VTE) after Isolated Leg Fractures Distal to the Knee without Thromboprophylaxis.,Blood,2004,10.1182/blood.v104.11.492.492,https://experts.mcmaster.ca/display/publication2135213,2025-07-27T15:03:35.873735
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anti-Xa Levels in Critically Ill Patients Receiving Dalteparin for Thromboprophylaxis.,Blood,2004,10.1182/blood.v104.11.4075.4075,https://experts.mcmaster.ca/display/publication2135210,2025-07-27T15:03:35.873738
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of Compression Ultrasound vs Ascending Contrast Venography for Proximal DVT in Medical-Surgical ICU Patients.,Blood,2004,10.1182/blood.v104.11.2603.2603,https://experts.mcmaster.ca/display/publication2135214,2025-07-27T15:03:35.873741
Mark Crowther,josips1@mcmaster.ca,journal_articles,Safety and Efficacy of Venous Thromboembolism Prophylaxis with Low Molecular Weight Heparin in Hospitalised Patients with Acute Medical Illness and Renal Failure.,Blood,2004,10.1182/blood.v104.11.4078.4078,https://experts.mcmaster.ca/display/publication2135209,2025-07-27T15:03:35.873794
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Risk of Hemorrhage and the Frequency of Vitamin K Use in Asymptomatic Patients with Warfarin-Associated Coagulopathy.,Blood,2004,10.1182/blood.v104.11.527.527,https://experts.mcmaster.ca/display/publication2499716,2025-07-27T15:03:35.873797
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fondaparinux was as effective as (noninferior to) enoxaparin in acute symptomatic deep venous thrombosis,ACP journal club,2004,10.7326/acpjc-2004-141-3-074,https://experts.mcmaster.ca/display/publication1520951,2025-07-27T15:03:35.873799
Mark Crowther,josips1@mcmaster.ca,journal_articles,New anticoagulants: an update.,Clinical Advances in Hematology and Oncology,2004,,https://experts.mcmaster.ca/display/publication763373,2025-07-27T15:03:35.873800
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin cessation prior to cardiopulmonary bypass,Journal of Surgical Research,2004,10.1016/j.jss.2004.07.059,https://experts.mcmaster.ca/display/publication2135260,2025-07-27T15:03:35.873801
Mark Crowther,josips1@mcmaster.ca,journal_articles,Acute reversal of anticoagulant-induced bleeding complications.,Clinical Advances in Hematology and Oncology,2004,,https://experts.mcmaster.ca/display/publication925760,2025-07-27T15:03:35.873803
Mark Crowther,josips1@mcmaster.ca,journal_articles,Methodology for Guideline Development for the Seventh American College of Chest Physicians Conference on Antithrombotic and Thrombolytic Therapy,Chest,2004,10.1378/chest.126.3_suppl.174s,https://experts.mcmaster.ca/display/publication180628,2025-07-27T15:03:35.873804
Mark Crowther,josips1@mcmaster.ca,journal_articles,Antiphospholipid antibody syndrome: further evidence to guide clinical practice?,Journal of Rheumatology,2004,,https://experts.mcmaster.ca/display/publication440393,2025-07-27T15:03:35.873806
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Subspeciality training in hematology and oncology, 2003: results of a survey of training program directors conducted by the American Society of Hematology",Blood,2004,10.1182/blood-2003-11-3986,https://experts.mcmaster.ca/display/publication982297,2025-07-27T15:03:35.873807
Mark Crowther,josips1@mcmaster.ca,journal_articles,Ximelagatran: the first oral direct thrombin inhibitor,Expert Opinion on Investigational Drugs,2004,10.1517/13543784.13.4.403,https://experts.mcmaster.ca/display/publication440437,2025-07-27T15:03:35.873809
Mark Crowther,josips1@mcmaster.ca,journal_articles,Ximelagatran: the first oral direct thrombin inhibitor.,Expert Opinion on Investigational Drugs,2004,10.1517/13543784.13.4.403,https://experts.mcmaster.ca/display/publication763394,2025-07-27T15:03:35.873810
Mark Crowther,josips1@mcmaster.ca,journal_articles,Randomized Trial of Warfarin Nomograms,ACP journal club,2004,10.7326/0003-4819-140-6-200403160-00022,https://experts.mcmaster.ca/display/publication1752173,2025-07-27T15:03:35.873811
Mark Crowther,josips1@mcmaster.ca,journal_articles,Randomized Trial of Warfarin Nomograms,Annals of Internal Medicine,2004,10.7326/0003-4819-140-6-200403160-00027,https://experts.mcmaster.ca/display/publication925776,2025-07-27T15:03:35.873813
Mark Crowther,josips1@mcmaster.ca,journal_articles,Randomized trial of warfarin nomograms.,ACP journal club,2004,10.7326/0003-4819-140-6-200403160-00028,https://experts.mcmaster.ca/display/publication440455,2025-07-27T15:03:35.873814
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review,CANADIAN MEDICAL ASSOCIATION JOURNAL,2004,10.1503/cmaj.1030478,https://experts.mcmaster.ca/display/publication440554,2025-07-27T15:03:35.873815
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of Low-Intensity Warfarin Therapy With Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism,Obstetrical and Gynecological Survey,2004,10.1097/01.ogx.0000109271.86907.14,https://experts.mcmaster.ca/display/publication2135265,2025-07-27T15:03:35.873817
Mark Crowther,josips1@mcmaster.ca,journal_articles,Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists.,Critical Care,2004,10.1186/cc2859,https://experts.mcmaster.ca/display/publication190297,2025-07-27T15:03:35.873818
Mark Crowther,josips1@mcmaster.ca,journal_articles,Evidence-based treatment of the antiphospholipid syndrome,Thrombosis Research,2004,10.1016/j.thromres.2004.05.006,https://experts.mcmaster.ca/display/publication1521021,2025-07-27T15:03:35.873819
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-dose oral vitamin K is safe and effective for outpatient management of patients with an INR>10,Thrombosis Research,2004,10.1016/j.thromres.2004.03.004,https://experts.mcmaster.ca/display/publication440457,2025-07-27T15:03:35.873820
Mark Crowther,josips1@mcmaster.ca,journal_articles,Patient preferences for capillary vs. venous INR determination in an anticoagulation clinic: a randomized controlled trial,Thrombosis Research,2004,10.1016/j.thromres.2004.05.013,https://experts.mcmaster.ca/display/publication440358,2025-07-27T15:03:35.873822
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombocytopenia in medical–surgical ICU patients,Critical Care,2004,10.1186/cc2592,https://experts.mcmaster.ca/display/publication2135281,2025-07-27T15:03:35.873823
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome,New England Journal of Medicine,2003,10.1056/nejm200312253492627,https://experts.mcmaster.ca/display/publication440538,2025-07-27T15:03:35.873824
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin Prophylaxis in the Antiphospholipid Antibody Syndrome,New England Journal of Medicine,2003,10.1056/nejm200312253492620,https://experts.mcmaster.ca/display/publication1818459,2025-07-27T15:03:35.873828
Mark Crowther,josips1@mcmaster.ca,journal_articles,Warfarin prophylaxis in the antiphospholipid antibody syndrome - Reply,New England Journal of Medicine,2003,,https://experts.mcmaster.ca/display/publication1374161,2025-07-27T15:03:35.873829
Mark Crowther,josips1@mcmaster.ca,journal_articles,Lipoprotein(a): another risk factor for venous thrombosis?,American Journal of Medicine,2003,10.1016/j.amjmed.2003.09.022,https://experts.mcmaster.ca/display/publication1520982,2025-07-27T15:03:35.873830
Mark Crowther,josips1@mcmaster.ca,journal_articles,A 44-year-old woman with dry cough and solitary nodule.,CANADIAN MEDICAL ASSOCIATION JOURNAL,2003,,https://experts.mcmaster.ca/display/publication440631,2025-07-27T15:03:35.873832
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome,New England Journal of Medicine,2003,10.1056/nejmoa035241,https://experts.mcmaster.ca/display/publication440205,2025-07-27T15:03:35.873833
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism,New England Journal of Medicine,2003,10.1056/nejmoa035422,https://experts.mcmaster.ca/display/publication440675,2025-07-27T15:03:35.873834
Mark Crowther,josips1@mcmaster.ca,journal_articles,Unraveling Severe Sepsis,Journal of the American Medical Association (JAMA),2003,10.1001/jama.290.2.256,https://experts.mcmaster.ca/display/publication440641,2025-07-27T15:03:35.873835
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Diagnostic Strategy Involving a Quantitative Latexd-Dimer Assay Reliably Excludes Deep Venous Thrombosis,ACP journal club,2003,10.7326/0003-4819-138-10-200305200-00006,https://experts.mcmaster.ca/display/publication180545,2025-07-27T15:03:35.873836
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-Molecular-Weight Heparin for Anticoagulation During Continuous Venovenous Hemofiltration—Reply,Archives of Internal Medicine,2003,10.1001/archinte.163.8.981-a,https://experts.mcmaster.ca/display/publication1637045,2025-07-27T15:03:35.873838
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply,JAMA Internal Medicine,2003,10.1001/archinte.163.8.981-a,https://experts.mcmaster.ca/display/publication820442,2025-07-27T15:03:35.873839
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral Vitamin K for Warfarin-Associated Coagulopathy,ACP journal club,2003,10.7326/0003-4819-138-7-200304010-00030,https://experts.mcmaster.ca/display/publication440663,2025-07-27T15:03:35.873840
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral vitamin K for warfarin-associated coagulopathy.,ACP journal club,2003,10.7326/0003-4819-138-7-200304010-00029,https://experts.mcmaster.ca/display/publication1897953,2025-07-27T15:03:35.873841
Mark Crowther,josips1@mcmaster.ca,journal_articles,Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System,ACP journal club,2003,10.7326/0003-4819-138-2-200301210-00014,https://experts.mcmaster.ca/display/publication440659,2025-07-27T15:03:35.873843
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Deep venous thrombosis in medical–surgical ICU patients: prevalence, incidence and risk factors",Critical Care,2003,10.1186/cc2000,https://experts.mcmaster.ca/display/publication2135266,2025-07-27T15:03:35.873844
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fetal-Maternal Hemorrhage Detection in Ontario,American Journal of Clinical Pathology,2003,10.1309/3u97v7327jbdpayn,https://experts.mcmaster.ca/display/publication1520952,2025-07-27T15:03:35.873845
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fetal-maternal hemorrhage detection in Ontario,American Journal of Clinical Pathology,2003,10.1309/3U97V7327JBDPAYN,https://experts.mcmaster.ca/display/publication1521007,2025-07-27T15:03:35.873846
Mark Crowther,josips1@mcmaster.ca,journal_articles,New Anticoagulants,American Journal of Cardiovascular Drugs,2003,10.2165/00129784-200303030-00006,https://experts.mcmaster.ca/display/publication763396,2025-07-27T15:03:35.873847
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral Anticoagulant Initiation: Rationale for the Use of Warfarin Dosing Nomograms,Seminars in Thrombosis and Hemostasis,2003,10.1055/s-2003-44461,https://experts.mcmaster.ca/display/publication925775,2025-07-27T15:03:35.873849
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin k in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial",ACC Cardiosource Review Journal,2003,10.1016/s1062-1458(02)00999-6,https://experts.mcmaster.ca/display/publication2135286,2025-07-27T15:03:35.873850
Mark Crowther,josips1@mcmaster.ca,journal_articles,Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin,Critical Care,2003,10.1186/cc2001,https://experts.mcmaster.ca/display/publication2135283,2025-07-27T15:03:35.873851
Mark Crowther,josips1@mcmaster.ca,journal_articles,Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?,JAMA Internal Medicine,2002,10.1001/archinte.162.22.2605,https://experts.mcmaster.ca/display/publication425702,2025-07-27T15:03:35.873852
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-Intensity Warfarin Is Ineffective for the Prevention of PTFE Graft Failure in Patients on Hemodialysis,Journal of the American Society of Nephrology,2002,10.1097/01.asn.0000027356.16598.99,https://experts.mcmaster.ca/display/publication438884,2025-07-27T15:03:35.873854
Mark Crowther,josips1@mcmaster.ca,journal_articles,Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy,ACP journal club,2002,10.7326/0003-4819-137-4-200208200-00009,https://experts.mcmaster.ca/display/publication440661,2025-07-27T15:03:35.873855
Mark Crowther,josips1@mcmaster.ca,journal_articles,Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement,JAMA Internal Medicine,2002,10.1001/archinte.162.13.1465,https://experts.mcmaster.ca/display/publication440811,2025-07-27T15:03:35.873857
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low dose oral vitamin K to reverse acenocoumarol-induced coagulopathy: a randomized controlled trial.,Thrombosis and Haemostasis,2002,,https://experts.mcmaster.ca/display/publication1599898,2025-07-27T15:03:35.873858
Mark Crowther,josips1@mcmaster.ca,journal_articles,Direct thrombin inhibitors,Thrombosis Research,2002,10.1016/s0049-3848(02)00093-2,https://experts.mcmaster.ca/display/publication763414,2025-07-27T15:03:35.873859
Mark Crowther,josips1@mcmaster.ca,journal_articles,Selecting patients for home treatment of deep vein thrombosis: the problem of cancer.,Haematologica,2002,,https://experts.mcmaster.ca/display/publication440723,2025-07-27T15:03:35.873861
Mark Crowther,josips1@mcmaster.ca,journal_articles,Elevated Cardiac Troponin Levels in Patients With Submassive Pulmonary Embolism,JAMA Internal Medicine,2002,10.1001/archinte.162.1.79,https://experts.mcmaster.ca/display/publication440748,2025-07-27T15:03:35.873862
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulant Effect at the Time of Epidural Catheter Removal in Patients Receiving Twice-daily or Once-daily Low-molecular-weight Heparin and Continuous Epidural Analgesia after Orthopedic Surgery,Thrombosis and Haemostasis,2002,10.1055/s-0037-1613150,https://experts.mcmaster.ca/display/publication440799,2025-07-27T15:03:35.873863
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Identifying patients at increased risk for recurrent venous thromboembolism: Clinical, biochemical, and radiologic risk factors",Cardiovascular Reviews and Reports,2002,,https://experts.mcmaster.ca/display/publication1748499,2025-07-27T15:03:35.873864
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low Dose Oral Vitamin K to Reverse Acenocoumarol-induced Coagulopathy: A Randomized Controlled Trial,Thrombosis and Haemostasis,2002,10.1055/s-0037-1613152,https://experts.mcmaster.ca/display/publication1520995,2025-07-27T15:03:35.873866
Mark Crowther,josips1@mcmaster.ca,journal_articles,Mechanisms responsible for the failure of protamine  to inactivate low‐molecular‐weight heparin,British Journal of Haematology,2002,10.1046/j.1365-2141.2002.03233.x,https://experts.mcmaster.ca/display/publication412811,2025-07-27T15:03:35.873867
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversing anticoagulants both old and new.,Canadian Journal of Anaesthesia,2002,,https://experts.mcmaster.ca/display/publication440622,2025-07-27T15:03:35.873868
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study,Blood Coagulation and Fibrinolysis,2002,10.1097/00001721-200201000-00007,https://experts.mcmaster.ca/display/publication190373,2025-07-27T15:03:35.873870
Mark Crowther,josips1@mcmaster.ca,journal_articles,Prevention of venous thromboembolism in critically ill surgery patients: A cross-sectional study,Journal of Critical Care,2001,10.1053/jcrc.2001.30665,https://experts.mcmaster.ca/display/publication190388,2025-07-27T15:03:35.873871
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment of Warfarin-Associated Coagulopathy,Chest,2001,10.1378/chest.120.6.1972,https://experts.mcmaster.ca/display/publication914253,2025-07-27T15:03:35.873872
Mark Crowther,josips1@mcmaster.ca,journal_articles,Continuing Challenges of Sepsis Research,Journal of the American Medical Association (JAMA),2001,10.1001/jama.286.15.1894,https://experts.mcmaster.ca/display/publication440895,2025-07-27T15:03:35.873873
Mark Crowther,josips1@mcmaster.ca,journal_articles,Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors,Journal of Leukocyte Biology,2001,10.1189/jlb.70.4.478,https://experts.mcmaster.ca/display/publication1599912,2025-07-27T15:03:35.873875
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of Suspected Deep Venous Thrombosis in Outpatients by Using Clinical Assessment andd-dimer Testing,ACP journal club,2001,10.7326/0003-4819-135-2-200107170-00011,https://experts.mcmaster.ca/display/publication763425,2025-07-27T15:03:35.873876
Mark Crowther,josips1@mcmaster.ca,journal_articles,Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/,American Journal of Medicine,2001,10.1016/s0002-9343(01)00661-1,https://experts.mcmaster.ca/display/publication440823,2025-07-27T15:03:35.874299
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vitamin K in anticoagulation therapy,The Lancet,2001,10.1016/s0140-6736(05)71429-x,https://experts.mcmaster.ca/display/publication1747654,2025-07-27T15:03:35.874301
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vitamin K in anticoagulation therapy,The Lancet,2001,10.1016/s0140-6736(05)71432-x,https://experts.mcmaster.ca/display/publication821119,2025-07-27T15:03:35.874303
Mark Crowther,josips1@mcmaster.ca,journal_articles,Anticoagulation Therapy,Hematology. American Society of Hematology. Education Program,2001,10.1182/asheducation-2001.1.339,https://experts.mcmaster.ca/display/publication925779,2025-07-27T15:03:35.874305
Mark Crowther,josips1@mcmaster.ca,journal_articles,Fibrinolytic Variables in Patients with Recurrent Venous Thrombosis: a Prospective Cohort Study,Thrombosis and Haemostasis,2001,10.1055/s-0037-1615594,https://experts.mcmaster.ca/display/publication440885,2025-07-27T15:03:35.874306
Mark Crowther,josips1@mcmaster.ca,journal_articles,Thrombolysis for restoration of patency to haemodialysis central venous catheters: a systematic review.,Journal of Thrombosis and Thrombolysis,2001,10.1023/a:1011272632286,https://experts.mcmaster.ca/display/publication438937,2025-07-27T15:03:35.874308
Mark Crowther,josips1@mcmaster.ca,journal_articles,Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy,JAMA Internal Medicine,2000,10.1001/archinte.160.22.3431,https://experts.mcmaster.ca/display/publication440926,2025-07-27T15:03:35.874309
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Reliable Screening Test to Identify Adult Carriers of the (--SEA) alpha0-Thalassemia Deletion,American Journal of Clinical Pathology,2000,10.1309/26g7-bqh4-93bv-ur0q,https://experts.mcmaster.ca/display/publication440922,2025-07-27T15:03:35.874310
Mark Crowther,josips1@mcmaster.ca,journal_articles,Effectiveness of reconstituted and then frozen tpa for dysfunctional percutaneous dialysis catheters,Blood,2000,,https://experts.mcmaster.ca/display/publication1748868,2025-07-27T15:03:35.874312
Mark Crowther,josips1@mcmaster.ca,journal_articles,Use of vitamin k to reverse warfarin-induced excessive anticoagulation: a survey of current practice habits,Blood,2000,,https://experts.mcmaster.ca/display/publication1748500,2025-07-27T15:03:35.874313
Mark Crowther,josips1@mcmaster.ca,journal_articles,Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients,Journal of Critical Care,2000,10.1053/jcrc.2000.19224,https://experts.mcmaster.ca/display/publication190423,2025-07-27T15:03:35.874315
Mark Crowther,josips1@mcmaster.ca,journal_articles,Treatment of warfarin-associated coagulopathy with oral vitamin K: a randomised controlled trial,The Lancet,2000,10.1016/s0140-6736(00)03125-1,https://experts.mcmaster.ca/display/publication440629,2025-07-27T15:03:35.874316
Mark Crowther,josips1@mcmaster.ca,journal_articles,Sibrafiban was not more efficacious than aspirin in preventing death and cardiovascular events in patients with acute coronary syndromes,Evidence-based Cardiovascular Medicine,2000,10.1054/ebcm.2000.0297,https://experts.mcmaster.ca/display/publication2135264,2025-07-27T15:03:35.874317
Mark Crowther,josips1@mcmaster.ca,journal_articles,Stability and sterility of recombinant tissue plasminogen activator at −30°C,The Lancet,2000,10.1016/s0140-6736(00)02411-9,https://experts.mcmaster.ca/display/publication412885,2025-07-27T15:03:35.874319
Mark Crowther,josips1@mcmaster.ca,journal_articles,Optimal Dosing of Subcutaneous Unfractionated Heparin for the Treatment of Deep Vein Thrombosis,Thrombosis Research,2000,10.1016/s0049-3848(99)00189-9,https://experts.mcmaster.ca/display/publication1520953,2025-07-27T15:03:35.874320
Mark Crowther,josips1@mcmaster.ca,journal_articles,Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey.,Canadian Journal of Cardiology,2000,,https://experts.mcmaster.ca/display/publication440934,2025-07-27T15:03:35.874321
Mark Crowther,josips1@mcmaster.ca,journal_articles,Erratum: Sensitivity and specificity of a rapid whole-blood assay for D- dimer in the diagnosis of pulmonary embolism (Annals of Internal Medicine (1998) 129 (1006-1011)),Annals of Internal Medicine,2000,,https://experts.mcmaster.ca/display/publication1745005,2025-07-27T15:03:35.874323
Mark Crowther,josips1@mcmaster.ca,journal_articles,Management of Patients with Hereditary Hypercoagulable Disorders,Annual Review of Medicine,2000,10.1146/annurev.med.51.1.169,https://experts.mcmaster.ca/display/publication821628,2025-07-27T15:03:35.874324
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Sensitivity and specificity of a rapid whole-blood assay for D-dimer in the diagnosis of pulmonary embolism (vol 129, pg 1006, 1998)",Annals of Internal Medicine,2000,10.7326/0003-4819-129-12-199812150-00003,https://experts.mcmaster.ca/display/publication764683,2025-07-27T15:03:35.874326
Mark Crowther,josips1@mcmaster.ca,journal_articles,Physician Preferences for Perioperative Anticoagulation in Patients With a Mechanical Heart Valve Who Are Undergoing Elective Noncardiac Surgery,Chest,1999,10.1378/chest.116.5.1240,https://experts.mcmaster.ca/display/publication440888,2025-07-27T15:03:35.874327
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparing 5-mg and 10-mg warfarin loading doses: Are the groups similar? Reply,Archives of Internal Medicine,1999,,https://experts.mcmaster.ca/display/publication440891,2025-07-27T15:03:35.874328
Mark Crowther,josips1@mcmaster.ca,journal_articles,ETIOLOGY,Evidence-based Cardiovascular Medicine,1999,10.1054/ebcm.1999.0207,https://experts.mcmaster.ca/display/publication2135285,2025-07-27T15:03:35.874330
Mark Crowther,josips1@mcmaster.ca,journal_articles,The A1/A2 polymorphism of glycoprotein IIIa was not a risk factor for adverse events complicating coronary interventionsand the homozygous 807T/873A polymorphisms of the glycoprotein Ia/IIa collagen receptor gene was associated with acute MI,JBI evidence implementation,1999,10.1054/ebhc.1999.0207,https://experts.mcmaster.ca/display/publication2135270,2025-07-27T15:03:35.874332
Mark Crowther,josips1@mcmaster.ca,journal_articles,What is the best warfarin loading dose... 5 mg or 10 mg?,Journal of Respiratory Diseases,1999,,https://experts.mcmaster.ca/display/publication1818441,2025-07-27T15:03:35.874333
Mark Crowther,josips1@mcmaster.ca,journal_articles,A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses,JAMA Internal Medicine,1999,10.1001/archinte.159.1.46,https://experts.mcmaster.ca/display/publication440468,2025-07-27T15:03:35.874335
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Effects of Low-intensity Warfarin on Coagulation Activation in Patients with Antiphospholipid Antibodies and Systemic Lupus Erythematosus,Thrombosis and Haemostasis,1999,10.1055/s-0037-1614324,https://experts.mcmaster.ca/display/publication440389,2025-07-27T15:03:35.874336
Mark Crowther,josips1@mcmaster.ca,journal_articles,Sensitivity and Specificity of a Rapid Whole-Blood Assay for D-Dimer in the Diagnosis of Pulmonary Embolism,ACP journal club,1998,10.7326/0003-4819-129-12-199812150-00003,https://experts.mcmaster.ca/display/publication763454,2025-07-27T15:03:35.874337
Mark Crowther,josips1@mcmaster.ca,journal_articles,Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin,JAMA Internal Medicine,1998,10.1001/archinte.158.18.2001,https://experts.mcmaster.ca/display/publication820125,2025-07-27T15:03:35.874338
Mark Crowther,josips1@mcmaster.ca,journal_articles,Relation of Factor V Leiden Genotype to Risk for Acute Deep Venous Thrombosis after Joint Replacement Surgery,ACP journal club,1998,10.7326/0003-4819-128-4-199802150-00003,https://experts.mcmaster.ca/display/publication440952,2025-07-27T15:03:35.874340
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-dose Oral Vitamin K Reliably Reverses Over-anticoagulation due to Warfarin,Thrombosis and Haemostasis,1998,10.1055/s-0037-1615026,https://experts.mcmaster.ca/display/publication440221,2025-07-27T15:03:35.874342
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reply: Warfarin: Less May Be Better,ACP journal club,1997,10.7326/0003-4819-127-4-199708150-00019,https://experts.mcmaster.ca/display/publication439963,2025-07-27T15:03:35.874343
Mark Crowther,josips1@mcmaster.ca,journal_articles,A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy,JAMA Internal Medicine,1997,10.1001/archinte.157.14.1522,https://experts.mcmaster.ca/display/publication914277,2025-07-27T15:03:35.874344
Mark Crowther,josips1@mcmaster.ca,journal_articles,The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis,JAMA Internal Medicine,1997,10.1001/archinte.157.10.1077,https://experts.mcmaster.ca/display/publication763466,2025-07-27T15:03:35.874346
Mark Crowther,josips1@mcmaster.ca,journal_articles,Immune Thrombocytopenic Purpura,Journal of Clinical Rheumatology,1997,10.1097/00124743-199704000-00006,https://experts.mcmaster.ca/display/publication925780,2025-07-27T15:03:35.874347
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low-Molecular-Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results,Seminars in Thrombosis and Hemostasis,1997,10.1055/s-2007-996073,https://experts.mcmaster.ca/display/publication821910,2025-07-27T15:03:35.874348
Mark Crowther,josips1@mcmaster.ca,journal_articles,Comparison of 5-mg and 10-mg Loading Doses in Initiation of Warfarin Therapy,ACP journal club,1997,10.7326/0003-4819-126-2-199701150-00006,https://experts.mcmaster.ca/display/publication820947,2025-07-27T15:03:35.874350
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low Molecular Weight Heparin for the Out-of-Hospital Treatment of Venous Thrombosis: Rationale and Clinical Results,Thrombosis and Haemostasis,1997,10.1055/s-0038-1657613,https://experts.mcmaster.ca/display/publication821994,2025-07-27T15:03:35.874351
Mark Crowther,josips1@mcmaster.ca,journal_articles,Low molecular weight heparin and asa therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL),American Journal of Obstetrics and Gynecology,1997,10.1016/s0002-9378(97)80495-4,https://experts.mcmaster.ca/display/publication2135276,2025-07-27T15:03:35.874352
Mark Crowther,josips1@mcmaster.ca,journal_articles,Splenectomy Done during Hematologic Remission To Prevent Relapse in Patients with Thrombotic Thrombocytopenic Purpura,ACP journal club,1996,10.7326/0003-4819-125-4-199608150-00006,https://experts.mcmaster.ca/display/publication178859,2025-07-27T15:03:35.874354
Mark Crowther,josips1@mcmaster.ca,journal_articles,The Evaluation of Various Mathematical RBC Indices and Their Efficacy in Discriminating Between Thalassemic and Non-Thalassemic Microcytosis,American Journal of Clinical Pathology,1996,10.1093/ajcp/106.2.201,https://experts.mcmaster.ca/display/publication440147,2025-07-27T15:03:35.874355
Mark Crowther,josips1@mcmaster.ca,journal_articles,"Thrombocytopenia in pregnancy: diagnosis, pathogenesis and management",Blood Reviews,1996,10.1016/s0268-960x(96)90015-6,https://experts.mcmaster.ca/display/publication440742,2025-07-27T15:03:35.874356
Mark Crowther,josips1@mcmaster.ca,journal_articles,Free Protein S Deficiency May Be Found in Patients with Antiphospholipid Antibodies who Do not Have Systemic Lupus Erythematosus,Thrombosis and Haemostasis,1996,10.1055/s-0038-1650644,https://experts.mcmaster.ca/display/publication188935,2025-07-27T15:03:35.874358
Mark Crowther,josips1@mcmaster.ca,journal_articles,Profound thrombocytopenia complicating dietary erucic acid therapy for adrenoleukodystrophy,American Journal of Hematology,1995,10.1002/ajh.2830480217,https://experts.mcmaster.ca/display/publication440954,2025-07-27T15:03:35.874359
Mark Crowther,josips1@mcmaster.ca,journal_articles,Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines,International Journal of Laboratory Hematology,1994,10.1111/j.1365-2257.1994.tb00419.x,https://experts.mcmaster.ca/display/publication435458,2025-07-27T15:03:35.874361
Mark Crowther,josips1@mcmaster.ca,journal_articles,Menstrual Toxic Shock Syndrome Complicated by Persistent Bacteremia: Case Report and Review,Clinical Infectious Diseases,1993,10.1093/clind/16.2.288,https://experts.mcmaster.ca/display/publication440896,2025-07-27T15:03:35.874362
Mark Crowther,josips1@mcmaster.ca,journal_articles,Dideoxyinosine-associated nephrotoxicity,AIDS,1993,10.1097/00002030-199301000-00024,https://experts.mcmaster.ca/display/publication440894,2025-07-27T15:03:35.874363
Mark Crowther,josips1@mcmaster.ca,journal_articles,GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR FOR THE THERAPY OF CYTOMEGALOVIRUS AND GANCICLOVIR-INDUCED LEUKOPENIA IN A RENAL TRANSPLANT RECIPIENT,Transplantation,1992,10.1097/00007890-199204000-00041,https://experts.mcmaster.ca/display/publication440689,2025-07-27T15:03:35.874364
Mark Crowther,josips1@mcmaster.ca,journal_articles,Vascular collagen fibril morphology in type IV ehlers-Danlos syndrome,Connective Tissue Research,1991,10.3109/03008209109029157,https://experts.mcmaster.ca/display/publication440356,2025-07-27T15:03:35.874366
Mark Crowther,josips1@mcmaster.ca,journal_articles,Eltrombopag for the treatment of chronic idiopathic (immune) thrombocytopenic purpura (ITP),Health Technology Assessment,,10.3310/hta15suppl1-03,https://experts.mcmaster.ca/display/publication2135196,2025-07-27T15:03:35.874367
Mark Crowther,josips1@mcmaster.ca,journal_articles,P1600: USE OF RITUXIMAB PLUS STANDARD OF CARE FOR TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS,HemaSphere,,10.1097/01.hs9.0000973276.11676.38,https://experts.mcmaster.ca/display/publication3397478,2025-07-27T15:03:35.874369
Mark Crowther,josips1@mcmaster.ca,journal_articles,P1652: SAFETY OF DOACS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS,HemaSphere,,10.1097/01.hs9.0000973480.97414.1e,https://experts.mcmaster.ca/display/publication3397474,2025-07-27T15:03:35.874370
Mark Crowther,josips1@mcmaster.ca,journal_articles,P1665: USE OF DOACS IN THE MANAGEMENT OF UPPER EXTREMITY DEEP VENOUS THROMBOSIS; A SYSTEMATIC REVIEW,HemaSphere,,10.1097/01.hs9.0000973532.28562.11,https://experts.mcmaster.ca/display/publication3397477,2025-07-27T15:03:35.874371
Mark Crowther,josips1@mcmaster.ca,journal_articles,P1667: ATTRIBUTES OF RANDOMIZED CONTROLLED TRIALS AND THEIR ASSOCIATIONS WITH FUNDING SOURCE IN VENOUS THROMBOEMBOLISM PROPHYLAXIS FOR PATIENTS WITH CANCER: A BIBLIOGRAPHICAL ANALYSIS,HemaSphere,,10.1097/01.hs9.0000973540.85675.29,https://experts.mcmaster.ca/display/publication3281157,2025-07-27T15:03:35.874373
Mark Crowther,josips1@mcmaster.ca,journal_articles,P1669: DIRECT ORAL ANTICOAGULANTS VS LOW MOLECULAR WEIGHT HEPARIN IN THE MANAGEMENT OF PATIENTS WITH PRIMARY OR METASTATIC BRAIN TUMOURS: A SYSTEMATIC REVIEW AND META-ANALYSIS,HemaSphere,,10.1097/01.hs9.0000973548.20044.8c,https://experts.mcmaster.ca/display/publication3397475,2025-07-27T15:03:35.874374
Mark Crowther,josips1@mcmaster.ca,journal_articles,PB2045: USE OF ANAKINRA IN THE TREATMENT OF ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A SYSTEMATIC REVIEW,HemaSphere,,10.1097/01.hs9.0000974984.02232.24,https://experts.mcmaster.ca/display/publication3397476,2025-07-27T15:03:35.874375
Mark Crowther,josips1@mcmaster.ca,journal_articles,Reversal of Apixaban and Rivaroxaban Anticoagulation by Andexanet Alfa in ANNEXA-A and ANNEXA-R as Assessed by Non-Tissue Factor-Initiated Thrombin Generation Independent of Tissue Factor Pathway Inhibitor,EMJ Cardiology,,10.33590/emjcardiol/10312045,https://experts.mcmaster.ca/display/publication2446689,2025-07-27T15:03:35.874376
Mark Crowther,josips1@mcmaster.ca,journal_articles,Romiplostim for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a single technology appraisal,Health Technology Assessment,,10.3310/hta13suppl2-09,https://experts.mcmaster.ca/display/publication2135197,2025-07-27T15:03:35.874378
Mark Crowther,josips1@mcmaster.ca,journal_articles,Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users,Journal of Thrombosis and Haemostasis,,10.1111/j.1538-7933.2010.03756.x,https://experts.mcmaster.ca/display/publication2135239,2025-07-27T15:03:35.874379
Mark Crowther,josips1@mcmaster.ca,chapters,Chapter 154 Hematologic Manifestations of Renal Disease,,2018,10.1016/b978-0-323-35762-3.00154-2,https://experts.mcmaster.ca/display/publication1980358,2025-07-27T15:03:35.874381
Mark Crowther,josips1@mcmaster.ca,chapters,Hematologic Manifestations of Renal Disease,,2018,10.1016/b978-0-323-35762-3.00154-2,https://experts.mcmaster.ca/display/publication1891520,2025-07-27T15:03:35.874383
Mark Crowther,josips1@mcmaster.ca,chapters,Antiphospholipid Syndrome,,2017,10.1002/9781118344729.ch19,https://experts.mcmaster.ca/display/publication2184293,2025-07-27T15:03:35.874384
Mark Crowther,josips1@mcmaster.ca,chapters,The Direct Oral Anticoagulants,,2017,10.1002/9781118344729.ch18,https://experts.mcmaster.ca/display/publication2171394,2025-07-27T15:03:35.874385
Mark Crowther,josips1@mcmaster.ca,chapters,15th International Congress on Antiphospholipid Antibodies Task Force on Antiphospholipid Syndrome Treatment Trends Report,,2017,10.1007/978-3-319-55442-6_18,https://experts.mcmaster.ca/display/publication2135247,2025-07-27T15:03:35.874387
Mark Crowther,josips1@mcmaster.ca,chapters,Hematologic Manifestations of Renal Disease,,2017,10.1016/B978-0-323-35762-3.00154-2,https://experts.mcmaster.ca/display/publication2472944,2025-07-27T15:03:35.874388
Mark Crowther,josips1@mcmaster.ca,chapters,Prevention and Treatment of Thrombotic Antiphospholipid Syndrome,,2017,10.1007/978-3-319-55442-6_11,https://experts.mcmaster.ca/display/publication2135246,2025-07-27T15:03:35.874389
Mark Crowther,josips1@mcmaster.ca,chapters,Perioperative Management of the Patient with Immune Thrombocytopenic Purpura De Novo and the Thrombocytopenia of Antiphospholipid Antibody Syndrome,,2013,10.1007/978-1-4614-2203-7_10,https://experts.mcmaster.ca/display/publication1820014,2025-07-27T15:03:35.874390
Mark Crowther,josips1@mcmaster.ca,chapters,Thrombosis,,2013,10.1007/978-1-4614-6705-2_5,https://experts.mcmaster.ca/display/publication2135259,2025-07-27T15:03:35.874392
Mark Crowther,josips1@mcmaster.ca,chapters,Direct Thrombin Inhibitors,,2009,10.3109/9781420069242.019,https://experts.mcmaster.ca/display/publication1752077,2025-07-27T15:03:35.874393
Mark Crowther,josips1@mcmaster.ca,chapters,Management of Antiphospholipid Antibody Syndrome,,2008,10.1002/9781444300857.ch21,https://experts.mcmaster.ca/display/publication1752038,2025-07-27T15:03:35.874394
Mark Crowther,josips1@mcmaster.ca,chapters,Antiphospholipid antibody syndrome,,2001,,https://experts.mcmaster.ca/display/publication1818437,2025-07-27T15:03:35.874396
Mark Crowther,josips1@mcmaster.ca,conferences,PREDICTORS OF ANEMIA RECOVERY IN PATIENTS WITH PRE-EXISTING ANEMIA UNDERGOING BARIATRIC-METABOLIC SURGERY,Obesity Surgery,2023,,https://experts.mcmaster.ca/display/publication3301409,2025-07-27T15:03:35.874397
Mark Crowther,josips1@mcmaster.ca,conferences,Use of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Agents for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis,Blood,2022,10.1182/blood-2022-170853,https://experts.mcmaster.ca/display/publication2922842,2025-07-27T15:03:35.874399
Mark Crowther,josips1@mcmaster.ca,conferences,Abstract P3: Andexanet Alfa for Acute Bleeding During Treatment With Edoxaban,Stroke,2021,10.1161/str.52.suppl_1.p3,https://experts.mcmaster.ca/display/publication2122364,2025-07-27T15:03:35.874400
Mark Crowther,josips1@mcmaster.ca,conferences,Effects of Andexanet Alfa on Thrombin Generation in Bleeding Associated with Factor Xa Inhibitors,Blood,2019,10.1182/blood-2019-124596,https://experts.mcmaster.ca/display/publication1925185,2025-07-27T15:03:35.874401
Mark Crowther,josips1@mcmaster.ca,conferences,Evaluating the Quality of Systematic Reviews & Meta-Analyses Published on Direct Oral Anticoagulants in the Past 5 Years,Blood,2019,10.1182/blood-2019-124130,https://experts.mcmaster.ca/display/publication1942650,2025-07-27T15:03:35.874403
Mark Crowther,josips1@mcmaster.ca,conferences,Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial,Blood,2019,10.1182/blood-2019-130257,https://experts.mcmaster.ca/display/publication1942288,2025-07-27T15:03:35.874404
Mark Crowther,josips1@mcmaster.ca,conferences,579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis,American Journal of Gastroenterology,2019,10.14309/01.ajg.0000591848.50785.d5,https://experts.mcmaster.ca/display/publication1695052,2025-07-27T15:03:35.874406
Mark Crowther,josips1@mcmaster.ca,conferences,Thrombotic events in bleeding patients treated with andexanet alpha: an ANNEXA-4 sub-study,European Heart Journal,2019,,https://experts.mcmaster.ca/display/publication1689009,2025-07-27T15:03:35.874407
Mark Crowther,josips1@mcmaster.ca,conferences,The FIBRES Randomized Controlled Noninferiority Trial of Fibrinogen Concentrates Versus Cryoprecipitate in Cardiac Surgery: Subgroup and Safety Analysis,Transfusion,2019,,https://experts.mcmaster.ca/display/publication1685738,2025-07-27T15:03:35.874409
Mark Crowther,josips1@mcmaster.ca,conferences,Andexanet alfa for treatment of factor Xa inhibitor-related acute major bleeding,Journal of Thrombosis and Thrombolysis,2019,,https://experts.mcmaster.ca/display/publication1644586,2025-07-27T15:03:35.874410
Mark Crowther,josips1@mcmaster.ca,conferences,ANDEXANET ALFA REVERSES ANTICOAGULATION IN FACTOR XA-ASSOCIATED MAJOR BLEEDING IN ANNEXA-4 STUDY,Critical Care Medicine,2019,,https://experts.mcmaster.ca/display/publication1683225,2025-07-27T15:03:35.874411
Mark Crowther,josips1@mcmaster.ca,conferences,VALIDATION OF ANDEXANET ALFA REGIMEN FOR REVERSAL OF ANTICOAGULATION IN PATIENTS WITH MAJOR BLEEDING,Critical Care Medicine,2019,,https://experts.mcmaster.ca/display/publication1683226,2025-07-27T15:03:35.874412
Mark Crowther,josips1@mcmaster.ca,conferences,Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis,Blood,2018,10.1182/blood-2018-99-110997,https://experts.mcmaster.ca/display/publication1631350,2025-07-27T15:03:35.874424
Mark Crowther,josips1@mcmaster.ca,conferences,Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies,Transfusion,2018,10.1111/trf.14952,https://experts.mcmaster.ca/display/publication1520978,2025-07-27T15:03:35.874426
Mark Crowther,josips1@mcmaster.ca,conferences,Recurrent Thrombosis in Patients with Antiphospholipid Antibodies Following an Initial Venous or Arterial Thromboembolic Event,Arthritis & Rheumatology,2018,,https://experts.mcmaster.ca/display/publication1603825,2025-07-27T15:03:35.874427
Mark Crowther,josips1@mcmaster.ca,conferences,USING AUTOMATIC CELL COUNTS TO CALCULATE THE I: T RATIO FOR INVESTIGATION OF EARLY ONSET NEONATAL SEPSIS,International Journal of Laboratory Hematology,2018,,https://experts.mcmaster.ca/display/publication1595841,2025-07-27T15:03:35.874428
Mark Crowther,josips1@mcmaster.ca,conferences,Reversal of apixaban and rivaroxaban anticoagulation by andexanet alfa in ANNEXA-A&R as assessed by non-tissue factor (TF)-initiated thrombin generation independent of TF pathway inhibitor (TFPI),European Heart Journal,2018,,https://experts.mcmaster.ca/display/publication1634149,2025-07-27T15:03:35.874430
Mark Crowther,josips1@mcmaster.ca,conferences,RESUMPTION OF ANTICOAGULANT THERAPY AFTER ANTICOAGULANT-RELATED GASTROINTESTINAL BLEEDING: A SYSTEMATIC REVIEW AND META-ANALYSIS,Gastroenterology,2018,,https://experts.mcmaster.ca/display/publication3276525,2025-07-27T15:03:35.874431
Mark Crowther,josips1@mcmaster.ca,conferences,Incidence of venous thromboembolic complications in controlled trials of inflammatory bowel disease,Journal of Crohn's and Colitis,2018,,https://experts.mcmaster.ca/display/publication1521002,2025-07-27T15:03:35.874433
Mark Crowther,josips1@mcmaster.ca,conferences,202: ANDEXANET ALFA REVERSES ANTICOAGULATION INDUCED BY BETRIXABAN IN HEALTHY VOLUNTEERS,Critical Care Medicine,2018,10.1097/01.ccm.0000528221.12371.1b,https://experts.mcmaster.ca/display/publication1567053,2025-07-27T15:03:35.874434
Mark Crowther,josips1@mcmaster.ca,conferences,33: PHARMACOKINETIC/PHARMACODYNAMIC MODELING OF ANDEXANET ALFA DOSE IN ACUTE MAJOR BLEEDING,Critical Care Medicine,2018,10.1097/01.ccm.0000528089.82823.18,https://experts.mcmaster.ca/display/publication1567055,2025-07-27T15:03:35.874435
Mark Crowther,josips1@mcmaster.ca,conferences,Using Automatic Cell Counts to Calculate the I:T Ratio for Investigation of Early Onset Neonatal Sepsis,Blood,2017,,https://experts.mcmaster.ca/display/publication1563460,2025-07-27T15:03:35.874437
Mark Crowther,josips1@mcmaster.ca,conferences,Analysis of Red Blood Cell Storage Duration and in-Hospital Mortality Using Time Dependent Exposure: Is the Oldest Blood Bad?,Transfusion,2017,,https://experts.mcmaster.ca/display/publication1459069,2025-07-27T15:03:35.874438
Mark Crowther,josips1@mcmaster.ca,conferences,Determining the Factors for Reassessment after Transfusion: A Canadian Survey,Transfusion,2017,,https://experts.mcmaster.ca/display/publication1520973,2025-07-27T15:03:35.874439
Mark Crowther,josips1@mcmaster.ca,conferences,MODIFICATION AND VALIDATION OF A BARCODED CLAUSS FIBRINOGEN ASSAY FOR USE IN CORE LABORATORIES,International Journal of Laboratory Hematology,2017,,https://experts.mcmaster.ca/display/publication441271,2025-07-27T15:03:35.874440
Mark Crowther,josips1@mcmaster.ca,conferences,Andexanet Alfa for the Management of Acute Major Bleeding Associated with FXa Inhibitors (P5.059),Neurology,2017,10.1212/wnl.88.16_supplement.p5.059,https://experts.mcmaster.ca/display/publication1942120,2025-07-27T15:03:35.874442
Mark Crowther,josips1@mcmaster.ca,conferences,An individual participant data meta-analysis of 13 randomized trials to evaluate the impact of prophylactic use of heparin in oncological patients,Blood,2017,10.1182/blood.v130.suppl_1.626.626,https://experts.mcmaster.ca/display/publication1563461,2025-07-27T15:03:35.874443
Mark Crowther,josips1@mcmaster.ca,conferences,Methodology and Systematic Review of the Literature for the Mcmaster RARE-Best Practice Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome,Arthritis & Rheumatology,2017,,https://experts.mcmaster.ca/display/publication1471695,2025-07-27T15:03:35.874444
Mark Crowther,josips1@mcmaster.ca,conferences,THU0561 Clinical practice guideline for diagnosis and management of catastrophic antiphospholipid syndrome,Annals of the Rheumatic Diseases,2017,10.1136/annrheumdis-2017-eular.2085,https://experts.mcmaster.ca/display/publication1477831,2025-07-27T15:03:35.874446
Mark Crowther,josips1@mcmaster.ca,conferences,The Khorana score for the prediction of venous thromboembolism in patients with solid cancer: an individual patient data meta-analysis,Journal of Thrombosis and Haemostasis,2017,10.1111/jth.14824,https://experts.mcmaster.ca/display/publication1563464,2025-07-27T15:03:35.874447
Mark Crowther,josips1@mcmaster.ca,conferences,Reversal of Betrixaban-Induced Anticoagulation in Healthy Volunteers By Andexanet Alfa,Blood,2016,10.1182/blood.v128.22.143.143,https://experts.mcmaster.ca/display/publication1365806,2025-07-27T15:03:35.874449
Mark Crowther,josips1@mcmaster.ca,conferences,Serial Trough Anti-Xa Levels to Assess Low Molecular Weight Heparin Accumulation in Patients with Chronic Kidney Disease: Analysis of Crcl <30 Ml/Min from the Trivet Study,Blood,2016,10.1182/blood.v128.22.90.90,https://experts.mcmaster.ca/display/publication455275,2025-07-27T15:03:35.874450
Mark Crowther,josips1@mcmaster.ca,conferences,Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis,Blood,2016,10.1182/blood.v128.22.3821.3821,https://experts.mcmaster.ca/display/publication710721,2025-07-27T15:03:35.874451
Mark Crowther,josips1@mcmaster.ca,conferences,"ANDEXANET ALFA, A UNIVERSAL ANTIDOTE FOR REVERSAL OF ANTICOAGULATION OF FACTOR XA INHIBITORS IN HEALTHY HUMAN VOLUNTEERS",American Journal of Hematology,2016,,https://experts.mcmaster.ca/display/publication1520964,2025-07-27T15:03:35.874453
Mark Crowther,josips1@mcmaster.ca,conferences,Developing a Data-driven Research Program: An Integrated Database Network Tool Driving Education and Research Forward,Transfusion,2016,,https://experts.mcmaster.ca/display/publication667613,2025-07-27T15:03:35.874454
Mark Crowther,josips1@mcmaster.ca,conferences,Informing Fresh Versus Old Red Cell Management (INFORM) Trial: A Large International Pragmatic Randomized Trial,Transfusion,2016,,https://experts.mcmaster.ca/display/publication440280,2025-07-27T15:03:35.874455
Mark Crowther,josips1@mcmaster.ca,conferences,Assessment of low molecular weight heparin accumulation in patients with chronic kidney disease: results from the TRIVET study,Journal of Thrombosis and Haemostasis,2016,,https://experts.mcmaster.ca/display/publication455282,2025-07-27T15:03:35.874456
Mark Crowther,josips1@mcmaster.ca,conferences,Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment: Pharmacoeconomic Analysis of a Prospective Randomized Trial,Value in Health,2016,10.1016/j.jval.2016.03.1616,https://experts.mcmaster.ca/display/publication1520992,2025-07-27T15:03:35.874458
Mark Crowther,josips1@mcmaster.ca,conferences,HOW DO THEY PERFORM? VALIDATION AND ASSESSMENT OF PERFORMANCE OF 19 COAGULATION ANALYZERS ACROSS A REGIONAL LABORATORY PROGRAM.,International Journal of Laboratory Hematology,2016,,https://experts.mcmaster.ca/display/publication440309,2025-07-27T15:03:35.874459
Mark Crowther,josips1@mcmaster.ca,conferences,"Andexanet Alfa, a Universal Antidote for Reversal of Anticoagulation of Factor Xa Inhibitors in Healthy Human Volunteers.",Stroke,2016,,https://experts.mcmaster.ca/display/publication1365805,2025-07-27T15:03:35.874460
Mark Crowther,josips1@mcmaster.ca,conferences,"ANNEXA (TM)-R Part 2: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Sustained Reversal of Rivaroxaban-Induced Anticoagulation in Older Subjects by Andexanet Alfa (PRT064445), a Universal Antidote for Factor XA (FXA) Inhibitors",Circulation,2015,,https://experts.mcmaster.ca/display/publication1365822,2025-07-27T15:03:35.874461
Mark Crowther,josips1@mcmaster.ca,conferences,A Qualitative Research Study to Understand Post-Transfusion Well-Being in Patients with Myelodysplastic Syndromes,Blood,2015,10.1182/blood.v126.23.4446.4446,https://experts.mcmaster.ca/display/publication440323,2025-07-27T15:03:35.874463
Mark Crowther,josips1@mcmaster.ca,conferences,Assessing Disease Stability of Patients with Myelodysplastic Syndrome for an Age of Blood Randomized Controlled Trial: A Chart Review,Blood,2015,10.1182/blood.v126.23.5252.5252,https://experts.mcmaster.ca/display/publication440303,2025-07-27T15:03:35.874464
Mark Crowther,josips1@mcmaster.ca,conferences,Bleeding in Patients Receiving Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis,Blood,2015,10.1182/blood.v126.23.1120.1120,https://experts.mcmaster.ca/display/publication440320,2025-07-27T15:03:35.874465
Mark Crowther,josips1@mcmaster.ca,conferences,Efficacy and Safety of Weight-Adjusted Extended Duration Tinzaparin for Prevention of Post-Operative Venous Thromboembolism after Bariatric Surgery,Blood,2015,10.1182/blood.v126.23.1130.1130,https://experts.mcmaster.ca/display/publication440297,2025-07-27T15:03:35.874467
Mark Crowther,josips1@mcmaster.ca,conferences,"Non-Specific Hemostatic Agents (PCC, aPCC, rVIIa) for Reversal of Direct Oral Anticoagulant Effect in Patients with Major Bleeding Complications: A Retrospective Review",Blood,2015,10.1182/blood.v126.23.1137.1137,https://experts.mcmaster.ca/display/publication440287,2025-07-27T15:03:35.874468
Mark Crowther,josips1@mcmaster.ca,conferences,Outcomes of Low-Molecular-Weight Heparintreatment for Venous Thromboembolism in Patients with Primary and Metastatic Brain Tumors,Blood,2015,10.1182/blood.v126.23.428.428,https://experts.mcmaster.ca/display/publication440317,2025-07-27T15:03:35.874469
Mark Crowther,josips1@mcmaster.ca,conferences,Rivaroxaban for Treatment of Suspected or Confirmed Heparin-Induced Thrombocytopenia Study,Blood,2015,10.1182/blood.v126.23.3468.3468,https://experts.mcmaster.ca/display/publication440295,2025-07-27T15:03:35.874470
Mark Crowther,josips1@mcmaster.ca,conferences,Switching to Warfarin after 6-Month Completion of Anticoagulant Treatment for Cancer-Associated Thrombosis,Blood,2015,10.1182/blood.v126.23.430.430,https://experts.mcmaster.ca/display/publication440289,2025-07-27T15:03:35.874472
Mark Crowther,josips1@mcmaster.ca,conferences,Systematic Review of Therapeutic Plasma Exchange for the Treatment of Catastrophic Antiphospholipid Antibody Syndrome,Journal of Rheumatology,2015,,https://experts.mcmaster.ca/display/publication626844,2025-07-27T15:03:35.874473
Mark Crowther,josips1@mcmaster.ca,conferences,"A Canadian consensus on venous thromboembolism (VTE) prophylaxis prevention in thoracic surgery, a national Delphi consensus survey",Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication576091,2025-07-27T15:03:35.874474
Mark Crowther,josips1@mcmaster.ca,conferences,"ANNEXA (TM)-A PART 2: A phase 3 randomized, double-blind, placebo-controlled trial demonstrating sustained reversal of apixaban-induced anticoagulation in older subjects by andexanet ALFA (PRT064445), a universal antidote for factor XA (FXA) inhibitors",Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication1520965,2025-07-27T15:03:35.874476
Mark Crowther,josips1@mcmaster.ca,conferences,Feasibility of comparing intermittent pneumatic compression vs. a novel device for prevention of venous thromboembolism in trauma patients with contraindication to anticoagulation,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication710871,2025-07-27T15:03:35.874477
Mark Crowther,josips1@mcmaster.ca,conferences,Hemodialysis for the treatment of dabigatran-associated bleeding: a systematic review of the literature,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication668949,2025-07-27T15:03:35.874479
Mark Crowther,josips1@mcmaster.ca,conferences,Interventions to reduce blood loss from laboratory testing in critically ill patients and impact on transfusion: a systematic review,Journal of Thrombosis and Haemostasis,2015,,https://experts.mcmaster.ca/display/publication440383,2025-07-27T15:03:35.874480
Mark Crowther,josips1@mcmaster.ca,conferences,OPTIMAL DURATION OF ANTICOAGULANT THERAPY FOR THE TREATMENT OF CANCER-ASSOCIATED THROMBOSIS,Haematologica,2015,,https://experts.mcmaster.ca/display/publication995712,2025-07-27T15:03:35.874481
Mark Crowther,josips1@mcmaster.ca,conferences,Serum coagulation markers and cerebral MRI in lupus patients with antiphospholipid antibodies and cognitive dysfunction,Clinical and Experimental Rheumatology,2015,,https://experts.mcmaster.ca/display/publication60433,2025-07-27T15:03:35.874482
Mark Crowther,josips1@mcmaster.ca,conferences,"FATAL BLEEDING, CASE-FATALITY RATE OF MAJOR BLEEDING AND ALL-CAUSE MORTALITY IN PATIENTS TAKING TARGET-SPECIFIC ORAL ANTICOAGULANT, A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS",Journal of the American College of Cardiology,2015,10.1016/s0735-1097(15)62052-6,https://experts.mcmaster.ca/display/publication988018,2025-07-27T15:03:35.874484
Mark Crowther,josips1@mcmaster.ca,conferences,"A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial Demonstrating Reversal of Edoxaban-Induced Anticoagulation in Healthy Subjects By Andexanet Alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors",Blood,2014,10.1182/blood.v124.21.4269.4269,https://experts.mcmaster.ca/display/publication1520960,2025-07-27T15:03:35.874485
Mark Crowther,josips1@mcmaster.ca,conferences,Difficulties in Establishing the Cause of Thrombocytopenia Among Ambulatory Patients Referred to Hematology: An Agreement Study,Blood,2014,10.1182/blood.v124.21.3521.3521,https://experts.mcmaster.ca/display/publication440373,2025-07-27T15:03:35.874486
Mark Crowther,josips1@mcmaster.ca,conferences,Low Dose Oral Vitamin K Does Not Increase Time in Therapeutic Range: Results of a Multicentre Clinical Trial,Blood,2014,10.1182/blood.v124.21.2872.2872,https://experts.mcmaster.ca/display/publication440377,2025-07-27T15:03:35.874487
Mark Crowther,josips1@mcmaster.ca,conferences,Retrospective Evaluation of Patients Referred for Hemochromatosis Genetic Testing,Blood,2014,10.1182/blood.v124.21.4035.4035,https://experts.mcmaster.ca/display/publication208858,2025-07-27T15:03:35.874489
Mark Crowther,josips1@mcmaster.ca,conferences,"ANNEXA (TM)-A: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, Demonstrating Reversal of Apixaban-Induced Anticoagulation in Older Subjects by Andexanet alfa (PRT064445), a Universal Antidote for Factor Xa (fXa) Inhibitors",Circulation,2014,,https://experts.mcmaster.ca/display/publication1520976,2025-07-27T15:03:35.874490
Mark Crowther,josips1@mcmaster.ca,conferences,REVERSAL OF FACTOR XA INHIBITORS-INDUCED ANTICOAGULATION IN HEALTHY SUBJECTS BY ANDEXANET ALFA,Critical Care Medicine,2014,,https://experts.mcmaster.ca/display/publication1520984,2025-07-27T15:03:35.874491
Mark Crowther,josips1@mcmaster.ca,conferences,Sustained reversal of apixaban anticoagulation with andexanet alfa using a bolus plus infusion regimen in a phase 2 placebo controlled trial,European Heart Journal,2014,,https://experts.mcmaster.ca/display/publication1520987,2025-07-27T15:03:35.874493
Mark Crowther,josips1@mcmaster.ca,conferences,"Reversal of enoxaparin-induced anticoagulation in healthy subjects by andexanet alfa (PRT064445), an antidote for direct and indirect fXa inhibitors-a phase 2 randomized, double-blind, placebo-controlled trial",Journal of Thrombosis and Haemostasis,2014,,https://experts.mcmaster.ca/display/publication1520988,2025-07-27T15:03:35.874494
Mark Crowther,josips1@mcmaster.ca,conferences,THE IMPACT OF BLEEDING COMPLICATIONS IN PATIENTS RECEIVING NOVEL ORAL ANTICOAGULANTS: A SYSTEMATIC REVIEW AND META-ANALYSIS,Haematologica,2014,,https://experts.mcmaster.ca/display/publication669162,2025-07-27T15:03:35.874495
Mark Crowther,josips1@mcmaster.ca,conferences,Is an aspirate for morphology and flow cytometry really necessary when a trephine is also being performed in the diagnosis and staging of lymphoma?,British Journal of Haematology,2014,,https://experts.mcmaster.ca/display/publication1599905,2025-07-27T15:03:35.874496
Mark Crowther,josips1@mcmaster.ca,conferences,"Monitoring Of Medical And Surgical Patients In Mulago Hospital, Uganda: A Pilot Observational Study Using The Modified Early Warning Score",American Journal of Respiratory and Critical Care Medicine,2014,,https://experts.mcmaster.ca/display/publication218359,2025-07-27T15:03:35.874498
Mark Crowther,josips1@mcmaster.ca,conferences,"Risk of thromboembolism, recurrent bleeding and death after warfarin interruption for gastrointestinal bleeding",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication1521009,2025-07-27T15:03:35.874499
Mark Crowther,josips1@mcmaster.ca,conferences,A Review Of Computed Tomography Pulmonary Angiograms In Three Teaching Hospitals: The Rise Of Sub-Segmental Pulmonary Emboli and Their Management,Blood,2013,10.1182/blood.v122.21.932.932,https://experts.mcmaster.ca/display/publication440462,2025-07-27T15:03:35.874500
Mark Crowther,josips1@mcmaster.ca,conferences,Analysis Of Warfarin Drug-Drug Interactions With Antibiotics In The Ambulatory Care Setting,Blood,2013,10.1182/blood.v122.21.1143.1143,https://experts.mcmaster.ca/display/publication440461,2025-07-27T15:03:35.874502
Mark Crowther,josips1@mcmaster.ca,conferences,Evaluation Of The Appropriateness Of Frozen Plasma Usage In The Era Of Prothrombin Complex Concentrates: A Retrospective Study,Blood,2013,10.1182/blood.v122.21.3664.3664,https://experts.mcmaster.ca/display/publication440469,2025-07-27T15:03:35.874503
Mark Crowther,josips1@mcmaster.ca,conferences,Long Term Treatment and Prevention Of Recurrent VTE In Cancer Patients: Results Of The Canadian Proact Survey,Blood,2013,10.1182/blood.v122.21.5581.5581,https://experts.mcmaster.ca/display/publication440471,2025-07-27T15:03:35.874504
Mark Crowther,josips1@mcmaster.ca,conferences,Non-Invasive Hemoglobin Measurements In Anemic Patients,Blood,2013,10.1182/blood.v122.21.2970.2970,https://experts.mcmaster.ca/display/publication440441,2025-07-27T15:03:35.874506
Mark Crowther,josips1@mcmaster.ca,conferences,Rituximab For The Treatment Of Hepatitis C Associated IgM Mediated Cold Hemolytic Anemia – Case Report and Literature Review,Blood,2013,10.1182/blood.v122.21.4653.4653,https://experts.mcmaster.ca/display/publication440466,2025-07-27T15:03:35.874507
Mark Crowther,josips1@mcmaster.ca,conferences,Systematic Review and Meta-Analysis Of Rituximab For The Treatment Of Immune Thrombocytopenia In Adults,Blood,2013,10.1182/blood.v122.21.1681.1681,https://experts.mcmaster.ca/display/publication440434,2025-07-27T15:03:35.874508
Mark Crowther,josips1@mcmaster.ca,conferences,"A phase 2 randomized, double-blind, placebo-controlled trial of PRT064445, a novel, universal antidote for direct and indirect factor Xa inhibitors",Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication1521003,2025-07-27T15:03:35.874510
Mark Crowther,josips1@mcmaster.ca,conferences,A review of computed tomography pulmonary angiograms in three teaching hospitals: the rise of sub-segmental pulmonary emboli and their management,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication1396026,2025-07-27T15:03:35.874511
Mark Crowther,josips1@mcmaster.ca,conferences,Active site-mutated thrombin S195A but not active site-blocked thrombin counteracts the anticoagulant activity of dabigatran in plasma,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication418473,2025-07-27T15:03:35.874512
Mark Crowther,josips1@mcmaster.ca,conferences,Efficacy and safety of weight-adjusted extended duration tinzaparin for prevention of post-operative venous thromboembolism after bariatric surgery,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication782506,2025-07-27T15:03:35.874514
Mark Crowther,josips1@mcmaster.ca,conferences,Prothrombin complex concentrate use for the emergency reversal of vitamin K antagonists,Journal of Thrombosis and Haemostasis,2013,,https://experts.mcmaster.ca/display/publication1521035,2025-07-27T15:03:35.874524
Mark Crowther,josips1@mcmaster.ca,conferences,A Review of Computed Tomography Pulmonary Angiograms in Three Teaching Hospitals: the rise of Sub-Segmental Pulmonary Emboli,Journal of Thrombosis and Thrombolysis,2013,,https://experts.mcmaster.ca/display/publication1396027,2025-07-27T15:03:35.874525
Mark Crowther,josips1@mcmaster.ca,conferences,Reversal of oral direct thrombin and factor Xa inhibitors: a systematic review,Journal of Thrombosis and Thrombolysis,2013,,https://experts.mcmaster.ca/display/publication440558,2025-07-27T15:03:35.874526
Mark Crowther,josips1@mcmaster.ca,conferences,"MAJOR BLEEDING IN MEDICAL-SURGICAL CRITICALLY ILL PATIENTS IS ASSOCIATED WITH INCREASED USE OF BLOOD PRODUCTS, LONGER HOSPITAL STAY AND HIGHER MORTALITY",Critical Care Medicine,2012,,https://experts.mcmaster.ca/display/publication218369,2025-07-27T15:03:35.874528
Mark Crowther,josips1@mcmaster.ca,conferences,"THROMBOCYTOPENIA IN THE CRITICALLY ILL: INCIDENCE, RISK FACTORS AND IMPACT ON TRANSFUSIONS, BLEEDING, MORTALITY",Critical Care Medicine,2012,,https://experts.mcmaster.ca/display/publication218345,2025-07-27T15:03:35.874529
Mark Crowther,josips1@mcmaster.ca,conferences,C0129 Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: A systematic review and meta-analysis of the literature,Thrombosis Research,2012,10.1016/j.thromres.2012.08.031,https://experts.mcmaster.ca/display/publication1520990,2025-07-27T15:03:35.874531
Mark Crowther,josips1@mcmaster.ca,conferences,Prothrombin Complex Concentrates Reduce Blood Loss in Mice Rendered Coagulopathic by Warfarin but Not Dabigatran Etexilate,Transfusion,2012,,https://experts.mcmaster.ca/display/publication418471,2025-07-27T15:03:35.874532
Mark Crowther,josips1@mcmaster.ca,conferences,Bleeding Risk in Randomized Controlled Trials Comparing Warfarin and Aspirin: A Systematic Review and Meta-Analysis,American Journal of Hematology,2012,,https://experts.mcmaster.ca/display/publication669886,2025-07-27T15:03:35.874533
Mark Crowther,josips1@mcmaster.ca,conferences,Death and Thrombosis After Interrupting Warfarin for Gastrointestinal Hemorrhage,American Journal of Hematology,2012,,https://experts.mcmaster.ca/display/publication1520991,2025-07-27T15:03:35.874534
Mark Crowther,josips1@mcmaster.ca,conferences,Heparin-Induced Thrombocytopenia In The ICU: ELISA Versus SRA Testing,A47. DIAGNOSTIC TECHNIQUES AND MONITORING,2012,10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1669,https://experts.mcmaster.ca/display/publication2135287,2025-07-27T15:03:35.874536
Mark Crowther,josips1@mcmaster.ca,conferences,"Patterns Of Use, Efficacy, And Safety Of Recombinant Factor VIIa At An Academic Teaching Centre",B49. NON-PULMONARY CRITICAL CARE,2012,10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3163,https://experts.mcmaster.ca/display/publication2135256,2025-07-27T15:03:35.874537
Mark Crowther,josips1@mcmaster.ca,conferences,Published Prediction Models Do Not Discriminate Among Critically Ill Patients In Clinically Suspected Pulmonary Embolism In ICU,A106. ADVANCES IN DIAGNOSIS AND TREATMENT OF PULMONARY EMBOLISM,2012,10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2360,https://experts.mcmaster.ca/display/publication2135261,2025-07-27T15:03:35.874539
Mark Crowther,josips1@mcmaster.ca,conferences,Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Available Literature,American Journal of Hematology,2012,,https://experts.mcmaster.ca/display/publication1520975,2025-07-27T15:03:35.874540
Mark Crowther,josips1@mcmaster.ca,conferences,Use of Thrombolytic Agents for Pulmonary Embolism During Cardiopulmonary Resuscitation: Systematic Review and Teleoanalysis,American Journal of Hematology,2012,,https://experts.mcmaster.ca/display/publication1195340,2025-07-27T15:03:35.874541
Mark Crowther,josips1@mcmaster.ca,conferences,The pathogenesis of warfarin-associated venous limb ischemia and gangrene complicating cancer: clinical and laboratory parallels with heparin-induced thrombocytopenia (HIT),Thrombosis Research,2012,10.1016/s0049-3848(12)70045-2,https://experts.mcmaster.ca/display/publication440544,2025-07-27T15:03:35.874543
Mark Crowther,josips1@mcmaster.ca,conferences,Comparison of the Villalta Post Thrombotic Syndrome (PTS) Score in the Ipsilateral Versus Contralateral Leg After a First Unprovoked Deep Vein Thrombosis (DVT): Results From the REVERSE Study,Blood,2011,,https://experts.mcmaster.ca/display/publication440612,2025-07-27T15:03:35.874544
Mark Crowther,josips1@mcmaster.ca,conferences,Family History of Venous Thromboembolism (VTE) and the Risk of VTE Recurrence in Patients with a First Unprovoked VTE: A Multicenter Prospective Cohort Study,Blood,2011,,https://experts.mcmaster.ca/display/publication440611,2025-07-27T15:03:35.874546
Mark Crowther,josips1@mcmaster.ca,conferences,"Frequency and Predictors of Post-Thrombotic Syndrome in Patients with a First, Unprovoked Deep Vein Thrombosis and No Prior Primary Venous Insufficiency: Results From the REVERSE Cohort Study",Blood,2011,,https://experts.mcmaster.ca/display/publication440628,2025-07-27T15:03:35.874547
Mark Crowther,josips1@mcmaster.ca,conferences,Laboratory HIT Testing in Critically III Patients,Blood,2011,,https://experts.mcmaster.ca/display/publication218302,2025-07-27T15:03:35.874548
Mark Crowther,josips1@mcmaster.ca,conferences,Relationship Between Subtherapeutic Warfarin Anticoagulation and the Development of Post Thrombotic Syndrome After a First Unprovoked Deep Vein Thrombosis: Results From the REVERSE Cohort Study,Blood,2011,,https://experts.mcmaster.ca/display/publication440617,2025-07-27T15:03:35.874550
Mark Crowther,josips1@mcmaster.ca,conferences,Rofecoxib Does Not Appear to Increase the Risk of Venous Thromboembolism: A Systematic Review of the Literature,Blood,2011,,https://experts.mcmaster.ca/display/publication440546,2025-07-27T15:03:35.874551
Mark Crowther,josips1@mcmaster.ca,conferences,The Inappropriate Use of the SimpliRed D-Dimer Assay in the Diagnosis of Venous Thromboembolism,Blood,2011,,https://experts.mcmaster.ca/display/publication440548,2025-07-27T15:03:35.874553
Mark Crowther,josips1@mcmaster.ca,conferences,"Can We Do a 25,000 Patient Pragmatic Study to Address the Age of Blood and Mortality Controversy? A Pilot to Determine Feasibility",Transfusion,2011,,https://experts.mcmaster.ca/display/publication179532,2025-07-27T15:03:35.874554
Mark Crowther,josips1@mcmaster.ca,conferences,A randomized controlled trial comparing aspirin with dalteparin for the prevention of venous thromboembolism following total hip arthroplasty,Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication1085574,2025-07-27T15:03:35.874555
Mark Crowther,josips1@mcmaster.ca,conferences,Does ABO blood group increase the rate of recurrent events after initial treatment for a first unprovoked venous thromboembolism (VTE) event? Reverse cohort subgroup analysis,Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication440354,2025-07-27T15:03:35.874557
Mark Crowther,josips1@mcmaster.ca,conferences,Extended follow-up of the multi-center prospective cohort that derived the 'men continue and HERDOO2' clinical decision rule identifying low risk unprovoked patients,Journal of Thrombosis and Haemostasis,2011,,https://experts.mcmaster.ca/display/publication1085782,2025-07-27T15:03:35.874558
Mark Crowther,josips1@mcmaster.ca,conferences,Amyloidosis and GCA/PMR: Case Report of a Rare Association,Journal of Rheumatology,2011,,https://experts.mcmaster.ca/display/publication638817,2025-07-27T15:03:35.874559
Mark Crowther,josips1@mcmaster.ca,conferences,Construction and validation of a clinical scoring model for heparin-induced thrombocytopenia (HIT),Haemophilia,2011,,https://experts.mcmaster.ca/display/publication440623,2025-07-27T15:03:35.874561
Mark Crowther,josips1@mcmaster.ca,conferences,Diagnostic And Outcome Prediction Models For Pulmonary Embolism In Critically Ill Patients: A Pilot Study,C50. CARDIOPULMONARY INTERACTIONS,2011,10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a4743,https://experts.mcmaster.ca/display/publication2135258,2025-07-27T15:03:35.874562
Mark Crowther,josips1@mcmaster.ca,conferences,Methods Center Adjudication Costs For 5 Morbidity Outcomes In A Thromboprophylaxis Trial,American Journal of Respiratory and Critical Care Medicine,2011,10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1678,https://experts.mcmaster.ca/display/publication211469,2025-07-27T15:03:35.874564
Mark Crowther,josips1@mcmaster.ca,conferences,PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS,Value in Health,2011,10.1016/j.jval.2011.02.421,https://experts.mcmaster.ca/display/publication360375,2025-07-27T15:03:35.874565
Mark Crowther,josips1@mcmaster.ca,conferences,"Practical issues with vitamin K antagonists: elevated INRs, low time-in-therapeutic range, and warfarin failure",Journal of Thrombosis and Thrombolysis,2011,10.1007/s11239-011-0555-z,https://experts.mcmaster.ca/display/publication1439407,2025-07-27T15:03:35.874567
Mark Crowther,josips1@mcmaster.ca,conferences,Prothrombin Complex Concentrate (Octaplex (R)) In Patients Requiring Immediate Reversal of Vitamin K Antagonist Anticoagulation,Blood,2010,,https://experts.mcmaster.ca/display/publication440608,2025-07-27T15:03:35.874568
Mark Crowther,josips1@mcmaster.ca,conferences,SAFETY of PROTHROMBIN COMPLEX CONCENTRATES IN PATIENTS REQUIRING RAPID REVERSAL of ANTICOAGULANT TREATMENT with the VITAMIN K ANTAGONISTS: a Systematic Review and a Meta-Analysis of the Literature,Blood,2010,,https://experts.mcmaster.ca/display/publication440616,2025-07-27T15:03:35.874569
Mark Crowther,josips1@mcmaster.ca,conferences,Central Statistical Monitoring Of An International Thromboprophylaxis Trial,American Journal of Respiratory and Critical Care Medicine,2010,10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a6041,https://experts.mcmaster.ca/display/publication211405,2025-07-27T15:03:35.874570
Mark Crowther,josips1@mcmaster.ca,conferences,Neither Red Blood Cell Transfusion Nor Age Of Blood Predict Deep Vein Thrombosis In Medical-Surgical Critically Ill Patients,C44. CARDIOPULMONARY INTERACTIONS AND NON-PULMONARY CRITICAL CARE,2010,10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a4556,https://experts.mcmaster.ca/display/publication2135277,2025-07-27T15:03:35.874572
Mark Crowther,josips1@mcmaster.ca,conferences,Weight loss is still a problem with reduced intensity conditioning transplants and modern supportive care,British Journal of Haematology,2010,,https://experts.mcmaster.ca/display/publication1599910,2025-07-27T15:03:35.874573
Mark Crowther,josips1@mcmaster.ca,conferences,A Cohort Study of Warfarin Administered to Achieve An INR of 2.0 to 3.0 for the Prevention of Recurrent Venous Thrombosis in Patients with An Antiphospholipid Antibody,Blood,2009,,https://experts.mcmaster.ca/display/publication440669,2025-07-27T15:03:35.874574
Mark Crowther,josips1@mcmaster.ca,conferences,A Multifaceted Strategy to Reduce Inappropriate Use of Fresh Frozen Plasma Transfusions in the Intensive Care Unit.,Blood,2009,,https://experts.mcmaster.ca/display/publication218342,2025-07-27T15:03:35.874575
Mark Crowther,josips1@mcmaster.ca,conferences,"Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the ""Men Continue and HERDOO2"" Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE).",Blood,2009,,https://experts.mcmaster.ca/display/publication440671,2025-07-27T15:03:35.874577
Mark Crowther,josips1@mcmaster.ca,conferences,Inter-Rater Reliability of the 4Ts Scoring System for Diagnosing Heparin-Induced Thrombocytopenia in Critically III Patients,Blood,2009,,https://experts.mcmaster.ca/display/publication440673,2025-07-27T15:03:35.874578
Mark Crowther,josips1@mcmaster.ca,conferences,Passive Transfer of Hepatitis B Core Antibody by Intravenous Immune Globulin-in Patients with Immune Thrombocytopenic Purpura,Blood,2009,,https://experts.mcmaster.ca/display/publication440679,2025-07-27T15:03:35.874579
Mark Crowther,josips1@mcmaster.ca,conferences,"Post-Thrombotic Syndrome (PTS) in Children: A Systematic Review of Prevalence, Validity of Outcome Measures, and Prognostic Factors",Blood,2009,,https://experts.mcmaster.ca/display/publication440657,2025-07-27T15:03:35.874580
Mark Crowther,josips1@mcmaster.ca,conferences,Alignment to prophylaxis guidelines and occurrence of venous thromboembolism after total hip and knee replacement,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3302688,2025-07-27T15:03:35.874582
Mark Crowther,josips1@mcmaster.ca,conferences,Burden of illness of venous thromboembolism after total hip and knee replacement in Canada,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3302687,2025-07-27T15:03:35.874583
Mark Crowther,josips1@mcmaster.ca,conferences,CHOP DELETION DOES NOT MITIGATE THE PHENOTYPE OF THE P0 R98C MOUSE MODEL OF EARLY-ONSET CMT 1 B,Journal of the Peripheral Nervous System,2009,,https://experts.mcmaster.ca/display/publication1599919,2025-07-27T15:03:35.874584
Mark Crowther,josips1@mcmaster.ca,conferences,Evaluating the feasibility of less frequent INR testing during chronic anticoagulation therapy,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3303254,2025-07-27T15:03:35.874586
Mark Crowther,josips1@mcmaster.ca,conferences,Hemorrhage in acute care setting is a risk factor for later venous thromboembolism in rehabilitation unit,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3303255,2025-07-27T15:03:35.874587
Mark Crowther,josips1@mcmaster.ca,conferences,Incidence and predictors of serious bleeding following polypectomy in patients receiving and not receiving oral anticoagulation therapy,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3303253,2025-07-27T15:03:35.874588
Mark Crowther,josips1@mcmaster.ca,conferences,JAK2V617F mutation for the early diagnosis of Ph-myeloproliferative neoplasms in patients with venous thromboembolism. a meta-analysis,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3303252,2025-07-27T15:03:35.874590
Mark Crowther,josips1@mcmaster.ca,conferences,Low-intensity adjusted-dose warfarin for the prevention of mechanical malfunction of doublelumen haemodialysis catheters: a randomized controlled trial,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3302896,2025-07-27T15:03:35.874591
Mark Crowther,josips1@mcmaster.ca,conferences,Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents,Journal of Thrombosis and Haemostasis,2009,10.1111/j.1538-7836.2009.03429.x,https://experts.mcmaster.ca/display/publication440753,2025-07-27T15:03:35.874592
Mark Crowther,josips1@mcmaster.ca,conferences,Natural history of mesenteric venous thrombosis in patients treated with oral anticoagulants,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3303251,2025-07-27T15:03:35.874594
Mark Crowther,josips1@mcmaster.ca,conferences,Validation of a diagnostic approach to exclude recurrent venous thromboembolism,Journal of Thrombosis and Haemostasis,2009,,https://experts.mcmaster.ca/display/publication3302686,2025-07-27T15:03:35.874595
Mark Crowther,josips1@mcmaster.ca,conferences,Myelin Structural Integrity in a Model for Human Early-Onset CMT1B,Biophysical Journal,2009,10.1016/j.bpj.2008.12.2371,https://experts.mcmaster.ca/display/publication1599916,2025-07-27T15:03:35.874596
Mark Crowther,josips1@mcmaster.ca,conferences,O8 Predicting DVT in pregnancy: out in “left” field?,Thrombosis Research,2009,10.1016/s0049-3848(09)70033-7,https://experts.mcmaster.ca/display/publication752393,2025-07-27T15:03:35.874598
Mark Crowther,josips1@mcmaster.ca,conferences,Alignment to ACCP Prophylaxis Guidelines and VTE Outcomes in THR and TKR Patients,Blood,2008,,https://experts.mcmaster.ca/display/publication440833,2025-07-27T15:03:35.874599
Mark Crowther,josips1@mcmaster.ca,conferences,Natural History of Mesenteric Venous Thrombosis: A Large Multicentre Study,Blood,2008,,https://experts.mcmaster.ca/display/publication440829,2025-07-27T15:03:35.874600
Mark Crowther,josips1@mcmaster.ca,conferences,The Efficacy of H. pylori Eradication Therapy in H. pylori-Infected and Uninfected Patients with Immune Thrombocytopenic Purpura: A Systematic Review,Blood,2008,,https://experts.mcmaster.ca/display/publication440813,2025-07-27T15:03:35.874602
Mark Crowther,josips1@mcmaster.ca,conferences,The Impact of Deep Vein Thrombosis on Outcomes in Critically III Patients: A Systematic Review and Meta-Analysis,Blood,2008,,https://experts.mcmaster.ca/display/publication218343,2025-07-27T15:03:35.874603
Mark Crowther,josips1@mcmaster.ca,conferences,THE IMPACT OF DEEP VEIN THROMBOSISON ON OUTCOMES IN CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS,Haematologica,2008,,https://experts.mcmaster.ca/display/publication1679471,2025-07-27T15:03:35.874604
Mark Crowther,josips1@mcmaster.ca,conferences,THE IMPACT OF DEEP VEIN THROMBOSISON ON OUTCOMES IN CRITICALLY ILL PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS,Haematologica,2008,,https://experts.mcmaster.ca/display/publication218311,2025-07-27T15:03:35.874606
Mark Crowther,josips1@mcmaster.ca,conferences,Thromboembolic Consequences of Subtherapeutic Anticoagulation in Patients Stabilized on Warfarin Therapy: The Low INR Study,Pharmacotherapy,2008,10.1592/phco.28.8.960,https://experts.mcmaster.ca/display/publication439943,2025-07-27T15:03:35.874607
Mark Crowther,josips1@mcmaster.ca,conferences,Nurse practioners improve compliance with venous thromboembolism prophylaxis in hospitalized heart failure patients at St. Joseph's Regional Medical Center,Circulation,2008,,https://experts.mcmaster.ca/display/publication439935,2025-07-27T15:03:35.874608
Mark Crowther,josips1@mcmaster.ca,conferences,Differential effects of systems that generate reactive oxygen species on PNS myelin,Journal of Neurochemistry,2008,,https://experts.mcmaster.ca/display/publication1599900,2025-07-27T15:03:35.874610
Mark Crowther,josips1@mcmaster.ca,conferences,Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin,Journal of Thrombosis and Thrombolysis,2008,10.1007/s11239-007-0138-1,https://experts.mcmaster.ca/display/publication1392541,2025-07-27T15:03:35.874611
Mark Crowther,josips1@mcmaster.ca,conferences,The clinical consequence of subtherapeutic anticoagulation: the low INR study (LINeRS),Journal of Thrombosis and Thrombolysis,2008,10.1007/s11239-007-0113-x,https://experts.mcmaster.ca/display/publication1521015,2025-07-27T15:03:35.874612
Mark Crowther,josips1@mcmaster.ca,conferences,Attributable morbidity and mortality of DVT,Critical Care Medicine,2007,,https://experts.mcmaster.ca/display/publication218259,2025-07-27T15:03:35.874614
Mark Crowther,josips1@mcmaster.ca,conferences,Increased detection of myocardial infarction in critical illness using screening troponin and eggs,Critical Care Medicine,2007,,https://experts.mcmaster.ca/display/publication211392,2025-07-27T15:03:35.874615
Mark Crowther,josips1@mcmaster.ca,conferences,A negative D-dimer excludes recurrent deep vein thrombosis: Results of a multicentre management study.,Blood,2007,,https://experts.mcmaster.ca/display/publication439949,2025-07-27T15:03:35.874616
Mark Crowther,josips1@mcmaster.ca,conferences,Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.,Blood,2007,10.1182/blood.v110.11.304.304,https://experts.mcmaster.ca/display/publication194289,2025-07-27T15:03:35.874617
Mark Crowther,josips1@mcmaster.ca,conferences,Fibrinolytic Agents for Restoration of Central Venous Catheter Patency: A Systematic Review.,Blood,2007,10.1182/blood.v110.11.971.971,https://experts.mcmaster.ca/display/publication439967,2025-07-27T15:03:35.874619
Mark Crowther,josips1@mcmaster.ca,conferences,Evaluation of the CapillaryS 2 capillary electrophoresis system for hemoglobinopathy screening,International Journal of Laboratory Hematology,2007,,https://experts.mcmaster.ca/display/publication1520969,2025-07-27T15:03:35.874620
Mark Crowther,josips1@mcmaster.ca,conferences,Acute HIT should be considered when cardio-respiratory arrest follows line insertion and/or heparin administration,Scottish Medical Journal,2007,,https://experts.mcmaster.ca/display/publication1599902,2025-07-27T15:03:35.874621
Mark Crowther,josips1@mcmaster.ca,conferences,PO-44 Incidence of venous thromboembolism in patients undergoing thoracotomy for cancer,Thrombosis Research,2007,10.1016/s0049-3848(07)70197-4,https://experts.mcmaster.ca/display/publication1520966,2025-07-27T15:03:35.874623
Mark Crowther,josips1@mcmaster.ca,conferences,FRESH FROZEN PLASMA TRANSFUSION IN THE CRITICALLY ILL.,Critical Care Medicine,2006,10.1097/00003246-200612002-00038,https://experts.mcmaster.ca/display/publication218270,2025-07-27T15:03:35.874624
Mark Crowther,josips1@mcmaster.ca,conferences,A Multicentre Trial of the Effectiveness of ζ Globin Enzyme Linked Immunosorbent Assay (ELISA) and Hb H Inclusion Body Screening for the Detection of α Thalassemia Trait.,Blood,2006,10.1182/blood.v108.11.1597.1597,https://experts.mcmaster.ca/display/publication439955,2025-07-27T15:03:35.874625
Mark Crowther,josips1@mcmaster.ca,conferences,Evaluation of the CapillaryS 2 CE System for Hemoglobinopathy Investigations.,Blood,2006,10.1182/blood.v108.11.3781.3781,https://experts.mcmaster.ca/display/publication439927,2025-07-27T15:03:35.874627
Mark Crowther,josips1@mcmaster.ca,conferences,Safety and efficacy of anti-fibrinolytics in orthopedic surgery: A meta analysis of randomized trials.,Blood,2006,,https://experts.mcmaster.ca/display/publication439931,2025-07-27T15:03:35.874628
Mark Crowther,josips1@mcmaster.ca,conferences,The management of anticoagulated patients requiring dental extraction: A cross-sectional survey of oral surgeons and hematologists.,Blood,2006,,https://experts.mcmaster.ca/display/publication668188,2025-07-27T15:03:35.874629
Mark Crowther,josips1@mcmaster.ca,conferences,Transmission of Chromosomally Integrated HHV6 by Allogeneic Peripheral Blood Stem Cell Transplantation Associated with the Development of a Fatal Macrophage Activation (Haemophagocytic) Syndrome.,Blood,2006,10.1182/blood.v108.11.5278.5278,https://experts.mcmaster.ca/display/publication1599901,2025-07-27T15:03:35.874631
Mark Crowther,josips1@mcmaster.ca,conferences,Unexpected harmful side effects triggered by immune modulation.,Blood,2006,,https://experts.mcmaster.ca/display/publication439939,2025-07-27T15:03:35.874632
Mark Crowther,josips1@mcmaster.ca,conferences,Use of therapeutic dose low molecular weight heparin in patients with renal insufficiency: Analysis of anti-Xa levels and creatinine clearance.,Blood,2006,,https://experts.mcmaster.ca/display/publication668190,2025-07-27T15:03:35.874633
Mark Crowther,josips1@mcmaster.ca,conferences,Postpartum management of women at increased risk of thrombosis results of a Canadian pilot survey.,Arthritis and Rheumatism,2006,,https://experts.mcmaster.ca/display/publication1520981,2025-07-27T15:03:35.874635
Mark Crowther,josips1@mcmaster.ca,conferences,Results from the HepASA trial: Low molecular weight heparin plus ASA vs ASA only for recurrent pregnancy loss.,Arthritis and Rheumatism,2006,,https://experts.mcmaster.ca/display/publication1350157,2025-07-27T15:03:35.874636
Mark Crowther,josips1@mcmaster.ca,conferences,New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management,Seminars in Hematology,2006,10.1053/j.seminhematol.2005.11.023,https://experts.mcmaster.ca/display/publication440141,2025-07-27T15:03:35.874637
Mark Crowther,josips1@mcmaster.ca,conferences,A prospective cohort study of the epidemiology of symptomatic venous thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis.,Blood,2005,,https://experts.mcmaster.ca/display/publication440117,2025-07-27T15:03:35.874638
Mark Crowther,josips1@mcmaster.ca,conferences,Anti-Xa levels and renal function: Analysis of the first 32 patients in the tinzaparin in renal insufficiency for venous thromboembolism study,Blood,2005,,https://experts.mcmaster.ca/display/publication440759,2025-07-27T15:03:35.874640
Mark Crowther,josips1@mcmaster.ca,conferences,Low molecular weight heparin and bleeding in patients with severe renal failure: A meta-analysis,Blood,2005,,https://experts.mcmaster.ca/display/publication440744,2025-07-27T15:03:35.874641
Mark Crowther,josips1@mcmaster.ca,conferences,Rituximab for the treatment of adults with ITP: A systematic review,Blood,2005,,https://experts.mcmaster.ca/display/publication440135,2025-07-27T15:03:35.874642
Mark Crowther,josips1@mcmaster.ca,conferences,"Trends in AIDS-Associated Cancers among Patients Attending a Palliative Care Service in Uganda in the ’Pre-HAART’ Era, 1994–2002.",Blood,2005,10.1182/blood.v106.11.4654.4654,https://experts.mcmaster.ca/display/publication440145,2025-07-27T15:03:35.874643
Mark Crowther,josips1@mcmaster.ca,conferences,Use of low dose oral vitamin K in the treatment of patients with INR values of more than 10.0.,Blood,2005,,https://experts.mcmaster.ca/display/publication440127,2025-07-27T15:03:35.874645
Mark Crowther,josips1@mcmaster.ca,conferences,I. Grades of recommendations and the levels of evidence,Journal des Maladies Vasculaires,2005,,https://experts.mcmaster.ca/display/publication1748203,2025-07-27T15:03:35.874646
Mark Crowther,josips1@mcmaster.ca,conferences,A prospective cohort study of the epidemiology of symptomatic venous thromboembolism (VTE) after isolated leg fractures distal to the knee without thromboprophylaxis.,Blood,2004,,https://experts.mcmaster.ca/display/publication440115,2025-07-27T15:03:35.874647
Mark Crowther,josips1@mcmaster.ca,conferences,Anti-Xa levels in critically ill patients receiving dalteparin for thromboprophylaxis.,Blood,2004,,https://experts.mcmaster.ca/display/publication1263412,2025-07-27T15:03:35.874648
Mark Crowther,josips1@mcmaster.ca,conferences,Comparison of compression ultrasound vs ascending contrast venography for proximal DVT in medical-surgical ICU patients.,Blood,2004,,https://experts.mcmaster.ca/display/publication218310,2025-07-27T15:03:35.874650
Mark Crowther,josips1@mcmaster.ca,conferences,PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT): A Pilot Study.,Blood,2004,10.1182/blood.v104.11.1784.1784,https://experts.mcmaster.ca/display/publication218373,2025-07-27T15:03:35.874651
Mark Crowther,josips1@mcmaster.ca,conferences,Platelet Transfusions in a Medical- Surgical Intensive Care Unit.,Blood,2004,10.1182/blood.v104.11.3637.3637,https://experts.mcmaster.ca/display/publication218253,2025-07-27T15:03:35.874652
Mark Crowther,josips1@mcmaster.ca,conferences,Prevalence and Incidence of Arterial and Venous Thrombosis in Critically Ill Patients.,Blood,2004,10.1182/blood.v104.11.2201.2201,https://experts.mcmaster.ca/display/publication218246,2025-07-27T15:03:35.874653
Mark Crowther,josips1@mcmaster.ca,conferences,Safety and Efficacy of Low Molecular Weight Heparins for Hemodialysis in Patients with End-Stage Renal Disease: A Meta-Analysis of Randomized Trials.,Blood,2004,10.1182/blood.v104.11.1778.1778,https://experts.mcmaster.ca/display/publication218242,2025-07-27T15:03:35.874655
Mark Crowther,josips1@mcmaster.ca,conferences,Safety and efficacy of venous thromboembolism prophylaxis with low molecular weight heparin in hospitalised patients with acute medical illness and renal failure.,Blood,2004,,https://experts.mcmaster.ca/display/publication440213,2025-07-27T15:03:35.874656
Mark Crowther,josips1@mcmaster.ca,conferences,Significant Differences in Neutralization of Heparin and Its Low Molecular Fragments by Protamine Sulfate: An In Vivo Study.,Blood,2004,10.1182/blood.v104.11.1850.1850,https://experts.mcmaster.ca/display/publication440129,2025-07-27T15:03:35.874657
Mark Crowther,josips1@mcmaster.ca,conferences,The Safety of Co-Administered Low-Molecular-Weight Heparin and Continuous Epidural Analgesia after Major Orthopedic Surgery: Assessment of a Standardized Management Protocol.,Blood,2004,10.1182/blood.v104.11.704.704,https://experts.mcmaster.ca/display/publication1520963,2025-07-27T15:03:35.874659
Mark Crowther,josips1@mcmaster.ca,conferences,The risk of hemorrhage and the frequency of vitamin K use in asymptomatic patients with warfarin-associated coagulopathy.,Blood,2004,,https://experts.mcmaster.ca/display/publication440107,2025-07-27T15:03:35.874660
Mark Crowther,josips1@mcmaster.ca,conferences,Screening results for 847 women attending a recurrent pregnancy loss clinic.,Arthritis and Rheumatism,2004,,https://experts.mcmaster.ca/display/publication440177,2025-07-27T15:03:35.874661
Mark Crowther,josips1@mcmaster.ca,conferences,Are brand-name and generic warfarin interchangeable?,Clinical Pharmacology and Therapeutics,2004,10.1016/j.clpt.2003.11.103,https://experts.mcmaster.ca/display/publication440301,2025-07-27T15:03:35.874663
Mark Crowther,josips1@mcmaster.ca,conferences,Anticoagulant therapy for the thrombotic complications of the antiphospholipid antibody syndrome,Thrombosis Research,2004,10.1016/j.thromres.2004.06.011,https://experts.mcmaster.ca/display/publication440199,2025-07-27T15:03:35.874664
Mark Crowther,josips1@mcmaster.ca,conferences,Optimal therapy of patients with antiphospholipid antibodies and thrombosis: The next steps,Thrombosis Research,2004,,https://experts.mcmaster.ca/display/publication440191,2025-07-27T15:03:35.874666
Mark Crowther,josips1@mcmaster.ca,conferences,Heparin-induced thrombocytopenia in medical-surgical ICU patients,Critical Care Medicine,2003,,https://experts.mcmaster.ca/display/publication218262,2025-07-27T15:03:35.874667
Mark Crowther,josips1@mcmaster.ca,conferences,A paper-based warfarin algorithm for maintenance of anticoagulation within an INR range of 2.0 to 3.0,Blood,2003,,https://experts.mcmaster.ca/display/publication440291,2025-07-27T15:03:35.874668
Mark Crowther,josips1@mcmaster.ca,conferences,Periprocedural anticoagulation for patients with mechnical heart valves: A survey of 324 clinicians.,Blood,2003,,https://experts.mcmaster.ca/display/publication440322,2025-07-27T15:03:35.874669
Mark Crowther,josips1@mcmaster.ca,conferences,Periprocedural anticoagulation in patients with mechanical heart valves: An international survey of expert clinicians.,Blood,2003,,https://experts.mcmaster.ca/display/publication440307,2025-07-27T15:03:35.874671
Mark Crowther,josips1@mcmaster.ca,conferences,Prevalence and predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis: Results from a randomized trial comparing two intensities of anticoagulation.,Blood,2003,,https://experts.mcmaster.ca/display/publication440299,2025-07-27T15:03:35.874672
Mark Crowther,josips1@mcmaster.ca,conferences,Red blood cell transfusion practices in a teaching hospital intensive care unit - Has the TRICC trial changed our standard of care?,Blood,2003,,https://experts.mcmaster.ca/display/publication440311,2025-07-27T15:03:35.874673
Mark Crowther,josips1@mcmaster.ca,conferences,The percentage of hemoglobin Barts as a predictor for the alpha thalassemia genotype in cord blood samples.,Blood,2003,,https://experts.mcmaster.ca/display/publication440381,2025-07-27T15:03:35.874675
Mark Crowther,josips1@mcmaster.ca,conferences,Video laparoscopic surgery: Is the out-of-hospital thromboprophylaxis necessary?,Blood,2003,,https://experts.mcmaster.ca/display/publication440313,2025-07-27T15:03:35.874676
Mark Crowther,josips1@mcmaster.ca,conferences,"Cardiac disease, vascular disease and medication use in patients with chronic renal insufficiency referred to nephrologists.",Journal of the American Society of Nephrology,2003,,https://experts.mcmaster.ca/display/publication438722,2025-07-27T15:03:35.874677
Mark Crowther,josips1@mcmaster.ca,conferences,Metabolic complications in patients with chronic renal insufficiency referred to nephrologists.,Journal of the American Society of Nephrology,2003,,https://experts.mcmaster.ca/display/publication438718,2025-07-27T15:03:35.874678
Mark Crowther,josips1@mcmaster.ca,conferences,Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy,Journal of Thrombosis and Thrombolysis,2003,10.1023/b:thro.0000014597.87575.e9,https://experts.mcmaster.ca/display/publication440346,2025-07-27T15:03:35.874680
Mark Crowther,josips1@mcmaster.ca,conferences,CALCULATED CREATININE CLEARANCE IN ICU PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN: AN INTER-RATER RELIABILITY STUDY,Critical Care Medicine,2002,10.1097/00003246-200212001-00526,https://experts.mcmaster.ca/display/publication218261,2025-07-27T15:03:35.875222
Mark Crowther,josips1@mcmaster.ca,conferences,DOPPLER COMPRESSION ULTRASOUND OF THE LOWER EXTREMITIES IN ICU PATIENTS: AN INTER-RATER RELIABILITY STUDY,Critical Care Medicine,2002,10.1097/00003246-200212001-00265,https://experts.mcmaster.ca/display/publication218252,2025-07-27T15:03:35.875239
Mark Crowther,josips1@mcmaster.ca,conferences,RELATIONSHIP BETWEEN TROUGH ANTI-XA LEVELS AND CALCULATED CREATININE CLEARANCE IN ICU PATIENTS RECEIVING LOW MOLECULAR WEIGHT HEPARIN,Critical Care Medicine,2002,10.1097/00003246-200212001-00527,https://experts.mcmaster.ca/display/publication218240,2025-07-27T15:03:35.875242
Mark Crowther,josips1@mcmaster.ca,conferences,A randomized trial of two intensities of warfarin (international normalized ratio of 2.0 to 3.0 versus 3.1 to 4.0) for the prevention of recurrent thrombosis in patients with antiphospholipid antibodies.,Blood,2002,,https://experts.mcmaster.ca/display/publication440615,2025-07-27T15:03:35.875246
Mark Crowther,josips1@mcmaster.ca,conferences,An assessment of APTT heparin therapeutic reference intervals in Ontario,Blood,2002,,https://experts.mcmaster.ca/display/publication1599907,2025-07-27T15:03:35.875249
Mark Crowther,josips1@mcmaster.ca,conferences,Case-fatality for major bleeding and intracranial hemorrhage in patients with venous thromboembolism on long-term oral anticoagulant therapy: A systematic review.,Blood,2002,,https://experts.mcmaster.ca/display/publication440621,2025-07-27T15:03:35.875252
Mark Crowther,josips1@mcmaster.ca,conferences,Diagnosis of deep vein thrombosis during pregnancy: A pilot study evaluating the role of D-dimer and compression leg ultrasound during pregnancy.,Blood,2002,,https://experts.mcmaster.ca/display/publication440626,2025-07-27T15:03:35.875256
Mark Crowther,josips1@mcmaster.ca,conferences,Low-intensity (INR 1.5-1.9) versus conventional-intensity (INR 2.0-3.0) anticoagulation for extended treatment of unprovoked VTE: A randomized double blind trial.,Blood,2002,,https://experts.mcmaster.ca/display/publication440643,2025-07-27T15:03:35.875259
Mark Crowther,josips1@mcmaster.ca,conferences,Variation of APTT EQA results obtained with various combinations of coagulation instruments and APTT reagents,Blood,2002,,https://experts.mcmaster.ca/display/publication1599908,2025-07-27T15:03:35.875645
Mark Crowther,josips1@mcmaster.ca,conferences,Employing a validated assessment tool to evaluate interactions of warfarin with drugs and food.,Clinical Pharmacology and Therapeutics,2002,,https://experts.mcmaster.ca/display/publication1375733,2025-07-27T15:03:35.875648
Mark Crowther,josips1@mcmaster.ca,conferences,"Twice daily enoxaparin, but not once daily dalteparin, is associated with elevated anti-factor Xa heparin levels at the time of epidural catheter removal.",Blood,2001,,https://experts.mcmaster.ca/display/publication440746,2025-07-27T15:03:35.875650
Mark Crowther,josips1@mcmaster.ca,conferences,Effectiveness of reconstituted and then frozen tPA for dysfunctional percutaneous dialysis catheters.,Blood,2000,,https://experts.mcmaster.ca/display/publication440881,2025-07-27T15:03:35.875652
Mark Crowther,josips1@mcmaster.ca,conferences,Factor V Leiden and arterial ischemic stroke in children: A meta-analysis.,Blood,2000,,https://experts.mcmaster.ca/display/publication440890,2025-07-27T15:03:35.875654
Mark Crowther,josips1@mcmaster.ca,conferences,Sulfate density of the low molecular weight heparins determine their protamine neutralizability.,Blood,2000,,https://experts.mcmaster.ca/display/publication440899,2025-07-27T15:03:35.875655
Mark Crowther,josips1@mcmaster.ca,conferences,Treatment of excessive anticoagulation due to warfarin with oral vitamin K: A randomized controlled trial.,Blood,2000,,https://experts.mcmaster.ca/display/publication440884,2025-07-27T15:03:35.875657
Mark Crowther,josips1@mcmaster.ca,conferences,Use of vitamin K to reverse warfarin-induced excessive anticoagulation: A survey of current practice habits.,Blood,2000,,https://experts.mcmaster.ca/display/publication440900,2025-07-27T15:03:35.875659
Mark Crowther,josips1@mcmaster.ca,conferences,Incomplete neutralization of low molecular weight heparin by protamine is due to decreased binding affinity,Pediatric Research,2000,,https://experts.mcmaster.ca/display/publication440223,2025-07-27T15:03:35.875660
Mark Crowther,josips1@mcmaster.ca,conferences,Pharmacokinetic Profile of a Low-Molecular Weight Heparin (Reviparin) in Pregnant Patients,Thrombosis Research,2000,10.1016/s0049-3848(99)00228-5,https://experts.mcmaster.ca/display/publication440897,2025-07-27T15:03:35.875700
Mark Crowther,josips1@mcmaster.ca,conferences,An interim analysis to improve precision of warfarin anticoagulation control in a randomized clinical trial.,Blood,1999,,https://experts.mcmaster.ca/display/publication1520968,2025-07-27T15:03:35.875705
Mark Crowther,josips1@mcmaster.ca,conferences,Assessment of a xi-globin enzyme-linked immuno-sorbent assay (ELISA) for the detection of alpha-thalassemia trait.,Blood,1999,,https://experts.mcmaster.ca/display/publication1520977,2025-07-27T15:03:35.875707
Mark Crowther,josips1@mcmaster.ca,conferences,In vitro assessment of hemostasis by the PFA-100 (TM): Direct comparison to bleeding in vivo in a rabbit ear bleeding model.,Blood,1999,,https://experts.mcmaster.ca/display/publication1520979,2025-07-27T15:03:35.875708
Mark Crowther,josips1@mcmaster.ca,conferences,Stabilty and sterility of recombinant tissue plasminogen activator under-39 degrees C.,Blood,1999,,https://experts.mcmaster.ca/display/publication455271,2025-07-27T15:03:35.875710
Mark Crowther,josips1@mcmaster.ca,conferences,Incomplete neutralization of low molecular weight heparin by protamine results from decreased binding affinity,Thrombosis and Haemostasis,1999,,https://experts.mcmaster.ca/display/publication440624,2025-07-27T15:03:35.875712
Mark Crowther,josips1@mcmaster.ca,conferences,Abnormal fibrinolysis does not predispose to first or recurrent thromboembolism.,Blood,1998,,https://experts.mcmaster.ca/display/publication440962,2025-07-27T15:03:35.875713
Mark Crowther,josips1@mcmaster.ca,conferences,Effects of low-intensity warfarin on coagulation activation in patients with antiphospholipid antibodies and systemic lupus erythematosus.,Blood,1998,,https://experts.mcmaster.ca/display/publication1283986,2025-07-27T15:03:35.875808
Mark Crowther,josips1@mcmaster.ca,conferences,Bone density results in women treated with low molecular weight heparin (LMWH) in pregnancy,Arthritis and Rheumatism,1997,,https://experts.mcmaster.ca/display/publication1374228,2025-07-27T15:03:35.875812
Mark Crowther,josips1@mcmaster.ca,conferences,Low molecular weight heparin (LMWH) and ASA therapy in women with autoantibodies and unexplained recurrent fetal loss (U-RFL).,Arthritis and Rheumatism,1997,,https://experts.mcmaster.ca/display/publication1374219,2025-07-27T15:03:35.875814
Mark Crowther,josips1@mcmaster.ca,conferences,A randomized comparison of a 5 mg and 10 mg loading dose for the initiation of warfarin therapy,Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication440958,2025-07-27T15:03:35.875816
Mark Crowther,josips1@mcmaster.ca,conferences,Alternative method for detecting APC resistance (APCR) in patients receiving warfarin (W),Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication1374222,2025-07-27T15:03:35.875818
Mark Crowther,josips1@mcmaster.ca,conferences,Comparison of 3 assays for the measurement of activated protein C resistance (APCR),Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication1374220,2025-07-27T15:03:35.875819
Mark Crowther,josips1@mcmaster.ca,conferences,Comparison of 3 assays for the measurement of activated protein C resistance (APCR).,Clinical Chemistry,1997,,https://experts.mcmaster.ca/display/publication1374216,2025-07-27T15:03:35.875821
Mark Crowther,josips1@mcmaster.ca,conferences,Diagnosis of a first dvt in outpatients: Interim analysis of a management based on clinical evaluation and D-dimer (SimpliRED(TM)) results,Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication191186,2025-07-27T15:03:35.875822
Mark Crowther,josips1@mcmaster.ca,conferences,Relationship of factor V Leiden genotype to risk of acute deep vein thrombosis following joint replacement surgery,Thrombosis and Haemostasis,1997,,https://experts.mcmaster.ca/display/publication440966,2025-07-27T15:03:35.875824
Mark Crowther,josips1@mcmaster.ca,conferences,Low-dose oral vitamin K for the reversal of warfarin associated coagulopathy,Blood,1996,,https://experts.mcmaster.ca/display/publication440938,2025-07-27T15:03:35.875826
Mark Crowther,josips1@mcmaster.ca,conferences,Activated protein C resistance is not associated with postoperative deep vein thrombosis in patients undergoing hip or knee surgery.,Blood,1995,,https://experts.mcmaster.ca/display/publication440942,2025-07-27T15:03:35.875839
Mark Crowther,josips1@mcmaster.ca,conferences,Splenectomy reduces the frequency of relapse in patients with chronic relapsing TTP.,Blood,1995,,https://experts.mcmaster.ca/display/publication440944,2025-07-27T15:03:35.875841
Mark Crowther,josips1@mcmaster.ca,conferences,USE OF VARIOUS INDEXES IN POPULATION-BASED SCREENING FOR THALASSEMIA - UTILITY OF THE MEAN CORPUSCULAR VOLUME,Blood,1994,,https://experts.mcmaster.ca/display/publication440948,2025-07-27T15:03:35.875842
Mark Crowther,josips1@mcmaster.ca,other,Evidence‐Based Hematology,,2008,10.1002/9781444300857,https://experts.mcmaster.ca/display/publication1749653,2025-07-27T15:03:35.875845
Mark Crowther,josips1@mcmaster.ca,preprints,Assessing use of surrogate outcome measures in randomized controlled trials investigating venous thromboembolism prophylaxis,,2022,10.21203/rs.3.rs-1582705/v1,https://experts.mcmaster.ca/display/publication3235727,2025-07-27T15:03:35.875846
Mark Crowther,josips1@mcmaster.ca,preprints,Restrictive Versus Liberal Transfusion for Anemic Patients with Acute Myocardial Infarction: Systematic Review and Meta-Analysis,,2022,10.2139/ssrn.4133630,https://experts.mcmaster.ca/display/publication3235726,2025-07-27T15:03:35.875848
